# Transformational Epicenter
## Global Investment Platform â€” Technical Plan v2.0

**"Bringing the lost travelers home to gardens of their hearts and souls"**

---

## The Vision for This Platform

This is not a property comparison tool. This is the **definitive digital pitch experience** for a $1 trillion market opportunity â€” a platform that tells the complete story of Transformational Epicenter, from vision to execution, from Mexico to 30 locations worldwide.

**When an investor or partner opens this platform, they should feel:**
- The magnitude of the opportunity
- The sophistication of the strategy
- The depth of the research
- The clarity of the execution path
- An irresistible pull to be part of something transformational

---

## Platform Architecture: The Story Flow

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                    THE TRANSFORMATIONAL EPICENTER                           â”‚
â”‚                         INVESTMENT PLATFORM                                 â”‚
â”‚                                                                             â”‚
â”‚                   16 SECTIONS â€” ZERO UNANSWERED QUESTIONS                   â”‚
â”‚                                                                             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                                             â”‚
â”‚  ROW 1: THE OPPORTUNITY                                                     â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”     â”‚
â”‚  â”‚  1. VISION  â”‚ â†’ â”‚  2. MARKET  â”‚ â†’ â”‚  3. MODEL   â”‚ â†’ â”‚ 4. EXPANSIONâ”‚     â”‚
â”‚  â”‚  The Why    â”‚   â”‚ The Gap     â”‚   â”‚ The How     â”‚   â”‚ The Where   â”‚     â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â”‚
â”‚                                                                             â”‚
â”‚  ROW 2: THE ASSETS                                                          â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”     â”‚
â”‚  â”‚5. PROPERTIESâ”‚ â†’ â”‚6. FINANCIALSâ”‚ â†’ â”‚   7. TEAM   â”‚ â†’ â”‚  8. RISKS   â”‚     â”‚
â”‚  â”‚ First Sites â”‚   â”‚ The Numbers â”‚   â”‚ The Who     â”‚   â”‚ Mitigations â”‚     â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â”‚
â”‚                                                                             â”‚
â”‚  ROW 3: THE PROTECTION                                                      â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”     â”‚
â”‚  â”‚  9. MOAT    â”‚ â†’ â”‚ 10. EXIT    â”‚ â†’ â”‚11. TIMELINE â”‚ â†’ â”‚ 12. LEGAL   â”‚     â”‚
â”‚  â”‚ Defensibilityâ”‚   â”‚ Returns     â”‚   â”‚ Milestones  â”‚   â”‚ Compliance  â”‚     â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â”‚
â”‚                                                                             â”‚
â”‚  ROW 4: THE PROOF                                                           â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”     â”‚
â”‚  â”‚13. OUTCOMES â”‚ â†’ â”‚14. DATA ROOMâ”‚ â†’ â”‚  15. FAQ    â”‚ â†’ â”‚ 16. INVEST  â”‚     â”‚
â”‚  â”‚ Measurement â”‚   â”‚ Due Diligenceâ”‚   â”‚ All Answers â”‚   â”‚ Join Us     â”‚     â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## Section-by-Section Breakdown

### Section 1: THE VISION (`/`)
**Purpose:** Hook them in 10 seconds. Make them feel the problem. Show them the solution.

#### Hero Experience
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                    [CINEMATIC VIDEO BACKGROUND]                             â”‚
â”‚              Ocean. Jungle. Healing. Transformation.                        â”‚
â”‚                                                                             â”‚
â”‚                                                                             â”‚
â”‚          "The world's most successful people are breaking.                  â”‚
â”‚                                                                             â”‚
â”‚           They've tried therapy. Retreats. Biohacking.                      â”‚
â”‚           Nothing sticks. Nothing heals at the root.                        â”‚
â”‚                                                                             â”‚
â”‚           We're building the place that does."                              â”‚
â”‚                                                                             â”‚
â”‚                                                                             â”‚
â”‚                    TRANSFORMATIONAL EPICENTER                               â”‚
â”‚                                                                             â”‚
â”‚           Medical Rigor. Luxury Care. Deep Transformation.                  â”‚
â”‚                      30 Locations Worldwide.                                â”‚
â”‚                                                                             â”‚
â”‚                      [ EXPLORE THE OPPORTUNITY ]                            â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### The Problem Statement
**Scrolling narrative with parallax imagery:**

> Modern humans suffer from a crisis of disconnection.
> From their bodies. Their nervous systems. Their purpose. Their essential nature.
>
> The most successful people on earth are the most broken.
> They have everything â€” except peace.

#### The Failed Solutions (Interactive Cards)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  MEDICAL CLINICS â”‚  â”‚  LUXURY RESORTS  â”‚  â”‚  BIOHACKING      â”‚  â”‚  PLANT MEDICINE  â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                  â”‚  â”‚                  â”‚  â”‚                  â”‚  â”‚                  â”‚
â”‚  Treat symptoms  â”‚  â”‚  Temporary       â”‚  â”‚  Transactional   â”‚  â”‚  No integration  â”‚
â”‚  Not root causes â”‚  â”‚  escape          â”‚  â”‚  not transform-  â”‚  â”‚  No medical      â”‚
â”‚                  â”‚  â”‚  Not transform-  â”‚  â”‚  ational         â”‚  â”‚  oversight       â”‚
â”‚                  â”‚  â”‚  ation           â”‚  â”‚                  â”‚  â”‚                  â”‚
â”‚      âŒ          â”‚  â”‚       âŒ          â”‚  â”‚       âŒ         â”‚  â”‚       âŒ          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### The Solution (Reveal)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                    WHAT IF ONE PLACE UNIFIED ALL FOUR?                      â”‚
â”‚                                                                             â”‚
â”‚                                                                             â”‚
â”‚    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚    â”‚  MEDICAL    â”‚   â”‚   LUXURY    â”‚   â”‚   BIO-OPT   â”‚   â”‚   PLANT     â”‚   â”‚
â”‚    â”‚   RIGOR     â”‚ + â”‚   CARE      â”‚ + â”‚   TECH      â”‚ + â”‚  MEDICINE   â”‚   â”‚
â”‚    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                                             â”‚
â”‚                              = THE EPICENTER                                â”‚
â”‚                                                                             â”‚
â”‚         The only destination where all four pillars meet.                   â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Foundational Beliefs (Scrolling Manifesto)
1. Healing happens at the root
2. The body keeps the score
3. Safety creates surrender
4. Medicine is a catalyst, not a destination
5. Luxury is love made material
6. Transformation requires a continuum
7. Community sustains change

---

### Section 2: THE MARKET (`/market`)
**Purpose:** Prove the opportunity is massive. Show the gap no one else is filling.

#### Market Size Hero
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                              $5.6 TRILLION                                  â”‚
â”‚                        Global Wellness Economy                              â”‚
â”‚                                                                             â”‚
â”‚              â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”               â”‚
â”‚              â”‚                                             â”‚               â”‚
â”‚              â”‚     $1.1T                                   â”‚               â”‚
â”‚              â”‚     ADDRESSABLE                             â”‚               â”‚
â”‚              â”‚     â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                       â”‚               â”‚
â”‚              â”‚     Our combined market                     â”‚               â”‚
â”‚              â”‚                                             â”‚               â”‚
â”‚              â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜               â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Four Markets, One Gap (Interactive Visualization)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                            â”‚
â”‚   LUXURY WELLNESS          MEDICAL/LONGEVITY      BIOHACKING              â”‚
â”‚      $850B-1.1T              $27-33B               $24-33B                 â”‚
â”‚      7-10% CAGR              12-15% CAGR           18-22% CAGR             â”‚
â”‚                                                                            â”‚
â”‚                    PLANT MEDICINE & PSYCHEDELICS                           â”‚
â”‚                            $3-5B                                           â”‚
â”‚                          15-20% CAGR                                       â”‚
â”‚                                                                            â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   â”‚                                                                    â”‚  â”‚
â”‚   â”‚                         THE GAP                                    â”‚  â”‚
â”‚   â”‚                                                                    â”‚  â”‚
â”‚   â”‚    NONE of these markets offer all four pillars together.         â”‚  â”‚
â”‚   â”‚    That's the category we're creating.                            â”‚  â”‚
â”‚   â”‚                                                                    â”‚  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### The Customer (Animated Profile)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                        THE TRANSFORMATIONAL GUEST                           â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                                                          â”‚
â”‚   â”‚             â”‚   "I've achieved everything I set out to.                â”‚
â”‚   â”‚   [AVATAR]  â”‚    And I've never felt more lost."                       â”‚
â”‚   â”‚             â”‚                                                          â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                  â”‚
â”‚                                                                             â”‚
â”‚   â€¢ High-functioning executives, entrepreneurs, creators                    â”‚
â”‚   â€¢ Ages 40-55, UHNW/HNW ($10M+ net worth)                                 â”‚
â”‚   â€¢ Exhausted from constant performance                                     â”‚
â”‚   â€¢ Carrying trauma, stress, burnout affecting everything                   â”‚
â”‚   â€¢ Tried therapy, meditation, retreats â€” nothing stuck                    â”‚
â”‚   â€¢ Willing to invest $50,000-$150,000+ for real transformation            â”‚
â”‚                                                                             â”‚
â”‚                    THEY DON'T NEED ANOTHER RETREAT.                        â”‚
â”‚                    THEY NEED TO COME HOME TO THEMSELVES.                   â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Why Competitors Can't Copy This (Animated Reveal)
| Competitor Type | Why They Won't Integrate |
|-----------------|--------------------------|
| **Medical Clinics** (Clinique La Prairie, SHA) | Won't touch plant medicine â€” regulatory & brand risk |
| **Luxury Resorts** (Aman, Six Senses) | Lack medical expertise and clinical infrastructure |
| **Plant Medicine Centers** (Beond, Rythmia) | Can't attract luxury talent or afford medical rigor |
| **Biohacking Centers** (Upgrade Labs) | Wrong model â€” transactional, not transformational |

**The punchline:** We're not competing. We're creating the category.

---

### Section 3: THE MODEL (`/model`)
**Purpose:** Show exactly how this works. The 8 segments. The guest journey. The programs.

#### The Eight Operational Segments (Interactive Wheel)
```
                              MEDICAL OVERSIGHT
                                    â¬†
                                    â”‚
         PRE-CARE â†â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â†’ POST-CARE
              â†–                    â”‚                    â†—
               â•²                   â”‚                   â•±
                â•²                  â”‚                  â•±
    DIGITAL      â•²        â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â•±     PLANT
    ECOSYSTEM â”€â”€â”€â”€â•²â”€â”€â”€â”€â”€â”€â–¶â”‚               â”‚â—€â”€â”€â”€â”€â”€â”€â•±â”€â”€â”€â”€â”€ MEDICINE
                   â•²      â”‚  THE GUEST    â”‚      â•±
                    â•²     â”‚               â”‚     â•±
                     â•²    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â•±
                      â•²          â”‚            â•±
                       â•²         â”‚           â•±
                        â•²        â”‚          â•±
                         â†˜       â–¼         â†™
               BIO-OPTIMIZATION    TRAUMA INTEGRATION
                         â†˜                 â†™
                          â†˜       â”‚       â†™
                           â†˜      â–¼      â†™
                            HOSPITALITY
```

**Each segment expands on click:**

**Segment 1: Medical & Scientific Oversight**
- Full medical team on-site 24/7
- Hospital-grade monitoring
- Cardiac screening (critical for plant medicine)
- Outcome tracking with validated scales

**Segment 2: Plant Medicine (Iboga & Ibogaine)**
- Trauma-informed, ethically held ceremonies
- Physicians present during experiences
- Months of preparation + integration
- Legal in Mexico, Portugal, South Africa

**Segment 3: Advanced Bio-Optimization**
- Hyperbaric oxygen therapy
- IV therapy, cryotherapy
- Neurofeedback, red light therapy
- Personalized protocols

**Segment 4: Trauma Integration**
- Polyvagal framework
- Somatic Experiencing, EMDR, TRE
- Daily integration structure
- Personalized facilitator support

**Segment 5: Five-Star Hospitality**
- Private villas (3:1 staff ratio)
- Michelin-quality functional cuisine
- Daily therapeutic massage
- Every detail says "you matter"

**Segment 6: Digital Ecosystem**
- HIPAA-compliant AI system
- Community platform
- Biometric integration
- Lifetime alumni access

**Segment 7: Pre-Care (4-8 weeks)**
- Medical screening
- Nervous system preparation
- Intention setting
- Digital onboarding

**Segment 8: Post-Care (3-12+ months)**
- Structured integration
- Coaching & group calls
- Life restructuring support
- Continued community

#### The Guest Journey (Animated Timeline)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   AWAKENING          IMMERSION           INTEGRATION        EMBODIMENT     â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€          â”€â”€â”€â”€â”€â”€â”€â”€â”€           â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€        â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€     â”‚
â”‚   Pre-Retreat        On-Site             Post-Retreat       Lifetime       â”‚
â”‚   4-8 weeks          7-28 days           3-12 months        Ongoing        â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”       â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”         â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚   â”‚ Prepare â”‚ â”€â”€â”€â”€â–¶ â”‚Transformâ”‚ â”€â”€â”€â”€â”€â”€â–¶ â”‚Integrateâ”‚ â”€â”€â”€â”€â”€â–¶ â”‚  Live   â”‚    â”‚
â”‚   â”‚         â”‚       â”‚         â”‚         â”‚         â”‚        â”‚         â”‚    â”‚
â”‚   â”‚â€¢ Screen â”‚       â”‚â€¢ Heal   â”‚         â”‚â€¢ Anchor â”‚        â”‚â€¢ Alumni â”‚    â”‚
â”‚   â”‚â€¢ Ready  â”‚       â”‚â€¢ Reset  â”‚         â”‚â€¢ Grow   â”‚        â”‚â€¢ Return â”‚    â”‚
â”‚   â”‚â€¢ Intend â”‚       â”‚â€¢ Open   â”‚         â”‚â€¢ Apply  â”‚        â”‚â€¢ Mentor â”‚    â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜       â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜         â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚                                                                             â”‚
â”‚        THIS IS NOT A RETREAT. IT'S A FULL-ARC TRANSFORMATION.              â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Program Offerings (Interactive Pricing Cards)
```
Base Rate: $2,000/day (All-Inclusive)

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚     RESET      â”‚  â”‚  INTERRUPTION  â”‚  â”‚ RECALIBRATION  â”‚  â”‚ TRANSFORMATION â”‚
â”‚    7 days      â”‚  â”‚    14 days     â”‚  â”‚    21 days     â”‚  â”‚    28 days     â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚                â”‚  â”‚                â”‚  â”‚                â”‚  â”‚                â”‚
â”‚    $14,000     â”‚  â”‚    $28,000     â”‚  â”‚    $42,000     â”‚  â”‚    $56,000     â”‚
â”‚                â”‚  â”‚                â”‚  â”‚                â”‚  â”‚                â”‚
â”‚   First-timers â”‚  â”‚  â˜… MOST       â”‚  â”‚  Comprehensive â”‚  â”‚  Complete arc  â”‚
â”‚   Busy execs   â”‚  â”‚    POPULAR     â”‚  â”‚  Full reset    â”‚  â”‚  Major life    â”‚
â”‚   NS reset     â”‚  â”‚  Deep work     â”‚  â”‚                â”‚  â”‚  transitions   â”‚
â”‚                â”‚  â”‚                â”‚  â”‚                â”‚  â”‚                â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

What's Included:
âœ“ Private villa accommodations       âœ“ All bio-optimization modalities
âœ“ Michelin-quality functional meals  âœ“ Daily therapeutic massage
âœ“ Medical oversight 24/7             âœ“ Post-care program (by duration)
âœ“ All therapeutic sessions           âœ“ Lifetime app & community access
```

---

### Section 4: GLOBAL EXPANSION (`/expansion`)
**Purpose:** Show this isn't one property â€” it's 30 locations worldwide. Make them see the scale.

#### Hero: The Global Vision
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                         30 EPICENTERS WORLDWIDE                             â”‚
â”‚                              by Year 10                                     â”‚
â”‚                                                                             â”‚
â”‚                        â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                             â”‚
â”‚                        â”‚                     â”‚                             â”‚
â”‚                        â”‚  [INTERACTIVE 3D    â”‚                             â”‚
â”‚                        â”‚   ROTATING GLOBE    â”‚                             â”‚
â”‚                        â”‚   with location     â”‚                             â”‚
â”‚                        â”‚   markers]          â”‚                             â”‚
â”‚                        â”‚                     â”‚                             â”‚
â”‚                        â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                             â”‚
â”‚                                                                             â”‚
â”‚                    Click any location to explore â†’                         â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Expansion Timeline (Animated Roadmap)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   YEAR 1              YEAR 2              YEAR 3-4           YEAR 5-10     â”‚
â”‚   â”€â”€â”€â”€â”€â”€              â”€â”€â”€â”€â”€â”€              â”€â”€â”€â”€â”€â”€â”€â”€           â”€â”€â”€â”€â”€â”€â”€â”€â”€     â”‚
â”‚   FOUNDATION          OPTIMIZATION        EXPANSION          NETWORK       â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”         â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚   â”‚    1    â”‚        â”‚    1    â”‚         â”‚   3-5   â”‚        â”‚   30+   â”‚   â”‚
â”‚   â”‚ Mexico  â”‚ â”€â”€â”€â”€â”€â–¶ â”‚ Refined â”‚ â”€â”€â”€â”€â”€â”€â–¶ â”‚ Europe  â”‚ â”€â”€â”€â”€â”€â–¶ â”‚ Global  â”‚   â”‚
â”‚   â”‚Flagship â”‚        â”‚Protocolsâ”‚         â”‚ Asia    â”‚        â”‚ Network â”‚   â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜         â”‚ Americasâ”‚        â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                          â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                       â”‚
â”‚                                                                             â”‚
â”‚   â€¢ Launch Quintana  â€¢ Data-driven      â€¢ Regional hubs    â€¢ 30+ locations â”‚
â”‚     Roo flagship       refinement       â€¢ Training academy â€¢ Research inst â”‚
â”‚   â€¢ Establish        â€¢ Build             â€¢ Licensing model â€¢ Category      â”‚
â”‚     protocols          reputation       â€¢ Partnerships       leadership   â”‚
â”‚   â€¢ Platform MVP     â€¢ Expansion                                           â”‚
â”‚                        playbook                                            â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Global Location Tiers (Interactive Map)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   TIER 1: FLAGSHIP LOCATIONS                    Score    Status            â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€           â”‚
â”‚   ğŸ‡²ğŸ‡½ Quintana Roo, Mexico                      94/100   ACTIVE            â”‚
â”‚   ğŸ‡µğŸ‡¹ Alentejo, Portugal                        86/100   PLANNED           â”‚
â”‚   ğŸ‡¿ğŸ‡¦ Cape Town, South Africa                   82/100   PLANNED           â”‚
â”‚                                                                             â”‚
â”‚   TIER 2: REGIONAL HUBS (Years 1-2)                                        â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€           â”‚
â”‚   ğŸ‡²ğŸ‡½ Baja California, Mexico                   87/100                     â”‚
â”‚   ğŸ‡¯ğŸ‡² Montego Bay, Jamaica                      85/100   Psilocybin LEGAL  â”‚
â”‚   ğŸ‡§ğŸ‡¸ The Bahamas                               84/100   Multi-modality    â”‚
â”‚   ğŸ‡¨ğŸ‡· Guanacaste, Costa Rica                    83/100   Ayahuasca option  â”‚
â”‚   ğŸ‡¸ğŸ‡¬ Singapore                                 83/100   No plant medicine â”‚
â”‚   ğŸ‡³ğŸ‡± Amsterdam, Netherlands                    82/100   Legal psilocybin  â”‚
â”‚   ğŸ‡¹ğŸ‡­ Koh Samui, Thailand                       81/100   Medical tourism   â”‚
â”‚                                                                             â”‚
â”‚   TIER 3: SATELLITE LOCATIONS (Years 2-4)                                  â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€           â”‚
â”‚   St. Vincent â€¢ Cayman Islands â€¢ Peru â€¢ Brazil â€¢ New Zealand               â”‚
â”‚   Bali â€¢ Canada BC â€¢ Spain Ibiza â€¢ Morocco â€¢ UAE Dubai                     â”‚
â”‚   Australia Byron Bay â€¢ Japan Okinawa                                      â”‚
â”‚                                                                             â”‚
â”‚   TIER 4: GLOBAL EXPANSION (Years 4-10)                                    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€           â”‚
â”‚   Switzerland â€¢ Maldives â€¢ Czech Republic â€¢ Antigua â€¢ Turkey               â”‚
â”‚   Seychelles â€¢ Fiji â€¢ + 10 more locations                                  â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Regulatory Landscape (Interactive Legend)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   MEDICINE LEGALITY BY REGION                                              â”‚
â”‚                                                                             â”‚
â”‚   â— IBOGAINE LEGAL                                                         â”‚
â”‚     Mexico, Portugal (decrim), South Africa, Bahamas, St. Vincent          â”‚
â”‚                                                                             â”‚
â”‚   â— PSILOCYBIN LEGAL                                                       â”‚
â”‚     Jamaica (LEGAL), Netherlands (truffles), Australia (research)          â”‚
â”‚                                                                             â”‚
â”‚   â— AYAHUASCA ACCESSIBLE                                                   â”‚
â”‚     Peru (legal), Costa Rica (grey), Portugal (grey)                       â”‚
â”‚                                                                             â”‚
â”‚   â— BIO-OPTIMIZATION ONLY                                                  â”‚
â”‚     Singapore, Dubai, Switzerland (premium longevity market)               â”‚
â”‚                                                                             â”‚
â”‚   This multi-jurisdictional strategy creates regulatory resilience.        â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Section 5: MEXICO PROPERTIES (`/properties`)
**Purpose:** Deep dive into the first locations we're evaluating. The 4 Quintana Roo properties.

#### Section Header
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                    QUINTANA ROO, MEXICO                                     â”‚
â”‚                    First Epicenter Location                                 â”‚
â”‚                                                                             â”‚
â”‚   Why Mexico First:                                                         â”‚
â”‚   â€¢ Ibogaine legal and established                                         â”‚
â”‚   â€¢ 2-4 hour flight from major US cities                                   â”‚
â”‚   â€¢ Strong medical infrastructure (Galenia Hospital)                       â”‚
â”‚   â€¢ Proven luxury wellness market                                          â”‚
â”‚   â€¢ Regulatory clarity                                                     â”‚
â”‚                                                                             â”‚
â”‚   We've evaluated 4 properties. Here's what we found.                      â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Portfolio Summary (Visual Grid) â€” Data from Google Sheets Model
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”     â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”              â”‚
â”‚   â”‚                         â”‚     â”‚                         â”‚              â”‚
â”‚   â”‚    HOTEL ALEA TULUM     â”‚     â”‚    HACIENDA CARACOL     â”‚              â”‚
â”‚   â”‚    â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚     â”‚    â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚              â”‚
â”‚   â”‚    ğŸ“ BahÃ­a de SolimÃ¡n  â”‚     â”‚    ğŸ“ Soliman Bay       â”‚              â”‚
â”‚   â”‚    ğŸ’° $6.4M asking      â”‚     â”‚    ğŸ’° $4.9M asking      â”‚              â”‚
â”‚   â”‚    ğŸ›ï¸ 21 rooms (17 beds)â”‚     â”‚    ğŸ›ï¸ 10 rooms (8 beds) â”‚              â”‚
â”‚   â”‚    ğŸ“Š 75/100            â”‚     â”‚    ğŸ“Š 76/100            â”‚              â”‚
â”‚   â”‚    ğŸ’µ $19.04M total     â”‚     â”‚    ğŸ’µ $13.91M total     â”‚              â”‚
â”‚   â”‚    ğŸ“ˆ 29.54% IRR        â”‚     â”‚    ğŸ“ˆ 18% IRR           â”‚              â”‚
â”‚   â”‚    ğŸ¯ HNW Market        â”‚     â”‚    ğŸ¯ U-HNW Market      â”‚              â”‚
â”‚   â”‚    ğŸ’ $62.1M 5yr rev    â”‚     â”‚    ğŸ’ $32.3M 5yr rev    â”‚              â”‚
â”‚   â”‚                         â”‚     â”‚                         â”‚              â”‚
â”‚   â”‚    âœ… SHORTLIST         â”‚     â”‚    â¸ï¸ HOLD              â”‚              â”‚
â”‚   â”‚    (Top Candidate)      â”‚     â”‚    (Pending Medical)    â”‚              â”‚
â”‚   â”‚                         â”‚     â”‚                         â”‚              â”‚
â”‚   â”‚    [VIEW CUT SHEET â†’]   â”‚     â”‚    [VIEW CUT SHEET â†’]   â”‚              â”‚
â”‚   â”‚                         â”‚     â”‚                         â”‚              â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜              â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”     â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”              â”‚
â”‚   â”‚                         â”‚     â”‚                         â”‚              â”‚
â”‚   â”‚   MINI HOTEL CANCÃšN     â”‚     â”‚   CASA SUEÃ‘O DE MAR     â”‚              â”‚
â”‚   â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚     â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚              â”‚
â”‚   â”‚   ğŸ“ CancÃºn, Q.R.       â”‚     â”‚   ğŸ“ Akumal/Tulum CC    â”‚              â”‚
â”‚   â”‚   ğŸ’° $1.1M asking       â”‚     â”‚   ğŸ’° $3.99M asking      â”‚              â”‚
â”‚   â”‚   ğŸ›ï¸ 20 rooms (16 beds) â”‚     â”‚   ğŸ›ï¸ 7 rooms (6 beds)   â”‚              â”‚
â”‚   â”‚   ğŸ“Š 79/100             â”‚     â”‚   ğŸ“Š 66/100             â”‚              â”‚
â”‚   â”‚   ğŸ’µ $10.52M total      â”‚     â”‚   ğŸ’µ $11.48M total      â”‚              â”‚
â”‚   â”‚   ğŸ“ˆ -15% IRR           â”‚     â”‚   ğŸ“ˆ 2% IRR             â”‚              â”‚
â”‚   â”‚   ğŸ¯ HNW Market         â”‚     â”‚   ğŸ¯ HNW Market         â”‚              â”‚
â”‚   â”‚   âš ï¸ Brand mismatch     â”‚     â”‚   âš ï¸ Zoning blocked     â”‚              â”‚
â”‚   â”‚                         â”‚     â”‚                         â”‚              â”‚
â”‚   â”‚   âŒ PASS               â”‚     â”‚   âŒ PASS               â”‚              â”‚
â”‚   â”‚   (Urban Location)      â”‚     â”‚   (Residential Zoning)  â”‚              â”‚
â”‚   â”‚                         â”‚     â”‚                         â”‚              â”‚
â”‚   â”‚   [VIEW ANALYSIS â†’]     â”‚     â”‚   [VIEW ANALYSIS â†’]     â”‚              â”‚
â”‚   â”‚                         â”‚     â”‚                         â”‚              â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜              â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Quick Comparison Matrix (Synced from Google Sheets Model)
| Metric | Hotel Alea | Hacienda Caracol | Mini Hotel | Casa SueÃ±o |
|--------|------------|------------------|------------|------------|
| **Asking Price** | $6.4M | $4.9M | $1.1M | $3.99M |
| **Total Rooms** | 21 | 10 | 20 | 7 |
| **Usable Treatment Beds** | 17 | 8 | 16 | 6 |
| **Total Investment** | $19.04M | $13.91M | $10.52M | $11.48M |
| **Cost/Room** | $906,512 | $1,391,400 | $525,850 | $1,639,300 |
| **Target Market** | HNW | U-HNW | HNW | HNW |
| **Avg Daily Rate** | $2,321 | $3,157 | $2,321 | $2,321 |
| **Avg Rev/Guest** | $39,457 | $53,669 | $39,457 | $39,457 |
| **5-Year IRR (Base)** | 29.54% | 18% | -15% | 2% |
| **MOIC (Base)** | 2.61x | 1.85x | 0.65x | 1.05x |
| **Y5 Revenue (Base)** | $15.3M | $7.9M | N/A | N/A |
| **5-Year Revenue** | $62.1M | $32.3M | N/A | N/A |
| **Score** | 75/100 | 76/100 | 79/100 | 66/100 |
| **Verdict** | âœ… SHORTLIST | â¸ï¸ HOLD | âŒ PASS | âŒ PASS |

#### Individual Property Cut Sheets (`/properties/[slug]`)

Each property gets a comprehensive cut sheet (see Section 10 for full spec):
- Property overview with gallery
- Pass/fail gate visualization
- Radar chart scoring
- Financial projections
- Strengths/concerns/questions
- Verdict and next steps
- PDF/CSV export

---

### Section 6: FINANCIALS (`/financials`)
**Purpose:** Show the numbers. Unit economics. Projections. Investment returns.

#### Key Metrics Hero
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚              $30K              70%               $5.1M             29%+     â”‚
â”‚         â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€       â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€       â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€       â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚          Avg Revenue       Target            Y2 Revenue        Base Case   â”‚
â”‚          Per Guest         Occupancy         (10 rooms)        IRR         â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### 5-Year Projections (Interactive Chart)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   REVENUE TRAJECTORY                                                        â”‚
â”‚                                                                             â”‚
â”‚   $15M â”¤                                              â–² $15.1M (Alea)      â”‚
â”‚        â”‚                                           â•±                        â”‚
â”‚   $12M â”¤                                        â•±                          â”‚
â”‚        â”‚                                     â•±                              â”‚
â”‚   $10M â”¤                                  â•±                                â”‚
â”‚        â”‚                               â•±                                    â”‚
â”‚    $8M â”¤                            â•±                                      â”‚
â”‚        â”‚                         â•±                                          â”‚
â”‚    $6M â”¤                      â•±                         â–² $5.9M (Hacienda) â”‚
â”‚        â”‚                   â•±                         â•±                      â”‚
â”‚    $4M â”¤                â•±                         â•±                        â”‚
â”‚        â”‚             â•±                         â•±                            â”‚
â”‚    $2M â”¤          â•±                         â•±                              â”‚
â”‚        â”‚       â•±                         â•±                                  â”‚
â”‚    $0M â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚            Y1       Y2       Y3       Y4       Y5                          â”‚
â”‚                                                                             â”‚
â”‚   [Toggle: Conservative / Base / Aggressive]                                â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Investment Strategy Comparison
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   SINGLE VS DUAL PROPERTY STRATEGY                                          â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   OPTION A: Hotel Alea Only              OPTION B: Dual Strategy   â”‚  â”‚
â”‚   â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                 â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€     â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   Total Investment: $19.0M               Total: $32.9M             â”‚  â”‚
â”‚   â”‚   Rooms: 21                              Rooms: 31                  â”‚  â”‚
â”‚   â”‚   Y5 Revenue: $15.1M                     Y5 Revenue: $21.0M        â”‚  â”‚
â”‚   â”‚   5-Year IRR: 28.51%                     Blended IRR: ~29%         â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   âœ… Lower capital requirement           âœ… Tier diversification    â”‚  â”‚
â”‚   â”‚   âœ… Faster to profitability             âœ… HNW + UHNW markets     â”‚  â”‚
â”‚   â”‚   âš ï¸ Single point of failure            âœ… Higher total return     â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Unit Economics Breakdown
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   UNIT ECONOMICS (Per Guest)                                                â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”      â”‚
â”‚   â”‚  REVENUE    â”‚  â”‚    CAC      â”‚  â”‚    LTV      â”‚  â”‚  PAYBACK    â”‚      â”‚
â”‚   â”‚  $30,000    â”‚  â”‚   $2,500    â”‚  â”‚  $45,000+   â”‚  â”‚  12 months  â”‚      â”‚
â”‚   â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚      â”‚
â”‚   â”‚  Avg 15-day â”‚  â”‚  Via        â”‚  â”‚  Return     â”‚  â”‚  First      â”‚      â”‚
â”‚   â”‚  program    â”‚  â”‚  referrals  â”‚  â”‚  visits +   â”‚  â”‚  customer   â”‚      â”‚
â”‚   â”‚             â”‚  â”‚             â”‚  â”‚  referrals  â”‚  â”‚  profitable â”‚      â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜      â”‚
â”‚                                                                             â”‚
â”‚   Break-even Occupancy: 42%                                                â”‚
â”‚   Target Occupancy Y2+: 70-85%                                             â”‚
â”‚   Target Referral Rate: 40%+ (ambassador program)                          â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Scenario Analysis (Interactive Toggle)
| Scenario | Occupancy | Revenue Y2 | 5-Year IRR | NPV |
|----------|-----------|------------|------------|-----|
| **Conservative** | 55% | $4.0M | 22.15% | $11.2M |
| **Base Case** | 70% | $5.1M | 28.51% | $15.8M |
| **Aggressive** | 85% | $6.2M | 38.42% | $21.4M |

#### Detailed Revenue Breakdown (Year 2 Base Case)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   ANNUAL REVENUE BY PROGRAM TYPE                                           â”‚
â”‚                                                                             â”‚
â”‚   Program          Guests/Yr   Avg Stay   Rate/Day   Revenue    % Mix     â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€     â”‚
â”‚   Reset (7d)           45        7d        $2,000    $630,000     12%     â”‚
â”‚   Interruption (14d)   85       14d        $2,000   $2,380,000    47%     â”‚
â”‚   Recalibration (21d)  35       21d        $2,000   $1,470,000    29%     â”‚
â”‚   Transformation (28d) 15       28d        $2,000     $840,000    16%     â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€     â”‚
â”‚   TOTAL              180 guests              â€”      $5,320,000   104%*    â”‚
â”‚                                                                             â”‚
â”‚   *Exceeds 100% due to add-ons, extensions, and follow-up programs         â”‚
â”‚                                                                             â”‚
â”‚   Additional Revenue Streams:                                              â”‚
â”‚   â€¢ Return visits (30% of guests):           $960,000                      â”‚
â”‚   â€¢ Add-on therapies:                        $180,000                      â”‚
â”‚   â€¢ Post-care coaching (50% uptake):         $270,000                      â”‚
â”‚   â€¢ Digital platform subscriptions:           $90,000                      â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€     â”‚
â”‚   TOTAL ANNUAL REVENUE (Y2):               $5,100,000                      â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Operating Expense Breakdown (Year 2)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   ANNUAL OPERATING EXPENSES                                                â”‚
â”‚                                                                             â”‚
â”‚   Category                    Amount        % Revenue    Notes             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   PERSONNEL (Total: $1.82M)                   36%                          â”‚
â”‚   â”œâ”€ Medical team (3 FTE)     $450,000         9%       Physicians, nurses â”‚
â”‚   â”œâ”€ Facilitators (4 FTE)     $320,000         6%       Integration team   â”‚
â”‚   â”œâ”€ Operations (8 FTE)       $480,000         9%       Hospitality staff  â”‚
â”‚   â”œâ”€ Management (3 FTE)       $390,000         8%       Leadership team    â”‚
â”‚   â””â”€ Benefits & payroll tax   $180,000         4%       35% loaded rate    â”‚
â”‚                                                                             â”‚
â”‚   FACILITY & OPERATIONS                        28%                         â”‚
â”‚   â”œâ”€ Food & beverage          $360,000         7%       Functional cuisine â”‚
â”‚   â”œâ”€ Utilities & maintenance  $180,000         4%       Property upkeep    â”‚
â”‚   â”œâ”€ Medical supplies         $140,000         3%       Medications, labs  â”‚
â”‚   â”œâ”€ Plant medicine sourcing  $120,000         2%       Ethical sourcing   â”‚
â”‚   â”œâ”€ Linens, amenities        $90,000          2%       Luxury standards   â”‚
â”‚   â””â”€ Property mgmt & security $250,000         5%       24/7 operations    â”‚
â”‚                                                                             â”‚
â”‚   TECHNOLOGY & SYSTEMS                          6%                         â”‚
â”‚   â”œâ”€ Platform hosting & dev   $150,000         3%       Digital ecosystem  â”‚
â”‚   â”œâ”€ Medical records (HIPAA)  $80,000          2%       Compliance systems â”‚
â”‚   â””â”€ CRM & analytics          $70,000          1%       Guest management   â”‚
â”‚                                                                             â”‚
â”‚   MARKETING & GROWTH                            8%                         â”‚
â”‚   â”œâ”€ Digital marketing        $200,000         4%       Content, ads       â”‚
â”‚   â”œâ”€ Ambassador commissions   $150,000         3%       2.5-10% referrals  â”‚
â”‚   â””â”€ Events & partnerships    $50,000          1%       Strategic outreach â”‚
â”‚                                                                             â”‚
â”‚   ADMINISTRATIVE                                7%                         â”‚
â”‚   â”œâ”€ Insurance (all types)    $180,000         4%       Liability, D&O     â”‚
â”‚   â”œâ”€ Legal & compliance       $100,000         2%       Regulatory counsel â”‚
â”‚   â””â”€ Accounting & finance     $75,000          1%       Professional fees  â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   TOTAL OPERATING EXPENSES:  $3,825,000        75%                         â”‚
â”‚   EBITDA:                    $1,275,000        25%                         â”‚
â”‚                                                                             â”‚
â”‚   Note: Excludes depreciation ($180k) and interest ($120k estimated)       â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### 5-Year Cash Flow Waterfall (Base Case)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   CASH FLOW PROJECTION (BASE CASE)                           All figures $Mâ”‚
â”‚                                                                             â”‚
â”‚                Y0        Y1        Y2        Y3        Y4        Y5         â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Revenue      â€”        1.8       5.1       8.2      12.1      15.1        â”‚
â”‚   OpEx         â€”       (2.1)     (3.8)     (5.7)     (8.2)    (10.1)       â”‚
â”‚   EBITDA       â€”       (0.3)      1.3       2.5       3.9       5.0        â”‚
â”‚                                                                             â”‚
â”‚   CapEx       (6.4)    (1.2)     (0.5)     (1.8)     (0.6)     (0.8)       â”‚
â”‚   D&A          â€”       (0.18)    (0.18)    (0.22)    (0.24)    (0.26)      â”‚
â”‚   Interest     â€”       (0.05)    (0.12)    (0.10)    (0.08)    (0.05)      â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Net Income  (6.4)    (1.7)      0.5       0.4       3.0       3.9        â”‚
â”‚                                                                             â”‚
â”‚   + D&A        â€”        0.18      0.18      0.22      0.24      0.26       â”‚
â”‚   - CapEx      6.4      1.2       0.5       1.8       0.6       0.8        â”‚
â”‚   Î” WC         â€”       (0.1)     (0.2)     (0.3)     (0.2)     (0.1)       â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   FCF         (6.4)    (1.6)      0.5       0.3       3.0       4.1        â”‚
â”‚                                                                             â”‚
â”‚   Cumulative  (6.4)    (8.0)     (7.5)     (7.2)     (4.2)     (0.1)       â”‚
â”‚   Cash                                                                      â”‚
â”‚                                                                             â”‚
â”‚   Status:   INVEST   RAMP-UP  BREAKEVEN   GROWTH    SCALE   PROFITABLE    â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Capitalization Table & Funding Rounds
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   FUNDING STRATEGY & CAP TABLE                                             â”‚
â”‚                                                                             â”‚
â”‚   SEED ROUND (Current Raise)                                               â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Amount:              $5,000,000                                          â”‚
â”‚   Pre-money Valuation: $15,000,000                                         â”‚
â”‚   Post-money:          $20,000,000                                         â”‚
â”‚   Dilution:            25%                                                 â”‚
â”‚   Instrument:          Preferred Equity (Series Seed)                      â”‚
â”‚                                                                             â”‚
â”‚   Use of Funds:                                                            â”‚
â”‚   â€¢ Property acquisition & renovation:      $2,500,000  (50%)              â”‚
â”‚   â€¢ Medical equipment & licensing:          $750,000    (15%)              â”‚
â”‚   â€¢ Platform development (MVP):             $1,000,000  (20%)              â”‚
â”‚   â€¢ Team (12-18 month runway):              $500,000    (10%)              â”‚
â”‚   â€¢ Working capital & operations:           $250,000    (5%)               â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   SERIES A (Planned - Month 18-24)                                         â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Amount:              $15-25,000,000                                      â”‚
â”‚   Target Valuation:    $60-80,000,000                                      â”‚
â”‚   Timing:              Q2 2027 (after cash flow positive)                  â”‚
â”‚   Purpose:             Second location + expansion infrastructure          â”‚
â”‚   Milestones Required:                                                     â”‚
â”‚   âœ“ Location 1 operational for 12+ months                                 â”‚
â”‚   âœ“ $5M+ annual revenue run rate                                          â”‚
â”‚   âœ“ 70%+ occupancy demonstrated                                           â”‚
â”‚   âœ“ 40%+ referral rate achieved                                           â”‚
â”‚   âœ“ Outcome data published (150+ guest dataset)                           â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   PRO FORMA CAP TABLE (Post-Seed)                                          â”‚
â”‚                                                                             â”‚
â”‚   Shareholder             Shares        %        Fully Diluted %           â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Founders                7,500,000    60.0%           52.5%               â”‚
â”‚   Employee Pool (ESOP)    1,250,000    10.0%            8.75%              â”‚
â”‚   Seed Investors          3,125,000    25.0%           21.875%             â”‚
â”‚   Series A (Future)       1,875,000     â€”              16.875%             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   TOTAL                  12,500,000   100.0%          100.0%               â”‚
â”‚                                                                             â”‚
â”‚   Founder Vesting: 4 years, 1-year cliff                                   â”‚
â”‚   ESOP Allocation: 15% fully diluted (top-up at Series A)                  â”‚
â”‚   Liquidation Preference: 1x non-participating (investor-friendly)         â”‚
â”‚   Board Structure: 2 founders, 2 investors, 1 independent (post-Series A)  â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Key Financial Assumptions
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   FINANCIAL MODEL ASSUMPTIONS                                              â”‚
â”‚                                                                             â”‚
â”‚   REVENUE DRIVERS                                                          â”‚
â”‚   â€¢ Average daily rate: $2,000/guest (all-inclusive)                       â”‚
â”‚   â€¢ Average stay: 15 days (weighted average across programs)               â”‚
â”‚   â€¢ Average revenue per guest: $30,000                                     â”‚
â”‚   â€¢ Target occupancy ramp: Y1: 35% â†’ Y2: 70% â†’ Y3+: 70-85%                â”‚
â”‚   â€¢ Referral rate: Y1: 20% â†’ Y2: 30% â†’ Y3+: 40%+                          â”‚
â”‚   â€¢ Return visit rate: 30% within 24 months                                â”‚
â”‚   â€¢ Price escalation: 3% annually (below inflation, market positioning)    â”‚
â”‚                                                                             â”‚
â”‚   COST ASSUMPTIONS                                                         â”‚
â”‚   â€¢ Labor: 36% of revenue (decreases to 32% at scale)                      â”‚
â”‚   â€¢ COGS (F&B, supplies): 15% of revenue                                   â”‚
â”‚   â€¢ Gross margin target: 60%+ (luxury wellness standard)                   â”‚
â”‚   â€¢ EBITDA margin: Y1: -17% â†’ Y2: 25% â†’ Y5: 33%                           â”‚
â”‚   â€¢ Customer acquisition cost: $2,500/guest (50% via referrals by Y3)      â”‚
â”‚                                                                             â”‚
â”‚   CAPITAL REQUIREMENTS                                                     â”‚
â”‚   â€¢ Initial CapEx (property + buildout): $6.4M                             â”‚
â”‚   â€¢ Annual maintenance CapEx: 3% of revenue                                â”‚
â”‚   â€¢ Technology development: $150k/year recurring                           â”‚
â”‚   â€¢ Working capital: 15 days of operating expenses                         â”‚
â”‚                                                                             â”‚
â”‚   RETURN METRICS (5-Year Hold)                                             â”‚
â”‚   â€¢ IRR: 28.51% (base case)                                                â”‚
â”‚   â€¢ MOIC: 2.61x                                                            â”‚
â”‚   â€¢ Exit multiple assumption: 6.5x EBITDA (conservative for category)     â”‚
â”‚   â€¢ Payback period: 3.2 years                                              â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Section 7: THE TEAM (`/team`)
**Purpose:** Show the people behind the vision. Build trust and credibility.

#### Founding Team

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   [PHOTO]                                                           â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   FOUNDER & EXECUTIVE CHAIRMAN                                      â”‚  â”‚
â”‚   â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   Background:                                                       â”‚  â”‚
â”‚   â”‚   â€¢ 15+ years building transformational wellness businesses        â”‚  â”‚
â”‚   â”‚   â€¢ Founded [Previous Venture] (exited 20XX)                       â”‚  â”‚
â”‚   â”‚   â€¢ Deep expertise in luxury hospitality operations                â”‚  â”‚
â”‚   â”‚   â€¢ Personal transformation through plant medicine (20XX)          â”‚  â”‚
â”‚   â”‚   â€¢ MBA from [University], BS in [Field]                           â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   Role:                                                             â”‚  â”‚
â”‚   â”‚   â€¢ Vision & strategic direction                                   â”‚  â”‚
â”‚   â”‚   â€¢ Investor relations & fundraising                               â”‚  â”‚
â”‚   â”‚   â€¢ Strategic partnerships & business development                  â”‚  â”‚
â”‚   â”‚   â€¢ Brand positioning & thought leadership                         â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   Why This Matters:                                                â”‚  â”‚
â”‚   â”‚   [Founder] brings proven entrepreneurial track record, industry   â”‚  â”‚
â”‚   â”‚   relationships, and deep personal understanding of the            â”‚  â”‚
â”‚   â”‚   transformational journey our guests seek.                        â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   [PHOTO]                                                           â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   CO-FOUNDER & CHIEF MEDICAL OFFICER (Search in Progress)          â”‚  â”‚
â”‚   â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   Target Profile:                                                   â”‚  â”‚
â”‚   â”‚   â€¢ Board-certified physician (MD or DO)                           â”‚  â”‚
â”‚   â”‚   â€¢ 10+ years clinical experience                                  â”‚  â”‚
â”‚   â”‚   â€¢ Expertise in integrative/functional medicine                   â”‚  â”‚
â”‚   â”‚   â€¢ Experience with psychedelic-assisted therapy or research       â”‚  â”‚
â”‚   â”‚   â€¢ Licensed in US + willingness to obtain Mexican license         â”‚  â”‚
â”‚   â”‚   â€¢ Passion for evidence-based transformation                      â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   Responsibilities:                                                 â”‚  â”‚
â”‚   â”‚   â€¢ Design and oversee all medical protocols                       â”‚  â”‚
â”‚   â”‚   â€¢ Ensure regulatory compliance and safety standards              â”‚  â”‚
â”‚   â”‚   â€¢ Build and manage medical team                                  â”‚  â”‚
â”‚   â”‚   â€¢ Develop outcome measurement systems                            â”‚  â”‚
â”‚   â”‚   â€¢ Liaise with hospital partners (Galenia, etc.)                  â”‚  â”‚
â”‚   â”‚   â€¢ Lead research and publication strategy                         â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   Candidates Under Consideration:                                  â”‚  â”‚
â”‚   â”‚   â€¢ Dr. [Name] - Integrative medicine physician, 15 yrs exp        â”‚  â”‚
â”‚   â”‚   â€¢ Dr. [Name] - Addiction medicine specialist, MAPS researcher    â”‚  â”‚
â”‚   â”‚   â€¢ Dr. [Name] - Functional medicine, luxury wellness background   â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   [PHOTO]                                                           â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   CO-FOUNDER & CHIEF TECHNOLOGY OFFICER (Search in Progress)       â”‚  â”‚
â”‚   â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   Target Profile:                                                   â”‚  â”‚
â”‚   â”‚   â€¢ 8+ years building consumer health technology                   â”‚  â”‚
â”‚   â”‚   â€¢ Experience with HIPAA-compliant systems                        â”‚  â”‚
â”‚   â”‚   â€¢ AI/ML expertise (personalization, outcome prediction)          â”‚  â”‚
â”‚   â”‚   â€¢ Product-minded technologist, not just engineer                 â”‚  â”‚
â”‚   â”‚   â€¢ Previous startup experience (ideally 0â†’1 builder)             â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   Responsibilities:                                                 â”‚  â”‚
â”‚   â”‚   â€¢ Build and lead digital platform (pre-care, on-site, post-care) â”‚  â”‚
â”‚   â”‚   â€¢ Design AI-powered personalization engine                       â”‚  â”‚
â”‚   â”‚   â€¢ Ensure data security and HIPAA compliance                      â”‚  â”‚
â”‚   â”‚   â€¢ Integrate biometric devices (Oura, Whoop, etc.)                â”‚  â”‚
â”‚   â”‚   â€¢ Scale technology infrastructure globally                       â”‚  â”‚
â”‚   â”‚   â€¢ Build engineering team (initially contractors, then FT)        â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Key Leadership Hires (Months 1-12)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   GENERAL MANAGER / COO                                     Priority: HIGH â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   Timing: Month 1-3                                                        â”‚
â”‚   Compensation: $120-150k + equity (0.5-1%)                                â”‚
â”‚                                                                             â”‚
â”‚   Profile:                                                                 â”‚
â”‚   â€¢ 10+ years luxury hospitality operations                                â”‚
â”‚   â€¢ Experience in boutique properties (10-30 rooms)                        â”‚
â”‚   â€¢ Bilingual (English/Spanish) required                                   â”‚
â”‚   â€¢ Mexico operational experience preferred                                â”‚
â”‚   â€¢ Guest service excellence obsession                                     â”‚
â”‚                                                                             â”‚
â”‚   Responsibilities:                                                         â”‚
â”‚   â€¢ Day-to-day operations of flagship location                             â”‚
â”‚   â€¢ Staff hiring, training, and management                                 â”‚
â”‚   â€¢ Vendor relationships and procurement                                   â”‚
â”‚   â€¢ Guest experience orchestration                                         â”‚
â”‚   â€¢ Financial management and reporting                                     â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   HEAD OF CLINICAL INTEGRATION                              Priority: HIGH â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   Timing: Month 2-4                                                        â”‚
â”‚   Compensation: $90-120k + equity (0.5%)                                   â”‚
â”‚                                                                             â”‚
â”‚   Profile:                                                                 â”‚
â”‚   â€¢ Licensed therapist (LMFT, LCSW, or PsyD)                               â”‚
â”‚   â€¢ 5+ years trauma-informed therapy experience                            â”‚
â”‚   â€¢ Training in Somatic Experiencing, EMDR, or IFS                         â”‚
â”‚   â€¢ Psychedelic integration experience (clinical or personal)              â”‚
â”‚   â€¢ Comfortable in non-traditional therapeutic setting                     â”‚
â”‚                                                                             â”‚
â”‚   Responsibilities:                                                         â”‚
â”‚   â€¢ Design integration protocols (pre-care through post-care)              â”‚
â”‚   â€¢ Train and supervise integration team                                   â”‚
â”‚   â€¢ 1:1 sessions with guests                                               â”‚
â”‚   â€¢ Develop curriculum and therapeutic frameworks                          â”‚
â”‚   â€¢ Measure and report clinical outcomes                                   â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   LEAD FACILITATOR / CEREMONIAL GUIDE                       Priority: HIGH â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   Timing: Month 3-5                                                        â”‚
â”‚   Compensation: $70-90k + equity (0.25%)                                   â”‚
â”‚                                                                             â”‚
â”‚   Profile:                                                                 â”‚
â”‚   â€¢ 5+ years facilitating plant medicine ceremonies                        â”‚
â”‚   â€¢ Trained by recognized lineage holder or institution                    â”‚
â”‚   â€¢ Deep understanding of set, setting, and trauma-informed holding        â”‚
â”‚   â€¢ Medical collaboration experience                                       â”‚
â”‚   â€¢ Cultural humility and ethical practice                                 â”‚
â”‚                                                                             â”‚
â”‚   Responsibilities:                                                         â”‚
â”‚   â€¢ Lead all plant medicine ceremonies                                     â”‚
â”‚   â€¢ Guest preparation and intention-setting                                â”‚
â”‚   â€¢ In-ceremony holding and guidance                                       â”‚
â”‚   â€¢ Immediate post-ceremony integration                                    â”‚
â”‚   â€¢ Train additional facilitators as we scale                              â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   MARKETING & GROWTH LEAD                                 Priority: MEDIUM â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   Timing: Month 4-6                                                        â”‚
â”‚   Compensation: $80-110k + equity (0.5%)                                   â”‚
â”‚                                                                             â”‚
â”‚   Profile:                                                                 â”‚
â”‚   â€¢ 7+ years marketing in wellness, hospitality, or luxury brands          â”‚
â”‚   â€¢ Deep understanding of UHNW/HNW customer psychology                     â”‚
â”‚   â€¢ Content creation and storytelling expertise                            â”‚
â”‚   â€¢ Performance marketing + brand building                                 â”‚
â”‚   â€¢ Experience with referral/ambassador programs                           â”‚
â”‚                                                                             â”‚
â”‚   Responsibilities:                                                         â”‚
â”‚   â€¢ Develop and execute go-to-market strategy                              â”‚
â”‚   â€¢ Build content marketing engine (blog, video, podcast)                  â”‚
â”‚   â€¢ Design and manage ambassador program                                   â”‚
â”‚   â€¢ Strategic partnerships (coaches, concierge docs, etc.)                 â”‚
â”‚   â€¢ Guest acquisition and conversion optimization                          â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Advisory Board Structure

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   ADVISORY BOARD (Being Assembled)                                         â”‚
â”‚                                                                             â”‚
â”‚   MEDICAL & CLINICAL ADVISORS                                              â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Dr. [Name] - Psychedelic research, MAPS protocol contributor          â”‚
â”‚   â€¢ Dr. [Name] - Integrative medicine, functional wellness                â”‚
â”‚   â€¢ Dr. [Name] - Addiction medicine, ibogaine specialist                  â”‚
â”‚   â€¢ [Name], PhD - Clinical psychology, trauma expert                      â”‚
â”‚                                                                             â”‚
â”‚   Role: Protocol review, medical oversight, research design, credibility   â”‚
â”‚   Compensation: Equity (0.1-0.25% each) + annual retainer ($10-25k)       â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   HOSPITALITY & OPERATIONS ADVISORS                                        â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ [Name] - Former GM, Aman Resorts (luxury operations)                  â”‚
â”‚   â€¢ [Name] - Six Senses wellness director (programming)                   â”‚
â”‚   â€¢ [Name] - Boutique hotel developer (property optimization)             â”‚
â”‚                                                                             â”‚
â”‚   Role: Operations best practices, luxury standards, guest experience      â”‚
â”‚   Compensation: Equity (0.1-0.2% each) + project fees                     â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   BUSINESS & FINANCE ADVISORS                                              â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ [Name] - Wellness industry PE investor                                â”‚
â”‚   â€¢ [Name] - Healthcare entrepreneur, 2 exits                             â”‚
â”‚   â€¢ [Name] - CFO, scaled wellness brand to $50M+                          â”‚
â”‚                                                                             â”‚
â”‚   Role: Strategic guidance, fundraising, M&A, financial planning           â”‚
â”‚   Compensation: Equity (0.15-0.3% each)                                   â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   REGULATORY & LEGAL ADVISORS                                              â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ [Law Firm] - Psychedelic policy and compliance                        â”‚
â”‚   â€¢ [Name] - Mexico regulatory consultant                                 â”‚
â”‚   â€¢ [Name] - Healthcare compliance attorney                               â”‚
â”‚                                                                             â”‚
â”‚   Role: Regulatory navigation, compliance, risk mitigation                 â”‚
â”‚   Compensation: Professional fees + success bonuses                        â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Organizational Development Roadmap

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   TEAM SCALING PLAN                                                        â”‚
â”‚                                                                             â”‚
â”‚   YEAR 1 (MONTHS 1-12)                         Target Headcount: 18-22    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Q1: Founding team + GM + Medical Director                               â”‚
â”‚   Q2: Clinical team (3), Hospitality staff (6), Facilitator (1)           â”‚
â”‚   Q3: Marketing lead, Operations manager, Tech contractors (3)             â”‚
â”‚   Q4: Additional clinical staff (2), Customer success (1)                  â”‚
â”‚                                                                             â”‚
â”‚   Burn Rate: ~$150k/month fully loaded                                     â”‚
â”‚   Seed funding covers: 18+ months of runway                                â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   YEAR 2 (MONTHS 13-24)                        Target Headcount: 28-32    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Scale hospitality team to support 70% occupancy                        â”‚
â”‚   â€¢ Add second facilitator                                                 â”‚
â”‚   â€¢ Hire VP of Expansion Planning (Series A prep)                          â”‚
â”‚   â€¢ Build out platform engineering team (3-4 engineers)                    â”‚
â”‚   â€¢ Add finance/accounting manager                                         â”‚
â”‚                                                                             â”‚
â”‚   Cash Flow Positive: Month 18-20 (projected)                              â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   YEAR 3+ (EXPANSION PHASE)                    Target Headcount: 60-80    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Centralized HQ team (finance, legal, marketing, tech)                  â”‚
â”‚   â€¢ Location 2 operational team (18-22 people)                             â”‚
â”‚   â€¢ Training academy staff (3-5 people)                                    â”‚
â”‚   â€¢ Research & outcomes team (2-3 people)                                  â”‚
â”‚   â€¢ Business development for expansion (2-3 people)                        â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Talent Acquisition Strategy

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   ATTRACTING WORLD-CLASS TALENT                                            â”‚
â”‚                                                                             â”‚
â”‚   Our Talent Advantages:                                                   â”‚
â”‚   âœ“ Mission-driven work (transformation + healing)                         â”‚
â”‚   âœ“ Category creation opportunity (build something new)                    â”‚
â”‚   âœ“ Equity participation (everyone shares in upside)                       â”‚
â”‚   âœ“ Beautiful locations (Mexico, Portugal, etc.)                           â”‚
â”‚   âœ“ Cutting-edge integration of medicine, science, luxury                  â”‚
â”‚   âœ“ Work with the world's most interesting guests                          â”‚
â”‚   âœ“ Professional growth in emerging field                                  â”‚
â”‚                                                                             â”‚
â”‚   Compensation Philosophy:                                                 â”‚
â”‚   â€¢ Market rate salaries (75th percentile for location)                    â”‚
â”‚   â€¢ Meaningful equity (0.1-1% depending on role and timing)                â”‚
â”‚   â€¢ Performance bonuses tied to guest outcomes                             â”‚
â”‚   â€¢ Comprehensive benefits (health, relocation, continuing education)      â”‚
â”‚   â€¢ Sabbatical program (4 weeks every 3 years)                             â”‚
â”‚                                                                             â”‚
â”‚   Recruitment Channels:                                                    â”‚
â”‚   â€¢ Industry conferences (MAPS, CIIS, Integrative Medicine)                â”‚
â”‚   â€¢ Luxury hospitality recruiters                                          â”‚
â”‚   â€¢ Personal network and referrals                                         â”‚
â”‚   â€¢ Strategic partnerships with training programs                          â”‚
â”‚   â€¢ Content marketing (attract passive candidates)                         â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Section 8: RISK & MITIGATION (`/risks`)
**Purpose:** Show we've thought through everything. Address concerns before they ask.

#### Risk Matrix (Interactive Cards)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                         RISK ANALYSIS & MITIGATION                          â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   REGULATORY RISK                                    LIKELIHOOD: â¬¤â¬¤â—‹ â”‚
â”‚   â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                 â”‚  â”‚
â”‚   â”‚   Risk: Regulatory change in key jurisdictions                     â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   Mitigation:                                                       â”‚  â”‚
â”‚   â”‚   âœ“ Multi-country strategy (30 locations across 20+ jurisdictions) â”‚  â”‚
â”‚   â”‚   âœ“ Diversified medicine offerings (not dependent on one modality) â”‚  â”‚
â”‚   â”‚   âœ“ Government relationships and regulatory counsel in each market â”‚  â”‚
â”‚   â”‚   âœ“ Wellness-only programs provide non-medicine revenue stream     â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   SAFETY INCIDENT                                    LIKELIHOOD: â¬¤â—‹â—‹ â”‚
â”‚   â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                   â”‚  â”‚
â”‚   â”‚   Risk: Medical emergency or adverse event                         â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   Mitigation:                                                       â”‚  â”‚
â”‚   â”‚   âœ“ Hospital-grade medical protocols (24/7 physician coverage)     â”‚  â”‚
â”‚   â”‚   âœ“ Cardiac screening BEFORE any plant medicine (mandatory EKG)    â”‚  â”‚
â”‚   â”‚   âœ“ JCI-accredited hospital within 30 min (Galenia CancÃºn)         â”‚  â”‚
â”‚   â”‚   âœ“ Helicopter evacuation protocol established                     â”‚  â”‚
â”‚   â”‚   âœ“ Comprehensive malpractice & liability insurance                â”‚  â”‚
â”‚   â”‚   âœ“ Crisis communication plan pre-established                      â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   KEY PERSON RISK                                    LIKELIHOOD: â¬¤â¬¤â—‹ â”‚
â”‚   â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                   â”‚  â”‚
â”‚   â”‚   Risk: Founder or key team member leaves                          â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   Mitigation:                                                       â”‚  â”‚
â”‚   â”‚   âœ“ 4-year vesting with 1-year cliff for all key hires             â”‚  â”‚
â”‚   â”‚   âœ“ Deep bench strategy (2+ trained people for each role)          â”‚  â”‚
â”‚   â”‚   âœ“ Documented systems and protocols (not in anyone's head)        â”‚  â”‚
â”‚   â”‚   âœ“ Training academy for rapid capability transfer                 â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   ECONOMIC DOWNTURN                                  LIKELIHOOD: â¬¤â¬¤â—‹ â”‚
â”‚   â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                 â”‚  â”‚
â”‚   â”‚   Risk: Recession reduces luxury wellness spending                 â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   Mitigation:                                                       â”‚  â”‚
â”‚   â”‚   âœ“ UHNW clients least affected by economic cycles                 â”‚  â”‚
â”‚   â”‚   âœ“ Transformation is "need" not "want" for our client profile     â”‚  â”‚
â”‚   â”‚   âœ“ Flexible pricing and payment options available                 â”‚  â”‚
â”‚   â”‚   âœ“ Low break-even occupancy (42%) provides cushion                â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   COMPETITIVE RESPONSE                               LIKELIHOOD: â¬¤â¬¤â¬¤ â”‚
â”‚   â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                              â”‚  â”‚
â”‚   â”‚   Risk: Established players copy our model                         â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   Mitigation:                                                       â”‚  â”‚
â”‚   â”‚   âœ“ 18-24 month head start on integration                          â”‚  â”‚
â”‚   â”‚   âœ“ Top talent locked with equity + long-term contracts            â”‚  â”‚
â”‚   â”‚   âœ“ Brand established before competitors can react                 â”‚  â”‚
â”‚   â”‚   âœ“ Network effects compound with each guest (referrals)           â”‚  â”‚
â”‚   â”‚   âœ“ Structural barriers: medical clinics won't touch plant medicineâ”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Comprehensive Risk Scoring Matrix

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   RISK HEAT MAP                                                            â”‚
â”‚                                                                             â”‚
â”‚   Impact â†‘                                                                  â”‚
â”‚   HIGH  â”‚   2. Safety         1. Regulatory      3. Key Person             â”‚
â”‚         â”‚   Incident          Risk               Risk                      â”‚
â”‚         â”‚                                                                   â”‚
â”‚   MED   â”‚                     4. Economic        5. Competitive            â”‚
â”‚         â”‚                     Downturn           Response                  â”‚
â”‚         â”‚                                                                   â”‚
â”‚   LOW   â”‚   [None identified]                                              â”‚
â”‚         â”‚                                                                   â”‚
â”‚         â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â†’        â”‚
â”‚                LOW              MEDIUM             HIGH                     â”‚
â”‚                                                    Likelihood               â”‚
â”‚                                                                             â”‚
â”‚   RISK PRIORITY RANKING                                                    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                    â”‚
â”‚   1ï¸âƒ£  Safety Incident (High Impact, Low Likelihood) - HIGHEST PRIORITY    â”‚
â”‚   2ï¸âƒ£  Regulatory Risk (High Impact, Medium Likelihood)                     â”‚
â”‚   3ï¸âƒ£  Key Person Risk (High Impact, Medium Likelihood)                     â”‚
â”‚   4ï¸âƒ£  Competitive Response (Medium Impact, High Likelihood)                â”‚
â”‚   5ï¸âƒ£  Economic Downturn (Medium Impact, Medium Likelihood)                 â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Detailed Risk Mitigation Playbooks

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   RISK #1: SAFETY INCIDENT â€” DETAILED MITIGATION PLAN                      â”‚
â”‚                                                                             â”‚
â”‚   Pre-Event Prevention (Layers of Screening):                              â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Layer 1: Initial Health Questionnaire (pre-booking)                      â”‚
â”‚   â€¢ 50+ medical history questions                                          â”‚
â”‚   â€¢ Automatic red flags: cardiac history, psychiatric medications, etc.    â”‚
â”‚   â€¢ Medical team review required for any flags                             â”‚
â”‚                                                                             â”‚
â”‚   Layer 2: Physician Consultation (4 weeks pre-arrival)                    â”‚
â”‚   â€¢ Video consultation with our Medical Director                           â”‚
â”‚   â€¢ Review of current medications and supplements                          â”‚
â”‚   â€¢ Assessment of psychological readiness                                  â”‚
â”‚   â€¢ Decision: CLEAR / CONDITIONAL / DECLINE                                â”‚
â”‚                                                                             â”‚
â”‚   Layer 3: On-Site Medical Evaluation (Day 1)                              â”‚
â”‚   â€¢ Comprehensive physical exam                                            â”‚
â”‚   â€¢ EKG (mandatory for anyone over 40 or with any cardiac history)         â”‚
â”‚   â€¢ Blood pressure, heart rate, oxygen saturation                          â”‚
â”‚   â€¢ Liver function tests (ibogaine is hepatotoxic at high doses)           â”‚
â”‚   â€¢ Final GO/NO-GO decision by physician                                   â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   During-Event Monitoring:                                                 â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Physician present in ceremony space (not just on-call)                 â”‚
â”‚   â€¢ Continuous vital sign monitoring during medicine sessions              â”‚
â”‚   â€¢ Medical equipment on-site: AED, oxygen, emergency medications          â”‚
â”‚   â€¢ Maximum 4 guests per ceremony (never more than we can evacuate)        â”‚
â”‚   â€¢ Helicopter evacuation on 15-minute standby during ceremonies           â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   Post-Event Response Protocol:                                            â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   IF medical emergency occurs:                                             â”‚
â”‚   1. On-site physician stabilization (immediate)                           â”‚
â”‚   2. Contact Galenia Hospital emergency team (2 min)                       â”‚
â”‚   3. Activate helicopter evacuation if needed (15 min to arrival)          â”‚
â”‚   4. Ground ambulance backup (70 min to Galenia)                           â”‚
â”‚   5. Crisis communication protocol:                                        â”‚
â”‚      - Notify family (within 30 min)                                       â”‚
â”‚      - Notify board/investors (within 2 hours)                             â”‚
â”‚      - Legal counsel consultation (within 4 hours)                         â”‚
â”‚      - Media statement prepared (if necessary)                             â”‚
â”‚                                                                             â”‚
â”‚   Post-Incident Review:                                                    â”‚
â”‚   â€¢ Full investigation within 48 hours                                     â”‚
â”‚   â€¢ Protocol review and revision                                           â”‚
â”‚   â€¢ Additional training if gaps identified                                 â”‚
â”‚   â€¢ Insurance claim filed if applicable                                    â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   RISK #2: REGULATORY CHANGE â€” ADVANCED MITIGATION                         â”‚
â”‚                                                                             â”‚
â”‚   Multi-Jurisdiction Resilience Strategy:                                  â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Tier 1 Locations (Ibogaine Legal):                                       â”‚
â”‚   â€¢ Mexico (primary) - established precedent, 20+ clinics operating        â”‚
â”‚   â€¢ South Africa - legal, growing medical tourism                          â”‚
â”‚   â€¢ Portugal - decriminalized, moving toward regulated access              â”‚
â”‚   â€¢ St. Vincent & Grenadines - explicitly legal                            â”‚
â”‚                                                                             â”‚
â”‚   Tier 2 Locations (Psilocybin Legal):                                     â”‚
â”‚   â€¢ Jamaica - fully legal, tourism-friendly                                â”‚
â”‚   â€¢ Netherlands - legal truffles, established infrastructure               â”‚
â”‚   â€¢ Australia - regulated therapeutic use (TGA approved)                   â”‚
â”‚                                                                             â”‚
â”‚   Tier 3 Locations (Wellness-Only, No Medicine):                           â”‚
â”‚   â€¢ Singapore, UAE, Switzerland - premium longevity market                 â”‚
â”‚   â€¢ Revenue model: Bio-optimization + trauma therapy (no plant medicine)   â”‚
â”‚   â€¢ Serves as regulatory hedge if medicine access tightens                 â”‚
â”‚                                                                             â”‚
â”‚   Early Warning System:                                                    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Regulatory counsel in each jurisdiction (monthly briefings)            â”‚
â”‚   â€¢ Membership in GCDP (Global Commission on Drug Policy)                  â”‚
â”‚   â€¢ Relationships with MAPS, Multidisciplinary Association                 â”‚
â”‚   â€¢ Government liaison in Mexico (Q.R. health department)                  â”‚
â”‚   â€¢ Quarterly policy monitoring reports                                    â”‚
â”‚   â€¢ 12-18 month runway to pivot if regulation changes                      â”‚
â”‚                                                                             â”‚
â”‚   Diversification of Modalities:                                           â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Not dependent on any single medicine:                                    â”‚
â”‚   â€¢ Ibogaine (trauma, addiction)                                           â”‚
â”‚   â€¢ Psilocybin (depression, anxiety) - in jurisdictions where legal        â”‚
â”‚   â€¢ Ayahuasca (spiritual integration) - select locations                   â”‚
â”‚   â€¢ Ketamine (legal globally) - therapeutic use                            â”‚
â”‚   â€¢ Non-medicine modalities (60% of guest experience)                      â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Insurance Coverage Framework

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   COMPREHENSIVE INSURANCE PROGRAM                                          â”‚
â”‚                                                                             â”‚
â”‚   MEDICAL MALPRACTICE INSURANCE                                            â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Coverage:        $5,000,000 per occurrence / $15,000,000 aggregate       â”‚
â”‚   Premium:         ~$180,000/year (est.)                                   â”‚
â”‚   Provider:        [Specialty medical malpractice carrier]                 â”‚
â”‚   Covers:          Medical negligence, treatment errors, adverse events    â”‚
â”‚   Key Feature:     Covers psychedelic therapy (specialty endorsement)      â”‚
â”‚                                                                             â”‚
â”‚   GENERAL LIABILITY INSURANCE                                              â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Coverage:        $2,000,000 per occurrence / $4,000,000 aggregate        â”‚
â”‚   Premium:         ~$45,000/year                                           â”‚
â”‚   Covers:          Slip/fall, property damage, general injury              â”‚
â”‚                                                                             â”‚
â”‚   PROPERTY INSURANCE                                                       â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Coverage:        Replacement value of facility + equipment               â”‚
â”‚   Premium:         ~$60,000/year                                           â”‚
â”‚   Covers:          Fire, flood, hurricane, earthquake                      â”‚
â”‚   Key Feature:     Business interruption (6 months revenue protection)     â”‚
â”‚                                                                             â”‚
â”‚   DIRECTORS & OFFICERS (D&O) INSURANCE                                     â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Coverage:        $3,000,000                                              â”‚
â”‚   Premium:         ~$35,000/year                                           â”‚
â”‚   Covers:          Board decisions, fiduciary duty, shareholder claims     â”‚
â”‚   Key Feature:     Side A coverage (individual director protection)        â”‚
â”‚                                                                             â”‚
â”‚   CYBER LIABILITY INSURANCE                                                â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Coverage:        $1,000,000 (data breach, ransomware, HIPAA violations)  â”‚
â”‚   Premium:         ~$25,000/year                                           â”‚
â”‚   Covers:          Data breach notification, forensics, legal defense      â”‚
â”‚   Key Feature:     HIPAA violation coverage (critical for medical data)    â”‚
â”‚                                                                             â”‚
â”‚   EMPLOYMENT PRACTICES LIABILITY (EPLI)                                    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Coverage:        $1,000,000                                              â”‚
â”‚   Premium:         ~$18,000/year                                           â”‚
â”‚   Covers:          Wrongful termination, discrimination, harassment        â”‚
â”‚                                                                             â”‚
â”‚   MEDICAL EVACUATION & REPATRIATION                                        â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Coverage:        $250,000 per person                                     â”‚
â”‚   Premium:         ~$15,000/year                                           â”‚
â”‚   Covers:          Emergency medical transport, repatriation               â”‚
â”‚   Key Feature:     Helicopter evacuation to Galenia Hospital               â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   TOTAL INSURANCE COST: ~$378,000/year (~7.4% of Y2 revenue)              â”‚
â”‚                                                                             â”‚
â”‚   Note: Premiums decrease as safety record improves. Target: 5% by Y5.     â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Additional Risk Considerations

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   EMERGING RISKS MONITORED (Low Probability, Worth Tracking)               â”‚
â”‚                                                                             â”‚
â”‚   ğŸ” REPUTATIONAL RISK                                                     â”‚
â”‚   Risk: Negative media coverage or influencer criticism                    â”‚
â”‚   Mitigation:                                                              â”‚
â”‚   â€¢ Pre-vetted guest list (background checks)                              â”‚
â”‚   â€¢ NDA and media clauses in guest agreements                              â”‚
â”‚   â€¢ Proactive PR and media relationships                                   â”‚
â”‚   â€¢ Crisis communication firm on retainer                                  â”‚
â”‚   â€¢ Perfect safety record as best defense                                  â”‚
â”‚                                                                             â”‚
â”‚   ğŸ” SUPPLY CHAIN RISK (Plant Medicine Sourcing)                           â”‚
â”‚   Risk: Difficulty sourcing high-quality, ethical ibogaine/psilocybin      â”‚
â”‚   Mitigation:                                                              â”‚
â”‚   â€¢ Multiple supplier relationships (3+ for each medicine)                 â”‚
â”‚   â€¢ Long-term contracts with volume commitments                            â”‚
â”‚   â€¢ Quality testing protocols (every batch)                                â”‚
â”‚   â€¢ Strategic reserve (6-month supply on-hand)                             â”‚
â”‚   â€¢ Vertical integration exploration (grow our own psilocybin)             â”‚
â”‚                                                                             â”‚
â”‚   ğŸ” CURRENCY RISK                                                         â”‚
â”‚   Risk: MXN/USD exchange rate volatility                                   â”‚
â”‚   Mitigation:                                                              â”‚
â”‚   â€¢ Revenue priced in USD                                                  â”‚
â”‚   â€¢ 60% of costs in USD (imported goods, US team members)                  â”‚
â”‚   â€¢ Natural hedge through multi-currency operations                        â”‚
â”‚   â€¢ Forward contracts for large capital expenditures                       â”‚
â”‚                                                                             â”‚
â”‚   ğŸ” TALENT RETENTION RISK                                                 â”‚
â”‚   Risk: High turnover in skilled staff (physicians, facilitators)          â”‚
â”‚   Mitigation:                                                              â”‚
â”‚   â€¢ Competitive compensation (75th percentile)                             â”‚
â”‚   â€¢ Meaningful equity participation                                        â”‚
â”‚   â€¢ Professional development budget ($5k/person/year)                      â”‚
â”‚   â€¢ Mission-driven culture (retention through purpose)                     â”‚
â”‚   â€¢ Remote work options for non-clinical roles                             â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Section 9: COMPETITIVE MOAT (`/moat`)
**Purpose:** Show why we win. The 5 layers of defense.

#### The Five Moats (Interactive Reveal)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                           THE COMPETITIVE MOAT                              â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   1. FIRST-MOVER ADVANTAGE                                         â”‚  â”‚
â”‚   â”‚      First to integrate all 4 pillars with medical rigor           â”‚  â”‚
â”‚   â”‚      in a legal jurisdiction with luxury infrastructure            â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   2. TALENT LOCK-UP                                                â”‚  â”‚
â”‚   â”‚      Top physicians, hospitality leaders, and practitioners        â”‚  â”‚
â”‚   â”‚      on long-term contracts with equity vesting                    â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   3. BRAND & REPUTATION                                            â”‚  â”‚
â”‚   â”‚      Word-of-mouth among the wealthy is everything                 â”‚  â”‚
â”‚   â”‚      Target: 40%+ of guests from referrals                         â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   4. PROPRIETARY PROTOCOLS                                         â”‚  â”‚
â”‚   â”‚      Documented, refined, proven with outcome data                 â”‚  â”‚
â”‚   â”‚      Measurable transformation metrics                             â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   5. NETWORK EFFECTS                                               â”‚  â”‚
â”‚   â”‚      Alumni community creates compounding referrals                â”‚  â”‚
â”‚   â”‚      Each guest becomes an ambassador                              â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Competitor Analysis (Interactive Comparison)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   COMPETITIVE LANDSCAPE                                                     â”‚
â”‚                                                                             â”‚
â”‚                        Medical  Luxury   Bio-Opt  Plant Med  TOTAL         â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€         â”‚
â”‚   Clinique La Prairie    âœ…       âœ…       âš ï¸        âŒ       2.5/4        â”‚
â”‚   SHA Wellness           âœ…       âœ…       âœ…        âŒ       3/4          â”‚
â”‚   Aman Wellness          âš ï¸       âœ…       âš ï¸        âŒ       2/4          â”‚
â”‚   Beond                  âš ï¸       âš ï¸       âŒ        âœ…       2/4          â”‚
â”‚   Rythmia                âŒ       âš ï¸       âŒ        âœ…       1.5/4        â”‚
â”‚   Upgrade Labs           âŒ       âŒ       âœ…        âŒ       1/4          â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€         â”‚
â”‚   TRANSFORMATIONAL       âœ…       âœ…       âœ…        âœ…       4/4          â”‚
â”‚   EPICENTER                                                                â”‚
â”‚                                                                             â”‚
â”‚   We're the only player offering all four pillars.                         â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Deep Dive: The Five Moats Quantified

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   MOAT #1: FIRST-MOVER ADVANTAGE                         Strength: â–ˆâ–ˆâ–ˆâ–ˆâ–‘ 8/10â”‚
â”‚                                                                             â”‚
â”‚   Time-to-Replicate: 24-36 months (for any competitor)                     â”‚
â”‚                                                                             â”‚
â”‚   Why It's Hard to Copy:                                                   â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Medical Clinics (Clinique La Prairie, SHA Wellness):                     â”‚
â”‚   â€¢ Won't touch plant medicine (brand risk, regulatory complexity)         â”‚
â”‚   â€¢ 100+ year reputations at stake                                         â”‚
â”‚   â€¢ Board/shareholders would never approve                                 â”‚
â”‚   â€¢ Example: SHA considered ayahuasca in 2018 â†’ board veto                 â”‚
â”‚                                                                             â”‚
â”‚   Luxury Resorts (Aman, Six Senses):                                       â”‚
â”‚   â€¢ Lack medical infrastructure ($2M+ to build out)                        â”‚
â”‚   â€¢ No access to physicians willing to work with psychedelics              â”‚
â”‚   â€¢ Hospitality DNA, not clinical DNA                                      â”‚
â”‚   â€¢ Liability concerns override opportunity                                â”‚
â”‚                                                                             â”‚
â”‚   Plant Medicine Centers (Beond, Rythmia):                                 â”‚
â”‚   â€¢ Can't afford medical rigor ($500k+/year in physician costs)            â”‚
â”‚   â€¢ Can't attract luxury hospitality talent                                â”‚
â”‚   â€¢ Operate on thin margins (can't add $1M+ in overhead)                   â”‚
â”‚   â€¢ Example: Beond's physician is part-time, not 24/7 on-site             â”‚
â”‚                                                                             â”‚
â”‚   Time Window:                                                             â”‚
â”‚   â€¢ We have 18-24 months before anyone CAN copy (even if they want to)     â”‚
â”‚   â€¢ By then: brand established, talent locked, outcomes data published     â”‚
â”‚   â€¢ Market perception: "They're the original, others are copycats"         â”‚
â”‚                                                                             â”‚
â”‚   Defensibility Score: HIGH (structural barriers, not just timing)         â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   MOAT #2: TALENT LOCK-UP                                Strength: â–ˆâ–ˆâ–ˆâ–ˆâ–‘ 8/10â”‚
â”‚                                                                             â”‚
â”‚   The Talent Flywheel:                                                     â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   1. Attract top talent with equity + mission + beautiful locations        â”‚
â”‚   2. Lock them in with 4-year vesting (1-year cliff)                       â”‚
â”‚   3. They build protocols and train others                                 â”‚
â”‚   4. Institutional knowledge embedded (not in any one person)              â”‚
â”‚   5. Alumni network of trained staff creates talent pipeline               â”‚
â”‚                                                                             â”‚
â”‚   Key Talent Already Identified:                                           â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Medical Director candidate: Dr. [Name], 15 years integrative medicine  â”‚
â”‚     Currently: $280k/year â†’ Our offer: $180k + 2% equity (worth $400k-1M+) â”‚
â”‚     Status: Term sheet discussions                                         â”‚
â”‚                                                                             â”‚
â”‚   â€¢ Head Facilitator candidate: [Name], trained by [Lineage]               â”‚
â”‚     Currently: $60k/year + tips â†’ Our offer: $90k + 0.5% equity            â”‚
â”‚     Status: Verbal commitment                                              â”‚
â”‚                                                                             â”‚
â”‚   â€¢ GM candidate: [Name], former Aman Tulum                                â”‚
â”‚     Currently: $150k/year â†’ Our offer: $140k + 1% equity                   â”‚
â”‚     Status: In conversations                                               â”‚
â”‚                                                                             â”‚
â”‚   Competitive Advantage:                                                   â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Most competitors can't offer:                                            â”‚
â”‚   â€¢ Meaningful equity (we give 0.25-2% to key hires)                       â”‚
â”‚   â€¢ Category creation opportunity (not just another retreat)               â”‚
â”‚   â€¢ Medical rigor + plant medicine (rare combination)                      â”‚
â”‚   â€¢ Global expansion path (work in Portugal, Mexico, South Africa, etc.)   â”‚
â”‚                                                                             â”‚
â”‚   Retention Strategy:                                                      â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ 4-year vesting keeps key people for the critical growth phase          â”‚
â”‚   â€¢ Training academy creates internal promotion path                       â”‚
â”‚   â€¢ Profit-sharing after Year 3 (5% of EBITDA to team bonus pool)          â”‚
â”‚   â€¢ "First 10 employees" special equity pool (creates founding team feel)  â”‚
â”‚                                                                             â”‚
â”‚   Defensibility Score: HIGH (golden handcuffs + mission alignment)         â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   MOAT #3: BRAND & REPUTATION                            Strength: â–ˆâ–ˆâ–ˆâ–‘â–‘ 6/10â”‚
â”‚                                  (Grows to 9/10 by Year 3)                  â”‚
â”‚                                                                             â”‚
â”‚   The Luxury Wellness Referral Flywheel:                                   â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Year 1:   20% of guests from referrals  (network seeding)                â”‚
â”‚   Year 2:   35% of guests from referrals  (word spreading)                 â”‚
â”‚   Year 3+:  50%+ of guests from referrals (compounding effect)             â”‚
â”‚                                                                             â”‚
â”‚   Why Referrals Matter in This Market:                                     â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ UHNW individuals don't Google "psychedelic retreat"                    â”‚
â”‚   â€¢ They ask their trusted network: therapist, coach, concierge doc        â”‚
â”‚   â€¢ Social proof is EVERYTHING at $50k+ price point                        â”‚
â”‚   â€¢ One happy CEO refers 3-5 peers within 12 months                        â”‚
â”‚                                                                             â”‚
â”‚   Brand Building Strategy:                                                 â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Phase 1 (Months 1-12): Stealth + Quality                                â”‚
â”‚   â€¢ Invite-only access (creates exclusivity)                               â”‚
â”‚   â€¢ Perfect execution with first 50 guests                                 â”‚
â”‚   â€¢ Documented outcomes (testimonials, case studies)                       â”‚
â”‚   â€¢ No paid advertising (referral-only)                                    â”‚
â”‚                                                                             â”‚
â”‚   Phase 2 (Months 13-24): Thought Leadership                               â”‚
â”‚   â€¢ Publish outcome data (medical journals)                                â”‚
â”‚   â€¢ Speak at conferences (MAPS, CIIS, wellness forums)                     â”‚
â”‚   â€¢ Strategic PR (Forbes, NYT, Tim Ferriss podcast)                        â”‚
â”‚   â€¢ Ambassador program launch (2.5-10% commissions)                        â”‚
â”‚                                                                             â”‚
â”‚   Phase 3 (Year 3+): Category Ownership                                    â”‚
â”‚   â€¢ "The Transformational Epicenter" becomes the category                  â”‚
â”‚   â€¢ Book deal + documentary (founder's journey)                            â”‚
â”‚   â€¢ Annual thought leadership summit                                       â”‚
â”‚   â€¢ Industry partnerships (training other practitioners)                   â”‚
â”‚                                                                             â”‚
â”‚   Brand Moat Quantified:                                                   â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Year 1: $2,500 CAC â†’ 20% referral                                      â”‚
â”‚   â€¢ Year 3: $1,200 CAC â†’ 50% referral (52% reduction in CAC)              â”‚
â”‚   â€¢ Customer LTV increases with brand: $45k â†’ $60k+ (return visits)        â”‚
â”‚                                                                             â”‚
â”‚   Defensibility Score: MEDIUM (building) â†’ HIGH (by Year 3)                â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   MOAT #4: PROPRIETARY PROTOCOLS & IP                    Strength: â–ˆâ–ˆâ–ˆâ–‘â–‘ 7/10â”‚
â”‚                                                                             â”‚
â”‚   What We're Building:                                                     â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   1. The Epicenter Methodâ„¢                                                 â”‚
â”‚      â€¢ Documented protocols for each of the 8 segments                     â”‚
â”‚      â€¢ Pre-care â†’ On-site â†’ Post-care (full transformation arc)            â”‚
â”‚      â€¢ 200+ page operational playbook                                      â”‚
â”‚      â€¢ Trademarked methodology                                             â”‚
â”‚                                                                             â”‚
â”‚   2. Medical Protocols (Licensable)                                        â”‚
â”‚      â€¢ Ibogaine administration with cardiac safety protocols               â”‚
â”‚      â€¢ Integration therapy frameworks (polyvagal-informed)                 â”‚
â”‚      â€¢ Biometric tracking and outcome measurement                          â”‚
â”‚      â€¢ Partnership with research institutions for validation               â”‚
â”‚                                                                             â”‚
â”‚   3. Outcome Data (Competitive Moat)                                       â”‚
â”‚      â€¢ By Year 2: 200+ guest dataset                                       â”‚
â”‚      â€¢ Validated clinical scales (PCL-5, PHQ-9, GAD-7, HRV)                â”‚
â”‚      â€¢ Published research (medical journals)                               â”‚
â”‚      â€¢ Industry's first evidence-based transformation data                 â”‚
â”‚                                                                             â”‚
â”‚   4. Technology IP                                                         â”‚
â”‚      â€¢ AI personalization engine (patent-pending)                          â”‚
â”‚      â€¢ Integration tracking algorithms                                     â”‚
â”‚      â€¢ Biometric data analysis (HRV, sleep, recovery)                      â”‚
â”‚      â€¢ HIPAA-compliant platform architecture                               â”‚
â”‚                                                                             â”‚
â”‚   Intellectual Property Strategy:                                          â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Trademarks:                                                              â”‚
â”‚   â€¢ "Transformational Epicenter" (primary mark)                            â”‚
â”‚   â€¢ "The Epicenter Method"                                                 â”‚
â”‚   â€¢ "Four Pillar Transformation" (tagline)                                 â”‚
â”‚   â€¢ Logo and visual identity                                               â”‚
â”‚   Filing: Q1 2026 (US, Mexico, EU)                                         â”‚
â”‚                                                                             â”‚
â”‚   Trade Secrets:                                                           â”‚
â”‚   â€¢ Operational protocols (kept confidential)                              â”‚
â”‚   â€¢ Supplier relationships and sourcing                                    â”‚
â”‚   â€¢ Financial models and unit economics                                    â”‚
â”‚   â€¢ Customer acquisition playbooks                                         â”‚
â”‚   Protection: NDAs with all employees, advisors, contractors               â”‚
â”‚                                                                             â”‚
â”‚   Patents (Defensive):                                                     â”‚
â”‚   â€¢ AI personalization system (application Q3 2026)                        â”‚
â”‚   â€¢ Novel biometric integration methods                                    â”‚
â”‚   Note: Not core to moat, but prevents competitors from blocking us        â”‚
â”‚                                                                             â”‚
â”‚   Copyrights:                                                              â”‚
â”‚   â€¢ All content (website, guides, videos, curriculum)                      â”‚
â”‚   â€¢ Training materials and playbooks                                       â”‚
â”‚   â€¢ Automatically protected upon creation                                  â”‚
â”‚                                                                             â”‚
â”‚   Future Licensing Revenue:                                                â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   By Year 5+, we can license "The Epicenter Method" to:                    â”‚
â”‚   â€¢ High-end retreat centers (non-competing markets)                       â”‚
â”‚   â€¢ Training programs for practitioners                                    â”‚
â”‚   â€¢ Wellness resorts wanting to add transformation programming             â”‚
â”‚   Estimated licensing revenue: $2-5M/year by Year 7                        â”‚
â”‚                                                                             â”‚
â”‚   Defensibility Score: HIGH (becomes stronger with more guest data)        â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   MOAT #5: NETWORK EFFECTS                               Strength: â–ˆâ–ˆâ–ˆâ–ˆâ–‘ 8/10â”‚
â”‚                                  (Strongest moat long-term)                 â”‚
â”‚                                                                             â”‚
â”‚   The Compounding Alumni Network:                                          â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Year 1:    100 guests  â†’  100 alumni                                     â”‚
â”‚   Year 2:    180 guests  â†’  280 alumni  (40% referral rate)                â”‚
â”‚   Year 3:    250 guests  â†’  530 alumni  (compounding effect)               â”‚
â”‚   Year 5:    400 guests  â†’ 1,300 alumni (powerful network)                 â”‚
â”‚   Year 10: 8,000+ alumni across 30 locations (unstoppable)                 â”‚
â”‚                                                                             â”‚
â”‚   How Network Effects Create Value:                                        â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   1. Referral Compounding                                                  â”‚
â”‚      â€¢ Each guest refers 1.2 people on average (40% referral rate)         â”‚
â”‚      â€¢ Referrals convert 3x higher than cold leads (75% vs 25%)            â”‚
â”‚      â€¢ CAC drops from $2,500 â†’ $800 via referrals                          â”‚
â”‚                                                                             â”‚
â”‚   2. Community Platform Value                                              â”‚
â”‚      â€¢ Alumni-only community (lifelong access)                             â”‚
â”‚      â€¢ Monthly integration calls (facilitated)                             â”‚
â”‚      â€¢ Regional meetups (self-organized)                                   â”‚
â”‚      â€¢ Annual alumni retreats (reunion + depth work)                       â”‚
â”‚      â€¢ The more alumni, the more valuable membership becomes               â”‚
â”‚                                                                             â”‚
â”‚   3. Return Visits & Upsells                                               â”‚
â”‚      â€¢ 30% of guests return within 24 months                               â”‚
â”‚      â€¢ Average second visit: $35,000 (longer stay, advanced work)          â”‚
â”‚      â€¢ Third visit rate: 15% (becoming annual practice)                    â”‚
â”‚      â€¢ Post-care coaching: 50% uptake ($3k-10k/year)                       â”‚
â”‚                                                                             â”‚
â”‚   4. Brand Ambassadors                                                     â”‚
â”‚      â€¢ Top 10% of guests become active ambassadors                         â”‚
â”‚      â€¢ Commission: 2.5% (first visit) â†’ 10% (third+ referral)              â”‚
â”‚      â€¢ Average ambassador refers 8 people over 5 years                     â”‚
â”‚      â€¢ Creates passive evangelism (talking about us everywhere)            â”‚
â”‚                                                                             â”‚
â”‚   5. Strategic Partnerships Via Alumni                                     â”‚
â”‚      â€¢ Alumni introduce us to: coaches, therapists, concierge docs         â”‚
â”‚      â€¢ Corporate wellness programs (alumni are executives)                 â”‚
â”‚      â€¢ Investment opportunities (alumni are investors/operators)           â”‚
â”‚      â€¢ Media coverage (alumni are authors, podcasters, influencers)        â”‚
â”‚                                                                             â”‚
â”‚   Why This Is Unbreakable:                                                 â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Competitors can copy our facility, but not our 1,300+ alumni           â”‚
â”‚   â€¢ Each guest makes the network more valuable for the next guest          â”‚
â”‚   â€¢ By Year 5, we'll have 10x the alumni of any competitor                 â”‚
â”‚   â€¢ Network effects compound exponentially (metcalfe's law)                â”‚
â”‚   â€¢ Switching costs: leaving means losing the community                    â”‚
â”‚                                                                             â”‚
â”‚   Economic Impact:                                                         â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Referral-driven CAC reduction: $2,500 â†’ $800 (saves $1.7k/guest)      â”‚
â”‚   â€¢ Return visit LTV increase: $30k â†’ $60k+ (doubles LTV)                  â”‚
â”‚   â€¢ Ambassador commission cost: 5% of revenue (vs 20%+ for ads)            â”‚
â”‚   â€¢ Community platform revenue: $50/month Ã— 1,300 alumni = $780k/year      â”‚
â”‚                                                                             â”‚
â”‚   Defensibility Score: VERY HIGH (mathematically unbeatable at scale)      â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Why The Moat Gets Stronger Over Time

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   MOAT STRENGTH TRAJECTORY                                                 â”‚
â”‚                                                                             â”‚
â”‚   Defensibility â†‘                                                           â”‚
â”‚   10/10 â”‚                                               â•±â”€â”€â”€â”€â”€â”€             â”‚
â”‚         â”‚                                           â•±â”€â”€â”€                    â”‚
â”‚    9/10 â”‚                                       â•±â”€â”€â”€                        â”‚
â”‚         â”‚                                   â•±â”€â”€â”€                            â”‚
â”‚    8/10 â”‚                               â•±â”€â”€â”€                                â”‚
â”‚         â”‚                           â•±â”€â”€â”€                                    â”‚
â”‚    7/10 â”‚                       â•±â”€â”€â”€                                        â”‚
â”‚         â”‚                   â•±â”€â”€â”€                                            â”‚
â”‚    6/10 â”‚               â•±â”€â”€â”€                                                â”‚
â”‚         â”‚           â•±â”€â”€â”€                                                    â”‚
â”‚    5/10 â”‚       â•±â”€â”€â”€                                                        â”‚
â”‚         â”‚   â•±â”€â”€â”€                                                            â”‚
â”‚         â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â†’     â”‚
â”‚           Y1      Y2      Y3      Y4      Y5     Y7      Y10               â”‚
â”‚                                                                             â”‚
â”‚   Key Inflection Points:                                                   â”‚
â”‚   â€¢ Year 1: Building (protocols, team, first guests)                       â”‚
â”‚   â€¢ Year 2: Proving (outcomes data, cash flow positive)                    â”‚
â”‚   â€¢ Year 3: Compounding (network effects kick in)                          â”‚
â”‚   â€¢ Year 5: Unassailable (1,300+ alumni, multiple locations, category)     â”‚
â”‚                                                                             â”‚
â”‚   The Winner-Take-Most Dynamic:                                            â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   In luxury wellness, the leader captures disproportionate value:          â”‚
â”‚   â€¢ #1 player: 40-50% market share                                         â”‚
â”‚   â€¢ #2 player: 20-25% market share                                         â”‚
â”‚   â€¢ Everyone else: Fragmented 25-40%                                       â”‚
â”‚                                                                             â”‚
â”‚   We're racing to be #1. Once there, nearly impossible to unseat.          â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Section 10: EXIT STRATEGY (`/returns`)
**Purpose:** Show investors exactly how they get their money backâ€”and then some.

#### Return Pathways (Interactive Timeline)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                           INVESTOR RETURN PATHWAYS                          â”‚
â”‚                                                                             â”‚
â”‚   PATH 1: STRATEGIC ACQUISITION (Most Likely)          Target: Year 5-7    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   Potential Acquirers:                                                      â”‚
â”‚   â€¢ Luxury hospitality groups (Aman, Six Senses, Four Seasons)             â”‚
â”‚   â€¢ Healthcare systems expanding into wellness (Cleveland Clinic, Mayo)    â”‚
â”‚   â€¢ Private equity wellness platforms (KKR, Blackstone wellness funds)     â”‚
â”‚   â€¢ Longevity-focused investors (Altos Labs, Calico adjacents)             â”‚
â”‚                                                                             â”‚
â”‚   Why They'd Acquire:                                                       â”‚
â”‚   âœ“ Category leadership in $1T+ market                                     â”‚
â”‚   âœ“ Proven protocols and outcome data                                      â”‚
â”‚   âœ“ Established brand and referral network                                 â”‚
â”‚   âœ“ Platform and technology infrastructure                                 â”‚
â”‚   âœ“ Talent team with specialized expertise                                 â”‚
â”‚                                                                             â”‚
â”‚   Comparable Exits:                                                         â”‚
â”‚   â€¢ Equinox sold at 15x EBITDA                                             â”‚
â”‚   â€¢ Miraval acquired by Hyatt for $215M (12x revenue)                      â”‚
â”‚   â€¢ Life Time Fitness valued at $4B+ (public)                              â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€         â”‚
â”‚                                                                             â”‚
â”‚   PATH 2: IPO/SPAC (Ambitious)                         Target: Year 7-10   â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   Requirements:                                                             â”‚
â”‚   âœ“ $50M+ annual revenue                                                   â”‚
â”‚   âœ“ 15+ locations operational                                              â”‚
â”‚   âœ“ Strong unit economics demonstrated                                     â”‚
â”‚   âœ“ Category-defining brand recognition                                    â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€         â”‚
â”‚                                                                             â”‚
â”‚   PATH 3: DIVIDEND RECAPITALIZATION                    Target: Year 4+     â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   At 70%+ occupancy with strong margins:                                   â”‚
â”‚   âœ“ Annual distributions to investors                                      â”‚
â”‚   âœ“ Partial liquidity while maintaining ownership                          â”‚
â”‚   âœ“ Retained earnings fund expansion                                       â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€         â”‚
â”‚                                                                             â”‚
â”‚   PROJECTED RETURNS (Base Case)                                            â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                           â”‚
â”‚   Entry: $5M at ~$20M pre-money valuation                                  â”‚
â”‚   5-Year IRR: 29.54%                                                       â”‚
â”‚   MOIC: 2.61x                                                              â”‚
â”‚   Exit Value: $45-65M (5.5-7x EBITDA)                                      â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Comparable Transactions Analysis (Detailed)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   WELLNESS & HOSPITALITY M&A COMPS                                         â”‚
â”‚                                                                             â”‚
â”‚   Company              Buyer           Year   Price    Revenue  Multiple   â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚   LUXURY WELLNESS ACQUISITIONS                                             â”‚
â”‚   Miraval Resorts      Hyatt           2017   $215M    $18M     11.9x     â”‚
â”‚   â€¢ 3 properties, transformational wellness focus                          â”‚
â”‚   â€¢ EBITDA margin: ~30% â†’ implied 40x EBITDA                               â”‚
â”‚   â€¢ Strategic premium: Hyatt wanted wellness vertical                      â”‚
â”‚   â€¢ Comp Relevance: â­â­â­â­â­ (closest to our model)                      â”‚
â”‚                                                                             â”‚
â”‚   Canyon Ranch         Omni Hotels     2018   Private  ~$50M    ~3-4x     â”‚
â”‚   â€¢ 3 locations, medical wellness pioneer                                  â”‚
â”‚   â€¢ Struggled financially, distressed sale                                 â”‚
â”‚   â€¢ Lower multiple reflects operational issues                             â”‚
â”‚   â€¢ Comp Relevance: â­â­â­ (cautionary tale)                              â”‚
â”‚                                                                             â”‚
â”‚   SHA Wellness         Private Equity  2021   â‚¬100M    â‚¬20M     5x        â”‚
â”‚   â€¢ Single flagship property in Spain                                      â”‚
â”‚   â€¢ 90% occupancy, strong margins                                          â”‚
â”‚   â€¢ Sold to expand globally                                                â”‚
â”‚   â€¢ Comp Relevance: â­â­â­â­ (similar luxury positioning)                 â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚   PREMIUM FITNESS/WELLNESS PLATFORMS                                       â”‚
â”‚   Equinox               Various        2017   $1.8B    $1.5B    1.2x      â”‚
â”‚   â€¢ 100+ locations, membership model                                       â”‚
â”‚   â€¢ EBITDA: $120M â†’ 15x EBITDA multiple                                    â”‚
â”‚   â€¢ Premium brand with loyal following                                     â”‚
â”‚   â€¢ Comp Relevance: â­â­ (different model, but brand value lesson)        â”‚
â”‚                                                                             â”‚
â”‚   Life Time Fitness    TPG (â†’ IPO)    2015   $4B      $1.4B    2.9x       â”‚
â”‚   â€¢ 150+ locations, family-oriented                                        â”‚
â”‚   â€¢ Went private, then re-IPO'd in 2021                                    â”‚
â”‚   â€¢ Current market cap: $5.2B                                              â”‚
â”‚   â€¢ Comp Relevance: â­â­ (scale story, different segment)                 â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚   MENTAL HEALTH & TRANSFORMATION                                           â”‚
â”‚   Spring Health        Various (VC)   2023   $3.3B*   $100M    33x        â”‚
â”‚   â€¢ Digital mental health platform                                         â”‚
â”‚   â€¢ *Valuation, not exit (showing investor appetite)                       â”‚
â”‚   â€¢ $200M ARR by 2024                                                      â”‚
â”‚   â€¢ Comp Relevance: â­â­ (shows mental health premium)                    â”‚
â”‚                                                                             â”‚
â”‚   Headspace Health     Merger (public) 2021   $3B*     $100M+   30x       â”‚
â”‚   â€¢ Meditation app (Headspace + Ginger)                                    â”‚
â”‚   â€¢ SPAC merger, now public                                                â”‚
â”‚   â€¢ Shows digital health investor appetite                                 â”‚
â”‚   â€¢ Comp Relevance: â­â­ (category creation parallels)                    â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚   BOUTIQUE HOSPITALITY (Asset-Heavy)                                       â”‚
â”‚   Aman Resorts         Vlad Doronin    2014   $358M    ~$200M   1.8x      â”‚
â”‚   â€¢ 34 ultra-luxury properties                                             â”‚
â”‚   â€¢ Built on exclusivity and brand                                         â”‚
â”‚   â€¢ Lower revenue multiple, high EBITDA multiple (~12-15x)                 â”‚
â”‚   â€¢ Comp Relevance: â­â­â­ (luxury brand playbook)                        â”‚
â”‚                                                                             â”‚
â”‚   Six Senses          IHG               2019   $300M    ~$80M    3.8x      â”‚
â”‚   â€¢ 16 wellness resorts                                                    â”‚
â”‚   â€¢ Sustainability + wellness positioning                                  â”‚
â”‚   â€¢ Strategic acquisition for portfolio expansion                          â”‚
â”‚   â€¢ Comp Relevance: â­â­â­â­ (wellness-focused luxury)                    â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Valuation Methodology & Exit Scenarios

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   YEAR 5 EXIT VALUATION FRAMEWORK                                          â”‚
â”‚                                                                             â”‚
â”‚   Scenario 1: EBITDA Multiple Approach                                     â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚   Year 5 EBITDA (Base Case):  $5.0M                                        â”‚
â”‚   Exit Multiple Range:         5.5x - 8.5x                                 â”‚
â”‚                                                                             â”‚
â”‚   Conservative (5.5x):         $27.5M                                      â”‚
â”‚   â€¢ Single location, modest occupancy, buyer sees risk                     â”‚
â”‚   â€¢ Comparable: Canyon Ranch distressed sale                               â”‚
â”‚                                                                             â”‚
â”‚   Base Case (6.5x):            $32.5M                                      â”‚
â”‚   â€¢ 1-2 locations, strong unit economics, proven model                     â”‚
â”‚   â€¢ Comparable: SHA Wellness (5x revenue = ~6-7x EBITDA)                   â”‚
â”‚                                                                             â”‚
â”‚   Optimistic (8.5x):           $42.5M                                      â”‚
â”‚   â€¢ 3+ locations operational, category leadership established              â”‚
â”‚   â€¢ Comparable: Equinox (15x EBITDA reflects brand premium)                â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                             â”‚
â”‚   Scenario 2: Revenue Multiple Approach                                    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚   Year 5 Revenue (Base Case):  $15.1M                                      â”‚
â”‚   Exit Multiple Range:          3x - 6x                                    â”‚
â”‚                                                                             â”‚
â”‚   Conservative (3x):            $45.3M                                     â”‚
â”‚   â€¢ Industry standard for boutique wellness/hospitality                    â”‚
â”‚   â€¢ Comparable: Life Time (2.9x), Equinox (1.2x but EBITDA heavy)          â”‚
â”‚                                                                             â”‚
â”‚   Base Case (4.5x):             $67.9M                                     â”‚
â”‚   â€¢ Premium for transformation category + outcomes data                    â”‚
â”‚   â€¢ Comparable: Six Senses (3.8x), SHA (5x)                                â”‚
â”‚                                                                             â”‚
â”‚   Optimistic (6x):              $90.6M                                     â”‚
â”‚   â€¢ Strategic premium if bidding war or platform potential                 â”‚
â”‚   â€¢ Comparable: Miraval (11.9x shows strategic can pay up)                 â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                             â”‚
â”‚   Blended Valuation (Conservative)                                         â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚   60% EBITDA Method (6.5x):     $32.5M Ã— 0.6 = $19.5M                      â”‚
â”‚   40% Revenue Method (4.5x):    $67.9M Ã— 0.4 = $27.2M                      â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                   â”‚
â”‚   Blended Exit Value:           $46.7M                                     â”‚
â”‚                                                                             â”‚
â”‚   Less: Debt                    ($2.0M)   (assumed remaining debt)         â”‚
â”‚   Less: Transaction Costs        ($1.9M)   (4% of proceeds)                â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                   â”‚
â”‚   Net Proceeds:                 $42.8M                                     â”‚
â”‚                                                                             â”‚
â”‚   Investor Returns (Seed Round):                                           â”‚
â”‚   Ownership: 25% (post-seed)                                               â”‚
â”‚   Share of Proceeds: $10.7M                                                â”‚
â”‚   Investment: $5.0M                                                        â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                   â”‚
â”‚   MOIC: 2.14x                                                              â”‚
â”‚   IRR: 23.7% (5-year hold)                                                 â”‚
â”‚                                                                             â”‚
â”‚   Note: Base case assumptions. Series A dilution would reduce ownership    â”‚
â”‚   but increase absolute value through growth acceleration.                 â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Specific Acquirer Profiles

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   TOP 5 MOST LIKELY ACQUIRERS                                              â”‚
â”‚                                                                             â”‚
â”‚   1. HYATT (Most Likely)                               Probability: 30%    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚   Why They'd Buy:                                                          â”‚
â”‚   â€¢ Already own Miraval (transformational wellness)                        â”‚
â”‚   â€¢ Expanding wellness vertical aggressively                               â”‚
â”‚   â€¢ Want global footprint in transformation space                          â”‚
â”‚   â€¢ Our 30-location plan fits their growth strategy                        â”‚
â”‚                                                                             â”‚
â”‚   What They'd Pay:                                                         â”‚
â”‚   â€¢ Strategic premium (6-8x EBITDA)                                        â”‚
â”‚   â€¢ $50-70M for proven concept + expansion rights                          â”‚
â”‚   â€¢ Likely buyer in Year 5-7                                               â”‚
â”‚                                                                             â”‚
â”‚   Relationship Building:                                                   â”‚
â”‚   â€¢ Introduce Year 2 (too early Year 1)                                    â”‚
â”‚   â€¢ Invite Miraval leadership to visit as guests                           â”‚
â”‚   â€¢ Explore partnership on outcomes research                               â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                             â”‚
â”‚   2. ACCOR (Luxury Division)                           Probability: 20%    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚   Why They'd Buy:                                                          â”‚
â”‚   â€¢ Own Rixos, Raffles, Fairmont (luxury brands)                           â”‚
â”‚   â€¢ Looking to differentiate in wellness space                             â”‚
â”‚   â€¢ Strong presence in Mexico, Europe (our expansion markets)              â”‚
â”‚   â€¢ No transformational offering in portfolio                              â”‚
â”‚                                                                             â”‚
â”‚   What They'd Pay:                                                         â”‚
â”‚   â€¢ Portfolio expansion multiple (5-7x EBITDA)                             â”‚
â”‚   â€¢ $45-60M range                                                          â”‚
â”‚   â€¢ Likely buyer in Year 6-8                                               â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                             â”‚
â”‚   3. KKR / BLACKSTONE (PE Wellness Roll-Up)            Probability: 25%    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚   Why They'd Buy:                                                          â”‚
â”‚   â€¢ Building wellness platforms (roll-up strategy)                         â”‚
â”‚   â€¢ See $1T market opportunity                                             â”‚
â”‚   â€¢ Want category-defining brands to anchor portfolio                      â”‚
â”‚   â€¢ Can fund aggressive expansion                                          â”‚
â”‚                                                                             â”‚
â”‚   What They'd Pay:                                                         â”‚
â”‚   â€¢ Platform premium (7-10x EBITDA)                                        â”‚
â”‚   â€¢ $60-80M+ if we're clear category leader                                â”‚
â”‚   â€¢ Likely buyer in Year 5-6 (earlier than strategic)                      â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                             â”‚
â”‚   4. COMPASS PATHWAYS / ATAI LIFE SCIENCES (Psychedelic) Probability: 15% â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚   Why They'd Buy:                                                          â”‚
â”‚   â€¢ Need real-world delivery infrastructure for therapies                  â”‚
â”‚   â€¢ We have medical protocols + outcome data                               â”‚
â”‚   â€¢ Vertical integration play (research â†’ treatment delivery)              â”‚
â”‚   â€¢ Our model de-risks their regulatory pathway                            â”‚
â”‚                                                                             â”‚
â”‚   What They'd Pay:                                                         â”‚
â”‚   â€¢ Depends on their market cap + FDA approval timeline                    â”‚
â”‚   â€¢ Likely acqui-hire + infrastructure (lower multiple)                    â”‚
â”‚   â€¢ $30-50M range                                                          â”‚
â”‚   â€¢ Timing: Year 6-10 (when psychedelic therapy is approved)               â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚                                                                             â”‚
â”‚   5. SOVEREIGN WEALTH FUND (UAE, Saudi)                Probability: 10%    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”‚
â”‚   Why They'd Buy:                                                          â”‚
â”‚   â€¢ Diversifying into wellness/longevity                                   â”‚
â”‚   â€¢ Saudi Vision 2030, UAE wellness tourism push                           â”‚
â”‚   â€¢ Want Western brands to legitimize their markets                        â”‚
â”‚   â€¢ Deep pockets, patient capital                                          â”‚
â”‚                                                                             â”‚
â”‚   What They'd Pay:                                                         â”‚
â”‚   â€¢ Trophy asset premium (8-12x EBITDA)                                    â”‚
â”‚   â€¢ $70-100M+ (can overpay strategically)                                  â”‚
â”‚   â€¢ Likely buyer in Year 7-10 (want proven global brand)                   â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Exit Preparation Roadmap

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   BUILDING FOR EXIT FROM DAY 1                                             â”‚
â”‚                                                                             â”‚
â”‚   Year 1-2: Foundation                                                     â”‚
â”‚   â€¢ Clean cap table (no messy structures)                                  â”‚
â”‚   â€¢ Audited financials from inception (Big 4 preferred)                    â”‚
â”‚   â€¢ Board minutes meticulously documented                                  â”‚
â”‚   â€¢ All contracts in writing (no handshake deals)                          â”‚
â”‚   â€¢ IP properly assigned to company                                        â”‚
â”‚                                                                             â”‚
â”‚   Year 3-4: Optimization                                                   â”‚
â”‚   â€¢ Unit economics proven and documented                                   â”‚
â”‚   â€¢ Outcome data published (credibility)                                   â”‚
â”‚   â€¢ Key talent locked in (reduce key person risk)                          â”‚
â”‚   â€¢ Expansion playbook documented (proves scalability)                     â”‚
â”‚   â€¢ Strategic relationships cultivated (potential buyers)                  â”‚
â”‚                                                                             â”‚
â”‚   Year 5: Pre-Exit                                                         â”‚
â”‚   â€¢ Hire investment bank (Moelis, Jefferies, Guggenheim)                   â”‚
â”‚   â€¢ Prepare CIM (Confidential Information Memorandum)                      â”‚
â”‚   â€¢ Management presentations polished                                      â”‚
â”‚   â€¢ Data room organized (due diligence ready)                              â”‚
â”‚   â€¢ Quality of earnings study (financial validation)                       â”‚
â”‚   â€¢ "Quiet" outreach to strategic buyers                                   â”‚
â”‚                                                                             â”‚
â”‚   Year 5-7: Exit Execution                                                 â”‚
â”‚   â€¢ Dual-track process (strategic + PE)                                    â”‚
â”‚   â€¢ Competitive tension (3-5 serious bidders)                              â”‚
â”‚   â€¢ LOI negotiation                                                        â”‚
â”‚   â€¢ Due diligence (90-120 days)                                            â”‚
â”‚   â€¢ Definitive agreement                                                   â”‚
â”‚   â€¢ Close (6-9 months from LOI to wire)                                    â”‚
â”‚                                                                             â”‚
â”‚   Success Factors:                                                         â”‚
â”‚   âœ“ Multiple bidders (creates pricing tension)                             â”‚
â”‚   âœ“ Clean story (no surprises in due diligence)                            â”‚
â”‚   âœ“ Founder staying post-close (de-risks transition)                       â”‚
â”‚   âœ“ Growth trajectory visible (not just current state)                     â”‚
â”‚   âœ“ Strategic rationale clear (why WE'RE the answer to THEIR problem)      â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Section 11: MILESTONES & TIMELINE (`/timeline`)
**Purpose:** Concrete deliverables with dates. Show execution discipline.

#### 24-Month Roadmap (Interactive Gantt)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                        24-MONTH EXECUTION ROADMAP                           â”‚
â”‚                                                                             â”‚
â”‚   Q1 2026 (MONTHS 1-3)                                      â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–‘â–‘â–‘â–‘â–‘ 30% â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   â–¡ Close $5M seed round                                                   â”‚
â”‚   â–¡ Finalize property acquisition (Hotel Alea or Hacienda Caracol)         â”‚
â”‚   â–¡ Execute architectural plans for medical conversion                     â”‚
â”‚   â–¡ Begin key hires (Medical Director, Head of Operations)                 â”‚
â”‚   â–¡ Launch digital platform MVP (pre-care onboarding)                      â”‚
â”‚                                                                             â”‚
â”‚   Q2 2026 (MONTHS 4-6)                                      â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ 100%â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   â–¡ Complete facility renovation and medical buildout                      â”‚
â”‚   â–¡ Medical equipment installation and certification                       â”‚
â”‚   â–¡ Staff training and protocol dry-runs                                   â”‚
â”‚   â–¡ Regulatory approvals and permits finalized                             â”‚
â”‚   â–¡ Soft launch: First 5 guests (founder network)                          â”‚
â”‚   â˜… MILESTONE: First Epicenter Operational                                 â”‚
â”‚                                                                             â”‚
â”‚   Q3 2026 (MONTHS 7-9)                                                     â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   â–¡ Full operations launch                                                 â”‚
â”‚   â–¡ Digital platform v2.0 (AI integration, post-care)                      â”‚
â”‚   â–¡ Ambassador program launch                                              â”‚
â”‚   â–¡ First outcome data collection (HRV, PCL-5, PHQ-9)                      â”‚
â”‚   â–¡ 25+ guests served                                                      â”‚
â”‚   â˜… MILESTONE: Digital Platform Live                                       â”‚
â”‚                                                                             â”‚
â”‚   Q4 2026 (MONTHS 10-12)                                                   â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   â–¡ Reach 50% occupancy                                                    â”‚
â”‚   â–¡ 60+ guests served (Year 1 total: 85+)                                  â”‚
â”‚   â–¡ Referral rate: 30%+                                                    â”‚
â”‚   â–¡ Compile outcomes data for Series A preparation                         â”‚
â”‚   â–¡ Begin second property evaluation                                       â”‚
â”‚   â˜… MILESTONE: Proven Unit Economics                                       â”‚
â”‚                                                                             â”‚
â”‚   Q1-Q2 2027 (MONTHS 13-18)                                                â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   â–¡ Reach 70% occupancy                                                    â”‚
â”‚   â–¡ Cash flow positive (monthly basis)                                     â”‚
â”‚   â–¡ 150+ guests served cumulative                                          â”‚
â”‚   â–¡ Launch training academy for expansion                                  â”‚
â”‚   â–¡ Series A raise ($15-25M target)                                        â”‚
â”‚   â˜… MILESTONE: Cash Flow Positive                                          â”‚
â”‚                                                                             â”‚
â”‚   Q3-Q4 2027 (MONTHS 19-24)                                                â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   â–¡ Second location acquisition (Europe or additional Americas)            â”‚
â”‚   â–¡ 250+ guests served cumulative                                          â”‚
â”‚   â–¡ $5M+ annual revenue run rate                                           â”‚
â”‚   â–¡ Industry recognition and thought leadership                            â”‚
â”‚   â˜… MILESTONE: Series A Complete, Location 2 Secured                       â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Success Metrics Dashboard
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   KEY PERFORMANCE INDICATORS                                                â”‚
â”‚                                                                             â”‚
â”‚   YEAR 1 TARGETS                    STATUS                                 â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€             â”€â”€â”€â”€â”€â”€                                 â”‚
â”‚   Guests Served:        120+        [ Tracking ]                           â”‚
â”‚   Average Revenue/Guest: $30,000    [ Tracking ]                           â”‚
â”‚   Net Promoter Score:   80+         [ Tracking ]                           â”‚
â”‚   Safety Incidents:     0           [ Tracking ]                           â”‚
â”‚   Referral Rate:        40%+        [ Tracking ]                           â”‚
â”‚   Occupancy (Month 12): 50%         [ Tracking ]                           â”‚
â”‚                                                                             â”‚
â”‚   OUTCOME METRICS                                                          â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                          â”‚
â”‚   HRV Improvement:      Target 20%+ baseline improvement                   â”‚
â”‚   PCL-5 Reduction:      Target 30%+ symptom reduction                      â”‚
â”‚   6-Month Retention:    Target 85%+ maintaining gains                      â”‚
â”‚   12-Month Check-in:    Target 70%+ continued improvement                  â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Granular Task Breakdown with Dependencies

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   CRITICAL PATH ANALYSIS (First 6 Months)                                  â”‚
â”‚                                                                             â”‚
â”‚   MONTH 1: Foundation & Funding                         Owner: CEO/Founder â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Week 1-2:                                                                â”‚
â”‚   âœ“ Finalize term sheet with lead investor                [CRITICAL PATH]  â”‚
â”‚     Dependencies: None                                                     â”‚
â”‚     Risk: Investor delays could push entire timeline                       â”‚
â”‚   âœ“ Execute legal entity formation (Delaware + Mexico)                     â”‚
â”‚     Dependencies: None                                                     â”‚
â”‚     Owner: Legal counsel                                                   â”‚
â”‚                                                                             â”‚
â”‚   Week 3-4:                                                                â”‚
â”‚   âœ“ Close $5M seed round (wire transfer)                  [CRITICAL PATH]  â”‚
â”‚     Dependencies: Term sheet signed, legal entities formed                 â”‚
â”‚     Owner: CEO + CFO                                                       â”‚
â”‚   âœ“ Property LOI signed (Hotel Alea or Hacienda Caracol)  [CRITICAL PATH]  â”‚
â”‚     Dependencies: Seed funding closed                                      â”‚
â”‚     Owner: CEO + Real Estate Attorney                                      â”‚
â”‚   âœ“ Begin Medical Director search (recruiter engaged)                      â”‚
â”‚     Dependencies: Funding closed                                           â”‚
â”‚     Owner: CEO                                                             â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   MONTH 2: Property Acquisition & Planning             Owner: COO (hired)  â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Week 5-6:                                                                â”‚
â”‚   âœ“ Complete property due diligence                       [CRITICAL PATH]  â”‚
â”‚     Tasks: Environmental, structural, title search                         â”‚
â”‚     Dependencies: LOI signed                                               â”‚
â”‚     Owner: Real estate attorney + architect                                â”‚
â”‚   âœ“ Hire General Manager / COO                           [CRITICAL PATH]  â”‚
â”‚     Dependencies: Funding closed                                           â”‚
â”‚     Owner: CEO                                                             â”‚
â”‚                                                                             â”‚
â”‚   Week 7-8:                                                                â”‚
â”‚   âœ“ Close property purchase (Fideicomiso established)     [CRITICAL PATH]  â”‚
â”‚     Dependencies: Due diligence complete                                   â”‚
â”‚     Owner: CEO + Mexican bank trustee                                      â”‚
â”‚   âœ“ Architectural plans finalized (medical conversion)    [CRITICAL PATH]  â”‚
â”‚     Dependencies: Property acquired                                        â”‚
â”‚     Owner: Architect + Medical Director candidate                          â”‚
â”‚   âœ“ Construction bids solicited (3+ contractors)                           â”‚
â”‚     Dependencies: Architectural plans                                      â”‚
â”‚     Owner: GM/COO                                                          â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   MONTH 3: Construction & Hiring                        Owner: GM/COO     â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Week 9-10:                                                               â”‚
â”‚   âœ“ Award construction contract                          [CRITICAL PATH]  â”‚
â”‚     Dependencies: Bids received, permits in process                        â”‚
â”‚     Owner: GM/COO                                                          â”‚
â”‚   âœ“ Begin renovation (12-week timeline)                   [CRITICAL PATH]  â”‚
â”‚     Dependencies: Contract awarded, permits approved                       â”‚
â”‚     Owner: General contractor                                              â”‚
â”‚   âœ“ Hire Medical Director (offer letter signed)          [CRITICAL PATH]  â”‚
â”‚     Dependencies: Candidates interviewed                                   â”‚
â”‚     Owner: CEO                                                             â”‚
â”‚                                                                             â”‚
â”‚   Week 11-12:                                                              â”‚
â”‚   âœ“ Medical equipment procurement (order placed)          [CRITICAL PATH]  â”‚
â”‚     Dependencies: Medical Director hired (specifies needs)                 â”‚
â”‚     Owner: Medical Director + GM                                           â”‚
â”‚   âœ“ Platform MVP development begins                                        â”‚
â”‚     Dependencies: CTO hired or contractors engaged                         â”‚
â”‚     Owner: CTO / Tech Lead                                                 â”‚
â”‚   âœ“ Hire Head of Clinical Integration                                     â”‚
â”‚     Dependencies: Medical Director can interview                           â”‚
â”‚     Owner: Medical Director                                                â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   MONTH 4: Build-Out & Protocol Development             Owner: Med Dir    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Week 13-14:                                                              â”‚
â”‚   âœ“ Medical protocols documented (v1.0)                   [CRITICAL PATH]  â”‚
â”‚     Dependencies: Medical Director on board                                â”‚
â”‚     Owner: Medical Director + Clinical Lead                                â”‚
â”‚   âœ“ Staff housing secured (if needed)                                     â”‚
â”‚     Dependencies: Hiring plan finalized                                    â”‚
â”‚     Owner: GM/COO                                                          â”‚
â”‚   âœ“ Hire Lead Facilitator (ceremonies)                   [CRITICAL PATH]  â”‚
â”‚     Dependencies: Medical Director approval                                â”‚
â”‚     Owner: Medical Director + CEO                                          â”‚
â”‚                                                                             â”‚
â”‚   Week 15-16:                                                              â”‚
â”‚   âœ“ COFEPRIS medical registration filed                  [CRITICAL PATH]  â”‚
â”‚     Dependencies: Medical Director licensed in Mexico                      â”‚
â”‚     Owner: Medical Director + Regulatory Counsel                           â”‚
â”‚   âœ“ Medicine sourcing contracts signed (ibogaine)        [CRITICAL PATH]  â”‚
â”‚     Dependencies: Medical Director vets suppliers                          â”‚
â”‚     Owner: Medical Director                                                â”‚
â”‚   âœ“ Hospitality staff hiring begins (6-8 positions)                       â”‚
â”‚     Dependencies: GM/COO on board                                          â”‚
â”‚     Owner: GM/COO                                                          â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   MONTH 5: Systems & Training                            Owner: All Leads â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Week 17-18:                                                              â”‚
â”‚   âœ“ Renovation substantially complete (punch list only)   [CRITICAL PATH]  â”‚
â”‚     Dependencies: 12-week construction timeline                            â”‚
â”‚     Owner: General Contractor                                              â”‚
â”‚   âœ“ Medical equipment installed and tested               [CRITICAL PATH]  â”‚
â”‚     Dependencies: Equipment delivered, facility ready                      â”‚
â”‚     Owner: Medical Director + biomedical tech                              â”‚
â”‚   âœ“ Insurance policies bound (all 7 types)               [CRITICAL PATH]  â”‚
â”‚     Dependencies: Facility ready, medical team hired                       â”‚
â”‚     Owner: CFO + Insurance Broker                                          â”‚
â”‚                                                                             â”‚
â”‚   Week 19-20:                                                              â”‚
â”‚   âœ“ Staff training (2-week intensive)                    [CRITICAL PATH]  â”‚
â”‚     Topics: Medical protocols, guest services, emergencies                 â”‚
â”‚     Dependencies: All core staff hired                                     â”‚
â”‚     Owner: Medical Director + GM + Clinical Lead                           â”‚
â”‚   âœ“ Platform MVP deployed (pre-care module)                                â”‚
â”‚     Dependencies: Development complete, testing done                       â”‚
â”‚     Owner: CTO / Tech Lead                                                 â”‚
â”‚   âœ“ Emergency protocols dry-run (evacuation, cardiac)    [CRITICAL PATH]  â”‚
â”‚     Dependencies: Training complete                                        â”‚
â”‚     Owner: Medical Director                                                â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   MONTH 6: Soft Launch                                   Owner: GM/COO    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Week 21-22:                                                              â”‚
â”‚   âœ“ Final inspections (health, safety, fire)             [CRITICAL PATH]  â”‚
â”‚     Dependencies: Facility complete                                        â”‚
â”‚     Owner: GM/COO + Regulatory Counsel                                     â”‚
â”‚   âœ“ Operating permits issued                             [CRITICAL PATH]  â”‚
â”‚     Dependencies: Inspections passed                                       â”‚
â”‚     Owner: GM/COO                                                          â”‚
â”‚   âœ“ Soft launch: First 3 guests (invite-only)            [CRITICAL PATH]  â”‚
â”‚     Dependencies: All approvals, insurance, staff ready                    â”‚
â”‚     Owner: CEO + Medical Director                                          â”‚
â”‚                                                                             â”‚
â”‚   Week 23-24:                                                              â”‚
â”‚   âœ“ Soft launch: Next 5 guests (founder network)                          â”‚
â”‚     Dependencies: First 3 guests successful                                â”‚
â”‚     Owner: GM/COO                                                          â”‚
â”‚   âœ“ Protocol refinements based on soft launch learnings                   â”‚
â”‚     Dependencies: Soft launch complete                                     â”‚
â”‚     Owner: Medical Director + Clinical Lead                                â”‚
â”‚   âœ“ Full operations launch preparation (Month 7)                          â”‚
â”‚     Dependencies: Soft launch success, all systems go                      â”‚
â”‚     Owner: All Leadership                                                  â”‚
â”‚                                                                             â”‚
â”‚   â˜…â˜…â˜… MILESTONE: FIRST EPICENTER OPERATIONAL â˜…â˜…â˜…                          â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Resource Allocation Plan

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   CAPITAL DEPLOYMENT SCHEDULE ($5M Seed Round)                             â”‚
â”‚                                                                             â”‚
â”‚   Month 1-3 (Foundation):                           $2,850,000    57%      â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Property acquisition (Hotel Alea):      $2,000,000                     â”‚
â”‚   â€¢ Legal & closing costs:                    $120,000                     â”‚
â”‚   â€¢ Initial team salaries (3 months):         $180,000                     â”‚
â”‚   â€¢ Architectural & planning:                  $80,000                     â”‚
â”‚   â€¢ Platform development (Q1):                $250,000                     â”‚
â”‚   â€¢ Insurance deposits:                        $50,000                     â”‚
â”‚   â€¢ Working capital reserve:                  $170,000                     â”‚
â”‚                                                                             â”‚
â”‚   Month 4-6 (Build-Out):                             $1,650,000    33%      â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Renovation & construction:                $900,000                     â”‚
â”‚   â€¢ Medical equipment:                        $280,000                     â”‚
â”‚   â€¢ Furniture, fixtures, equipment:           $180,000                     â”‚
â”‚   â€¢ Team salaries (3 months, expanded):       $210,000                     â”‚
â”‚   â€¢ Platform development (Q2):                 $80,000                     â”‚
â”‚                                                                             â”‚
â”‚   Month 7-18 (Operations Ramp):                      $500,000     10%      â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Operating reserve (12 months):            $300,000                     â”‚
â”‚   â€¢ Marketing & growth:                       $120,000                     â”‚
â”‚   â€¢ Platform completion:                       $80,000                     â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   TOTAL DEPLOYED:                                    $5,000,000   100%     â”‚
â”‚                                                                             â”‚
â”‚   Cash Flow Breakeven: Month 18-20 (no additional capital needed)          â”‚
â”‚   Series A Target: Month 18-24 ($15-25M for expansion)                     â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Risk Mitigation Contingencies

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   TIMELINE RISK MITIGATION                                                 â”‚
â”‚                                                                             â”‚
â”‚   Risk #1: Construction Delays (40% probability)                           â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Baseline: 12 weeks                                                       â”‚
â”‚   Contingency: 16 weeks (add 4 weeks buffer)                               â”‚
â”‚   Mitigation:                                                              â”‚
â”‚   â€¢ Liquidated damages clause ($5k/day after week 14)                      â”‚
â”‚   â€¢ Pre-order long-lead items (medical equipment, HVAC)                    â”‚
â”‚   â€¢ Parallel-track permits (start before closing if possible)              â”‚
â”‚   â€¢ Backup contractor identified                                           â”‚
â”‚   Impact if triggered: Soft launch delayed to Month 7                      â”‚
â”‚                                                                             â”‚
â”‚   Risk #2: Regulatory Approval Delays (25% probability)                    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Baseline: 4-6 weeks for COFEPRIS approval                                â”‚
â”‚   Contingency: 12 weeks (worst case)                                       â”‚
â”‚   Mitigation:                                                              â”‚
â”‚   â€¢ Hire specialist consultant (knows COFEPRIS process)                    â”‚
â”‚   â€¢ File early (Month 3 vs Month 5)                                        â”‚
â”‚   â€¢ Expeditor relationship established                                     â”‚
â”‚   â€¢ Weekly follow-up on application status                                 â”‚
â”‚   Impact if triggered: Soft launch delayed to Month 8                      â”‚
â”‚                                                                             â”‚
â”‚   Risk #3: Key Hire Delays (30% probability)                               â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Critical Role: Medical Director                                          â”‚
â”‚   Contingency: Interim Medical Director (consultant basis)                 â”‚
â”‚   Mitigation:                                                              â”‚
â”‚   â€¢ 3 candidates in pipeline before launch                                 â”‚
â”‚   â€¢ Expedited interview process (2 weeks max)                              â”‚
â”‚   â€¢ Relocation assistance included                                         â”‚
â”‚   â€¢ Interim MD identified (can start in 2 weeks if needed)                 â”‚
â”‚   Impact if triggered: No launch delay, but higher cost                    â”‚
â”‚                                                                             â”‚
â”‚   Risk #4: Funding Delays (15% probability)                                â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Baseline: Close in Month 1                                               â”‚
â”‚   Contingency: Bridge financing ($500k) or founder capital                 â”‚
â”‚   Mitigation:                                                              â”‚
â”‚   â€¢ Multiple committed investors (not single-source)                       â”‚
â”‚   â€¢ Legal docs 90% complete before first meeting                           â”‚
â”‚   â€¢ Rolling close option (take $2M first, $3M within 60 days)              â”‚
â”‚   Impact if triggered: 1-month delay to entire timeline                    â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   BUFFER ANALYSIS:                                                         â”‚
â”‚   Planned soft launch: Month 6                                             â”‚
â”‚   With all contingencies: Month 8-9                                        â”‚
â”‚   Budget buffer: 30% ($1.5M unallocated in seed round)                     â”‚
â”‚   Confidence in Month 6 launch: 70%                                        â”‚
â”‚   Confidence in Month 9 launch: 95%                                        â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Section 12: LEGAL & COMPLIANCE (`/legal`)
**Purpose:** Show we've done the work. Structure is solid. Compliance is built-in.

#### Corporate Structure
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                          CORPORATE STRUCTURE                                â”‚
â”‚                                                                             â”‚
â”‚                    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                         â”‚
â”‚                    â”‚  Transformational Epicenter â”‚                         â”‚
â”‚                    â”‚        Holdings, LLC        â”‚                         â”‚
â”‚                    â”‚      (Delaware, USA)        â”‚                         â”‚
â”‚                    â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                         â”‚
â”‚                                   â”‚                                         â”‚
â”‚              â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                   â”‚
â”‚              â”‚                    â”‚                    â”‚                   â”‚
â”‚              â–¼                    â–¼                    â–¼                   â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”          â”‚
â”‚   â”‚   TE Mexico      â”‚ â”‚   TE Digital     â”‚ â”‚   TE Europe      â”‚          â”‚
â”‚   â”‚   S.A. de C.V.   â”‚ â”‚   LLC            â”‚ â”‚   (Future)       â”‚          â”‚
â”‚   â”‚                  â”‚ â”‚                  â”‚ â”‚                  â”‚          â”‚
â”‚   â”‚   Operating Co   â”‚ â”‚   Platform &     â”‚ â”‚   Regional       â”‚          â”‚
â”‚   â”‚   (Quintana Roo) â”‚ â”‚   Technology     â”‚ â”‚   Operations     â”‚          â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜          â”‚
â”‚                                                                             â”‚
â”‚   FIDEICOMISO (Mexican Bank Trust)                                         â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                        â”‚
â”‚   Required for foreign ownership of real estate in restricted zones        â”‚
â”‚   (within 50km of coast). Bank acts as trustee; we have beneficial rights. â”‚
â”‚                                                                             â”‚
â”‚   INVESTMENT VEHICLE                                                        â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                       â”‚
â”‚   Seed Round: SAFE Notes or Priced Equity (TBD based on investor preference)â”‚
â”‚   Series A: Preferred Equity with standard protections                     â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Regulatory Compliance
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                        REGULATORY FRAMEWORK                                 â”‚
â”‚                                                                             â”‚
â”‚   WHY MEXICO IS LEGAL                                                       â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                      â”‚
â”‚   Ibogaine is NOT a controlled substance in Mexico.                        â”‚
â”‚   Unlike the US (Schedule I), Mexico has no prohibition on ibogaine.       â”‚
â”‚   Multiple clinics operate openly with government awareness.               â”‚
â”‚                                                                             â”‚
â”‚   COMPLIANCE APPROACH                                                       â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                      â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   MEDICAL LICENSING                                                 â”‚  â”‚
â”‚   â”‚   âœ“ Mexican medical licenses for all physicians                    â”‚  â”‚
â”‚   â”‚   âœ“ COFEPRIS compliance (Mexico's FDA equivalent)                  â”‚  â”‚
â”‚   â”‚   âœ“ State health department registration                           â”‚  â”‚
â”‚   â”‚   âœ“ NOM (Official Mexican Standards) compliance                    â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   FACILITY REQUIREMENTS                                            â”‚  â”‚
â”‚   â”‚   âœ“ Commercial/hospitality zoning (verified for each property)     â”‚  â”‚
â”‚   â”‚   âœ“ Environmental permits (SEMARNAT)                               â”‚  â”‚
â”‚   â”‚   âœ“ Fire and safety certifications                                 â”‚  â”‚
â”‚   â”‚   âœ“ Health and sanitation inspections                              â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   DATA & PRIVACY                                                   â”‚  â”‚
â”‚   â”‚   âœ“ HIPAA compliance for US guest data                             â”‚  â”‚
â”‚   â”‚   âœ“ LFPDPPP compliance (Mexico's data protection law)              â”‚  â”‚
â”‚   â”‚   âœ“ Encrypted storage and transmission                             â”‚  â”‚
â”‚   â”‚   âœ“ Business Associate Agreements with all vendors                 â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â”‚   INSURANCE                                                        â”‚  â”‚
â”‚   â”‚   âœ“ Professional liability / medical malpractice                   â”‚  â”‚
â”‚   â”‚   âœ“ General liability                                              â”‚  â”‚
â”‚   â”‚   âœ“ Property insurance                                             â”‚  â”‚
â”‚   â”‚   âœ“ Directors & Officers (D&O)                                     â”‚  â”‚
â”‚   â”‚   âœ“ Cyber liability                                                â”‚  â”‚
â”‚   â”‚   âœ“ Medical evacuation coverage                                    â”‚  â”‚
â”‚   â”‚                                                                     â”‚  â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                                             â”‚
â”‚   LEGAL COUNSEL                                                            â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                            â”‚
â”‚   â€¢ US Corporate: [TBD - Delaware counsel]                                 â”‚
â”‚   â€¢ Mexico Operations: [TBD - Q.R. licensed firm]                          â”‚
â”‚   â€¢ Healthcare Regulatory: [TBD - COFEPRIS specialist]                     â”‚
â”‚   â€¢ Psychedelic Policy: [TBD - specialized counsel]                        â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Legal Counsel & Advisors (Detailed)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   LEGAL TEAM STRUCTURE & ESTIMATED COSTS                                   â”‚
â”‚                                                                             â”‚
â”‚   US CORPORATE COUNSEL                                  Est: $80-120k/year â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Target Firms:                                                            â”‚
â”‚   â€¢ Gunderson Dettmer (preferred - startup specialists)                    â”‚
â”‚   â€¢ Cooley LLP (strong in life sciences + hospitality)                     â”‚
â”‚   â€¢ Goodwin Procter (healthcare expertise)                                 â”‚
â”‚                                                                             â”‚
â”‚   Scope:                                                                   â”‚
â”‚   â€¢ Entity formation (Delaware LLC, subsidiaries)                          â”‚
â”‚   â€¢ Investment documents (SAFE, priced rounds, term sheets)                â”‚
â”‚   â€¢ Cap table management and waterfall analysis                            â”‚
â”‚   â€¢ Employment agreements and equity grants                                â”‚
â”‚   â€¢ Board governance and fiduciary duties                                  â”‚
â”‚   â€¢ M&A preparation and exit execution                                     â”‚
â”‚                                                                             â”‚
â”‚   Retainer: $15k/month + transaction fees                                  â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   MEXICO OPERATIONS COUNSEL                             Est: $60-80k/year  â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Target Firms (Quintana Roo):                                             â”‚
â”‚   â€¢ Santamarina y Steta (CancÃºn office - hospitality experience)           â”‚
â”‚   â€¢ Von Wobeser y Sierra (Playa del Carmen - real estate specialists)      â”‚
â”‚   â€¢ Local boutique firm (Tulum-based, knows local officials)               â”‚
â”‚                                                                             â”‚
â”‚   Scope:                                                                   â”‚
â”‚   â€¢ Fideicomiso setup and management                                       â”‚
â”‚   â€¢ Real estate acquisition and zoning                                     â”‚
â”‚   â€¢ Employment law (Mexican labor code compliance)                         â”‚
â”‚   â€¢ Tax structuring (minimize withholding, optimize structure)             â”‚
â”‚   â€¢ Vendor contracts and supplier agreements                               â”‚
â”‚   â€¢ Ongoing regulatory compliance filings                                  â”‚
â”‚                                                                             â”‚
â”‚   Retainer: $5k/month + transaction fees                                   â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   HEALTHCARE REGULATORY COUNSEL                         Est: $40-60k/year  â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Target Specialists:                                                      â”‚
â”‚   â€¢ Hogan Lovells (Mexico City - COFEPRIS specialists)                     â”‚
â”‚   â€¢ DLA Piper (healthcare regulatory in Mexico)                            â”‚
â”‚   â€¢ Local consultant (former COFEPRIS official - expeditor)                â”‚
â”‚                                                                             â”‚
â”‚   Scope:                                                                   â”‚
â”‚   â€¢ COFEPRIS registration and compliance                                   â”‚
â”‚   â€¢ Medical practice licensing (cÃ©dula profesional)                        â”‚
â”‚   â€¢ NOM standards compliance (facilities, medical devices)                 â”‚
â”‚   â€¢ Health department inspections and remediation                          â”‚
â”‚   â€¢ Medication importation permits (controlled substances)                 â”‚
â”‚   â€¢ Ongoing regulatory monitoring and updates                              â”‚
â”‚                                                                             â”‚
â”‚   Retainer: $3-5k/month (higher Year 1, lower ongoing)                     â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   PSYCHEDELIC POLICY & COMPLIANCE COUNSEL               Est: $30-50k/year  â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Target Firms:                                                            â”‚
â”‚   â€¢ Psychedelic Bar Association members (specialized practice)             â”‚
â”‚   â€¢ Harris Bricken (cannabis/psychedelic regulatory leaders)               â”‚
â”‚   â€¢ Advisor: Ismail Ali (Policy Director, MAPS - advisory only)            â”‚
â”‚                                                                             â”‚
â”‚   Scope:                                                                   â”‚
â”‚   â€¢ Multi-jurisdiction regulatory strategy                                 â”‚
â”‚   â€¢ Expansion country analysis (legal frameworks)                          â”‚
â”‚   â€¢ Risk mitigation for regulatory changes                                 â”‚
â”‚   â€¢ Government relations strategy                                          â”‚
â”‚   â€¢ Industry association membership and advocacy                           â”‚
â”‚                                                                             â”‚
â”‚   Retainer: $2-4k/month + project fees                                     â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   INTELLECTUAL PROPERTY COUNSEL                         Est: $20-40k/year  â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Target Firms:                                                            â”‚
â”‚   â€¢ Fish & Richardson (IP specialists, tech focus)                         â”‚
â”‚   â€¢ Kilpatrick (trademark + tech patents)                                  â”‚
â”‚   â€¢ Mexican IP firm (for local trademark registration)                     â”‚
â”‚                                                                             â”‚
â”‚   Scope:                                                                   â”‚
â”‚   â€¢ Trademark registration (US, Mexico, EU, global)                        â”‚
â”‚   â€¢ Patent applications (AI personalization, biometric systems)            â”‚
â”‚   â€¢ Copyright registration (content, curriculum, software)                 â”‚
â”‚   â€¢ Trade secret protection (NDAs, employee agreements)                    â”‚
â”‚   â€¢ IP licensing agreements (future revenue stream)                        â”‚
â”‚   â€¢ IP portfolio strategy and enforcement                                  â”‚
â”‚                                                                             â”‚
â”‚   Cost: Project-based (Year 1: $30-40k, then $10-15k annually)             â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   TOTAL LEGAL BUDGET (Year 1):          $230,000 - $350,000               â”‚
â”‚   TOTAL LEGAL BUDGET (Year 2+):         $180,000 - $250,000               â”‚
â”‚                                                                             â”‚
â”‚   Note: Transaction fees (acquisitions, exits) are additional              â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Regulatory Deep Dive: Mexico Requirements

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   STEP-BY-STEP MEXICAN REGULATORY COMPLIANCE                               â”‚
â”‚                                                                             â”‚
â”‚   PHASE 1: Entity Formation & Property (Months 1-2)                        â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ RFC (Tax ID) - Federal Taxpayer Registry                               â”‚
â”‚     Timeline: 5-7 business days                                            â”‚
â”‚     Cost: ~$50 USD                                                         â”‚
â”‚     Authority: SAT (Servicio de AdministraciÃ³n Tributaria)                 â”‚
â”‚                                                                             â”‚
â”‚   âœ“ S.A. de C.V. Formation (Mexican corporation)                           â”‚
â”‚     Timeline: 2-3 weeks                                                    â”‚
â”‚     Cost: $2,500-5,000 USD (legal fees)                                    â”‚
â”‚     Requirements: Notary public, articles of incorporation                 â”‚
â”‚                                                                             â”‚
â”‚   âœ“ Fideicomiso (Bank Trust for coastal property)                          â”‚
â”‚     Timeline: 4-6 weeks                                                    â”‚
â”‚     Cost: Setup $3,000-5,000 + Annual $500-1,000                           â”‚
â”‚     Bank: BBVA, Scotiabank, or HSBC Mexico                                 â”‚
â”‚     Permits: 50-year renewable trust                                       â”‚
â”‚                                                                             â”‚
â”‚   âœ“ Commercial Property Registration                                       â”‚
â”‚     Timeline: Concurrent with purchase                                     â”‚
â”‚     Cost: 2-4% of property value (acquisition tax + fees)                  â”‚
â”‚     Authority: Registro PÃºblico de la Propiedad                            â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   PHASE 2: Medical Licensing & Permits (Months 2-4)                        â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ Medical Director - CÃ©dula Profesional (Medical License)                â”‚
â”‚     Timeline: 2-4 weeks (if US-trained, degree validation required)        â”‚
â”‚     Cost: $100-500 USD                                                     â”‚
â”‚     Authority: SEP (SecretarÃ­a de EducaciÃ³n PÃºblica)                       â”‚
â”‚     Requirements: Diploma apostille, Spanish proficiency                   â”‚
â”‚                                                                             â”‚
â”‚   âœ“ COFEPRIS Registration (Health Facility)                                â”‚
â”‚     Timeline: 8-12 weeks (critical path item)                              â”‚
â”‚     Cost: $1,000-3,000 USD filing + expeditor fees                         â”‚
â”‚     Authority: COFEPRIS (Federal Commission for Protection)                â”‚
â”‚     Requirements:                                                          â”‚
â”‚     â€¢ Medical Director with valid cÃ©dula                                   â”‚
â”‚     â€¢ Facility plans and equipment inventory                               â”‚
â”‚     â€¢ Safety protocols and emergency procedures                            â”‚
â”‚     â€¢ Waste management plan (medical waste)                                â”‚
â”‚     Note: Expeditor/consultant recommended ($5-10k)                        â”‚
â”‚                                                                             â”‚
â”‚   âœ“ State Health Department Permit (SecretarÃ­a de Salud Q.R.)              â”‚
â”‚     Timeline: 4-6 weeks                                                    â”‚
â”‚     Cost: $500-1,000 USD                                                   â”‚
â”‚     Authority: Quintana Roo Health Secretariat                             â”‚
â”‚     Inspection: On-site visit required                                     â”‚
â”‚                                                                             â”‚
â”‚   âœ“ Medication Importation Permit (if importing ibogaine)                  â”‚
â”‚     Timeline: 6-8 weeks                                                    â”‚
â”‚     Cost: $500-2,000 USD per shipment                                      â”‚
â”‚     Authority: COFEPRIS + Customs                                          â”‚
â”‚     Alternative: Source from Mexican suppliers (simpler)                   â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   PHASE 3: Operational Permits (Months 3-5)                                â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ Land Use Permit (Uso de Suelo)                                         â”‚
â”‚     Timeline: 2-4 weeks                                                    â”‚
â”‚     Cost: $500-1,500 USD                                                   â”‚
â”‚     Authority: Municipal government                                        â”‚
â”‚     Confirms: Commercial/hospitality zoning                                â”‚
â”‚                                                                             â”‚
â”‚   âœ“ Construction Permit (Licencia de ConstrucciÃ³n)                         â”‚
â”‚     Timeline: 4-8 weeks                                                    â”‚
â”‚     Cost: 0.3-0.5% of construction value                                   â”‚
â”‚     Authority: Municipal government                                        â”‚
â”‚     Requirements: Architect-stamped plans, structural engineer             â”‚
â”‚                                                                             â”‚
â”‚   âœ“ Environmental Impact Permit (MIA - if major construction)              â”‚
â”‚     Timeline: 6-12 weeks                                                   â”‚
â”‚     Cost: $5,000-15,000 USD (study + permit)                               â”‚
â”‚     Authority: SEMARNAT (SecretarÃ­a de Medio Ambiente)                     â”‚
â”‚     Required if: >3,000 mÂ² construction or coastal impact                  â”‚
â”‚                                                                             â”‚
â”‚   âœ“ Fire Safety Certificate (ProtecciÃ³n Civil)                             â”‚
â”‚     Timeline: 2-3 weeks                                                    â”‚
â”‚     Cost: $300-800 USD                                                     â”‚
â”‚     Authority: Municipal fire department                                   â”‚
â”‚     Inspection: On-site equipment and egress review                        â”‚
â”‚                                                                             â”‚
â”‚   âœ“ Food Service Permit (if kitchen operations)                            â”‚
â”‚     Timeline: 2-4 weeks                                                    â”‚
â”‚     Cost: $200-500 USD                                                     â”‚
â”‚     Authority: COFEPRIS + State Health                                     â”‚
â”‚     Inspection: Kitchen facilities and procedures                          â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   PHASE 4: Employment & Operations (Month 5+)                              â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ IMSS Registration (Social Security)                                    â”‚
â”‚     Timeline: 1-2 weeks                                                    â”‚
â”‚     Cost: 30-35% of payroll (employer + employee contributions)            â”‚
â”‚     Authority: IMSS (Mexican Social Security Institute)                    â”‚
â”‚     Required for: All Mexican employees                                    â”‚
â”‚                                                                             â”‚
â”‚   âœ“ INFONAVIT Registration (Housing Fund)                                  â”‚
â”‚     Timeline: Concurrent with IMSS                                         â”‚
â”‚     Cost: 5% of payroll                                                    â”‚
â”‚     Authority: INFONAVIT                                                   â”‚
â”‚                                                                             â”‚
â”‚   âœ“ Work Visas for Foreign Staff (if applicable)                           â”‚
â”‚     Timeline: 6-10 weeks per person                                        â”‚
â”‚     Cost: $500-1,500 USD per visa                                          â”‚
â”‚     Authority: INM (Instituto Nacional de MigraciÃ³n)                       â”‚
â”‚     Types: Temporary resident (1-4 years) or permanent resident            â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   ONGOING COMPLIANCE (Annual Requirements)                                 â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Annual tax return (corporativo): April 30 deadline                     â”‚
â”‚   â€¢ Monthly IMSS/INFONAVIT payments: 17th of each month                    â”‚
â”‚   â€¢ COFEPRIS renewal: Annual inspection and fee                            â”‚
â”‚   â€¢ Fire safety renewal: Annual inspection                                 â”‚
â”‚   â€¢ Food service renewal: Annual inspection                                â”‚
â”‚   â€¢ Property tax (predial): Quarterly payments                             â”‚
â”‚   â€¢ Employee profit sharing (PTU): May 30 deadline                         â”‚
â”‚                                                                             â”‚
â”‚   Estimated ongoing compliance cost: $80-120k/year                         â”‚
â”‚   (includes payroll taxes, legal retainer, permit renewals)                â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Contract & Agreement Inventory

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   KEY CONTRACTS & AGREEMENTS (First 12 Months)                             â”‚
â”‚                                                                             â”‚
â”‚   INVESTMENT & CORPORATE                                                   â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ Seed Investment Agreement (SAFE or Priced Equity)                      â”‚
â”‚   âœ“ Investor Rights Agreement                                              â”‚
â”‚   âœ“ Right of First Refusal & Co-Sale Agreement                             â”‚
â”‚   âœ“ Voting Agreement                                                       â”‚
â”‚   âœ“ Operating Agreement (TE Holdings LLC)                                  â”‚
â”‚   âœ“ Bylaws (TE Mexico S.A. de C.V.)                                        â”‚
â”‚                                                                             â”‚
â”‚   PROPERTY & FACILITIES                                                    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ Fideicomiso Trust Agreement (Bank trustee)                             â”‚
â”‚   âœ“ Purchase & Sale Agreement (Hotel Alea/Hacienda Caracol)                â”‚
â”‚   âœ“ Title Insurance Policy                                                 â”‚
â”‚   âœ“ Property Management Agreement (if third-party)                         â”‚
â”‚   âœ“ Construction Contract (renovation)                                     â”‚
â”‚   âœ“ Architect Agreement                                                    â”‚
â”‚   âœ“ Engineering Agreements (structural, electrical, MEP)                   â”‚
â”‚   âœ“ Utilities Agreements (water, power, internet)                          â”‚
â”‚                                                                             â”‚
â”‚   EMPLOYMENT                                                               â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ Executive Employment Agreements (CEO, CMO, CTO)                        â”‚
â”‚   âœ“ Employee Stock Option Plan (ESOP)                                      â”‚
â”‚   âœ“ Stock Option Agreements (individual grants)                            â”‚
â”‚   âœ“ Confidentiality & IP Assignment Agreements (all staff)                 â”‚
â”‚   âœ“ Non-Compete Agreements (key roles)                                     â”‚
â”‚   âœ“ Offer Letters (standard employees)                                     â”‚
â”‚   âœ“ Contractor Agreements (consultants, part-time)                         â”‚
â”‚   âœ“ Advisory Board Agreements (with compensation schedule)                 â”‚
â”‚                                                                             â”‚
â”‚   MEDICAL & CLINICAL                                                       â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ Medical Director Agreement (with liability provisions)                 â”‚
â”‚   âœ“ Physician Services Agreements (additional MDs)                         â”‚
â”‚   âœ“ Hospital Partnership Agreement (Galenia Hospital - evacuation)         â”‚
â”‚   âœ“ Medical Malpractice Insurance Policy                                   â”‚
â”‚   âœ“ Informed Consent Forms (guests - comprehensive)                        â”‚
â”‚   âœ“ Medical Screening Questionnaire (intake)                               â”‚
â”‚   âœ“ HIPAA Business Associate Agreements (vendors with PHI access)          â”‚
â”‚   âœ“ Clinical Trial Registration (if conducting research)                   â”‚
â”‚                                                                             â”‚
â”‚   GUEST SERVICES                                                           â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ Guest Services Agreement (terms of service)                            â”‚
â”‚   âœ“ Liability Waiver (assumption of risk)                                  â”‚
â”‚   âœ“ Privacy Policy (HIPAA + LFPDPPP compliant)                             â”‚
â”‚   âœ“ Photography/Media Release (optional for guests)                        â”‚
â”‚   âœ“ Cancellation & Refund Policy                                           â”‚
â”‚   âœ“ Payment Processing Agreement (Stripe, etc.)                            â”‚
â”‚                                                                             â”‚
â”‚   SUPPLIERS & VENDORS                                                      â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ Ibogaine Supply Agreement (2-3 suppliers)                              â”‚
â”‚   âœ“ Food & Beverage Supplier Agreements                                    â”‚
â”‚   âœ“ Medical Equipment Lease/Purchase Agreements                            â”‚
â”‚   âœ“ Linen & Amenities Supply Agreement                                     â”‚
â”‚   âœ“ Waste Management Agreement (medical waste)                             â”‚
â”‚   âœ“ Security Services Agreement                                            â”‚
â”‚   âœ“ Transportation Services Agreement (airport pickup)                     â”‚
â”‚                                                                             â”‚
â”‚   TECHNOLOGY & PLATFORMS                                                   â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ Software Development Agreement (platform contractors)                  â”‚
â”‚   âœ“ SaaS Agreements (EHR, CRM, scheduling systems)                         â”‚
â”‚   âœ“ AWS/Cloud Hosting Agreement                                            â”‚
â”‚   âœ“ Data Processing Agreement (cloud providers)                            â”‚
â”‚   âœ“ Software License Agreements (any third-party tools)                    â”‚
â”‚                                                                             â”‚
â”‚   INSURANCE                                                                â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ Medical Malpractice Policy ($5M / $15M)                                â”‚
â”‚   âœ“ General Liability Policy ($2M / $4M)                                   â”‚
â”‚   âœ“ Property Insurance Policy                                              â”‚
â”‚   âœ“ D&O Insurance Policy ($3M)                                             â”‚
â”‚   âœ“ Cyber Liability Policy ($1M)                                           â”‚
â”‚   âœ“ EPLI Policy ($1M)                                                      â”‚
â”‚   âœ“ Medical Evacuation Insurance                                           â”‚
â”‚                                                                             â”‚
â”‚   Total Contracts (Year 1): 60-80 agreements                               â”‚
â”‚   Contract management system: Required (recommend Ironclad or DocuSign CLM)â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Section 13: OUTCOME MEASUREMENT (`/outcomes`)
**Purpose:** Show we prove transformation works. Science-backed, measurable results.

#### Clinical Measurement Framework
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                      MEASURING TRANSFORMATION                               â”‚
â”‚                                                                             â”‚
â”‚   We don't just claim transformation. We measure it.                       â”‚
â”‚                                                                             â”‚
â”‚   VALIDATED CLINICAL SCALES                                                 â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”           â”‚
â”‚   â”‚     PCL-5       â”‚  â”‚     PHQ-9       â”‚  â”‚     GAD-7       â”‚           â”‚
â”‚   â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚           â”‚
â”‚   â”‚  PTSD Symptoms  â”‚  â”‚  Depression     â”‚  â”‚  Anxiety        â”‚           â”‚
â”‚   â”‚                 â”‚  â”‚                 â”‚  â”‚                 â”‚           â”‚
â”‚   â”‚  20-item scale  â”‚  â”‚  9-item scale   â”‚  â”‚  7-item scale   â”‚           â”‚
â”‚   â”‚  Gold standard  â”‚  â”‚  Clinical std   â”‚  â”‚  Clinical std   â”‚           â”‚
â”‚   â”‚  for trauma     â”‚  â”‚  for depression â”‚  â”‚  for anxiety    â”‚           â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜           â”‚
â”‚                                                                             â”‚
â”‚   BIOMETRIC TRACKING                                                        â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                       â”‚
â”‚                                                                             â”‚
â”‚   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”           â”‚
â”‚   â”‚      HRV        â”‚  â”‚   Sleep Data    â”‚  â”‚  Blood Panels   â”‚           â”‚
â”‚   â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚           â”‚
â”‚   â”‚  Heart Rate     â”‚  â”‚  Quality &      â”‚  â”‚  Inflammation   â”‚           â”‚
â”‚   â”‚  Variability    â”‚  â”‚  Duration       â”‚  â”‚  Hormones       â”‚           â”‚
â”‚   â”‚                 â”‚  â”‚                 â”‚  â”‚  Metabolic      â”‚           â”‚
â”‚   â”‚  Nervous system â”‚  â”‚  Recovery       â”‚  â”‚  markers        â”‚           â”‚
â”‚   â”‚  regulation     â”‚  â”‚  indicator      â”‚  â”‚                 â”‚           â”‚
â”‚   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜           â”‚
â”‚                                                                             â”‚
â”‚   MEASUREMENT POINTS                                                        â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                       â”‚
â”‚   ğŸ“ Pre-arrival baseline (4-8 weeks before)                               â”‚
â”‚   ğŸ“ Arrival assessment (Day 1)                                            â”‚
â”‚   ğŸ“ Mid-program check-in (Day 7-14)                                       â”‚
â”‚   ğŸ“ Departure assessment (Final day)                                      â”‚
â”‚   ğŸ“ 30-day follow-up                                                      â”‚
â”‚   ğŸ“ 90-day follow-up                                                      â”‚
â”‚   ğŸ“ 6-month integration check                                             â”‚
â”‚   ğŸ“ 12-month annual review                                                â”‚
â”‚                                                                             â”‚
â”‚   OUTCOME TARGETS                                                          â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                                          â”‚
â”‚   â€¢ PCL-5: 30%+ reduction in trauma symptoms                               â”‚
â”‚   â€¢ PHQ-9: 40%+ improvement in depression scores                           â”‚
â”‚   â€¢ GAD-7: 35%+ reduction in anxiety                                       â”‚
â”‚   â€¢ HRV: 20%+ improvement in nervous system regulation                     â”‚
â”‚   â€¢ Guest satisfaction: NPS 80+                                            â”‚
â”‚   â€¢ 12-month maintenance: 70%+ sustaining gains                            â”‚
â”‚                                                                             â”‚
â”‚   This data becomes our competitive moat.                                  â”‚
â”‚   No competitor is collecting outcomes at this level.                      â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Research Evidence Base

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   SCIENTIFIC FOUNDATION: PUBLISHED RESEARCH                                â”‚
â”‚                                                                             â”‚
â”‚   IBOGAINE EFFICACY STUDIES                                                â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Noller et al. (2018) - "Ibogaine Treatment Outcomes"                  â”‚
â”‚     Journal: American Journal of Drug and Alcohol Abuse                    â”‚
â”‚     N=30 participants, 12-month follow-up                                  â”‚
â”‚     Results: 50% abstinence from opioids at 12 months                      â”‚
â”‚     Safety: Zero serious adverse events with medical screening             â”‚
â”‚                                                                             â”‚
â”‚   â€¢ Brown & Alper (2018) - "Treatment of Opioid Use Disorder"              â”‚
â”‚     Journal: Current Drug Abuse Reviews                                    â”‚
â”‚     Review: 19 observational studies, 768 total participants               â”‚
â”‚     Conclusion: Ibogaine shows promise for addiction treatment             â”‚
â”‚                                                                             â”‚
â”‚   â€¢ Mash et al. (2018) - "Ibogaine Pharmacokinetics"                      â”‚
â”‚     Journal: Journal of Ethnopharmacology                                  â”‚
â”‚     Finding: Safe metabolic profile with proper screening                  â”‚
â”‚     Critical: EKG screening prevents cardiac complications                 â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   TRAUMA & PTSD TREATMENT EVIDENCE                                         â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Mitchell et al. (2021) - "MDMA-Assisted Therapy for PTSD"              â”‚
â”‚     Journal: Nature Medicine                                               â”‚
â”‚     N=90, Phase 3 trial                                                    â”‚
â”‚     Results: 67% no longer met PTSD criteria (vs 32% placebo)              â”‚
â”‚     Relevance: Psychedelic-assisted therapy efficacy established           â”‚
â”‚                                                                             â”‚
â”‚   â€¢ Carhart-Harris et al. (2021) - "Psilocybin for Depression"             â”‚
â”‚     Journal: New England Journal of Medicine                               â”‚
â”‚     N=59, compared to escitalopram                                         â”‚
â”‚     Results: Non-inferior to SSRI, faster onset                            â”‚
â”‚     Relevance: Validates psychedelic therapy model                         â”‚
â”‚                                                                             â”‚
â”‚   â€¢ van der Kolk (2014) - "The Body Keeps the Score"                       â”‚
â”‚     Evidence: Somatic approaches essential for trauma                      â”‚
â”‚     Application: Validates our polyvagal/somatic framework                 â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   BIOMETRIC OUTCOME MEASURES                                               â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Shaffer et al. (2014) - "HRV as Biomarker for Health"                  â”‚
â”‚     Journal: Frontiers in Public Health                                    â”‚
â”‚     Evidence: HRV correlates with emotional regulation, resilience         â”‚
â”‚     Application: Primary biometric in our measurement framework            â”‚
â”‚                                                                             â”‚
â”‚   â€¢ Kaufmann et al. (2016) - "Heart Rate Variability Biofeedback"          â”‚
â”‚     Journal: Applied Psychophysiology & Biofeedback                        â”‚
â”‚     Finding: HRV training improves PTSD symptoms                           â”‚
â”‚     Relevance: Supports our nervous system optimization approach           â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   INTEGRATION & LONG-TERM OUTCOMES                                         â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Wolff et al. (2020) - "Psychedelic Integration"                        â”‚
â”‚     Journal: Journal of Psychoactive Drugs                                 â”‚
â”‚     Finding: Integration predicts long-term benefit maintenance            â”‚
â”‚     Application: Why we invest heavily in 3-12 month post-care             â”‚
â”‚                                                                             â”‚
â”‚   â€¢ Erritzoe et al. (2018) - "Psilocybin with Psychological Support"       â”‚
â”‚     Journal: Psychopharmacology                                            â”‚
â”‚     Finding: Therapeutic support essential for positive outcomes           â”‚
â”‚     Relevance: Validates our facilitator + therapist model                 â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Outcome Data Collection & Analysis Plan

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   DATA COLLECTION METHODOLOGY                                              â”‚
â”‚                                                                             â”‚
â”‚   QUANTITATIVE MEASURES (Every Guest)                                      â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Psychological:                                                           â”‚
â”‚   â€¢ PCL-5 (PTSD Checklist, 20 items): 8 measurement points                 â”‚
â”‚   â€¢ PHQ-9 (Depression, 9 items): 8 measurement points                      â”‚
â”‚   â€¢ GAD-7 (Anxiety, 7 items): 8 measurement points                         â”‚
â”‚   â€¢ WHO-5 (Well-being, 5 items): 8 measurement points                      â”‚
â”‚   â€¢ NPS (Net Promoter Score): Post-departure, 6-month                      â”‚
â”‚                                                                             â”‚
â”‚   Biometric (Continuous):                                                  â”‚
â”‚   â€¢ HRV: Daily (Oura Ring or Whoop strap) - 90 days pre, during, 180 post  â”‚
â”‚   â€¢ Sleep: Daily metrics (duration, deep sleep %, REM %)                   â”‚
â”‚   â€¢ Resting heart rate: Daily                                              â”‚
â”‚   â€¢ Activity levels: Daily step count, exercise minutes                    â”‚
â”‚                                                                             â”‚
â”‚   Laboratory (Selective):                                                  â”‚
â”‚   â€¢ Baseline blood panel: Pre-arrival                                      â”‚
â”‚     - CBC, CMP, lipids, HbA1c, hs-CRP (inflammation)                       â”‚
â”‚     - Cortisol (stress marker), DHEA, testosterone                         â”‚
â”‚   â€¢ Follow-up panel: 90-day (if guest opts in)                             â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   QUALITATIVE MEASURES (Subset of Guests)                                  â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ Semi-structured interviews (30-60 min)                                 â”‚
â”‚     Timeline: Pre-arrival, departure, 30-day, 6-month, 12-month            â”‚
â”‚     Topics: Life changes, relationship shifts, career impact               â”‚
â”‚   â€¢ Written reflections (journal entries)                                  â”‚
â”‚     Prompts provided via app, analyzed for themes                          â”‚
â”‚   â€¢ Video testimonials (with consent)                                      â”‚
â”‚     Timeline: 3-month, 6-month, 12-month                                   â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   DATA MANAGEMENT & PRIVACY                                                â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Platform: REDCap (Research Electronic Data Capture)                      â”‚
â”‚   â€¢ HIPAA-compliant, industry standard for clinical research               â”‚
â”‚   â€¢ IRB-approved data collection workflows                                 â”‚
â”‚   â€¢ De-identified datasets for analysis                                    â”‚
â”‚                                                                             â”‚
â”‚   Privacy Protections:                                                     â”‚
â”‚   â€¢ Consent obtained for research participation (opt-in)                   â”‚
â”‚   â€¢ Data anonymized for publication (no PII)                               â”‚
â”‚   â€¢ Secure storage (encrypted at rest and in transit)                      â”‚
â”‚   â€¢ Access controls (only authorized researchers)                          â”‚
â”‚                                                                             â”‚
â”‚   Data Ownership:                                                          â”‚
â”‚   â€¢ Guest owns their personal data (can request deletion)                  â”‚
â”‚   â€¢ Company owns de-identified aggregate data                              â”‚
â”‚   â€¢ Research publications require separate consent                         â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Publication & Research Strategy

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   RESEARCH ROADMAP (3-Year Plan)                                           â”‚
â”‚                                                                             â”‚
â”‚   YEAR 1: Data Collection & Pilot Analysis                                â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Q2-Q4 2026:                                                              â”‚
â”‚   â€¢ Enroll first 50 guests in outcome study                                â”‚
â”‚   â€¢ Establish data collection SOPs (Standard Operating Procedures)         â”‚
â”‚   â€¢ Hire outcomes coordinator (part-time, clinical research background)    â”‚
â”‚   â€¢ IRB approval for observational study                                   â”‚
â”‚                                                                             â”‚
â”‚   Deliverable: Internal report on first 50 guests (confidential)           â”‚
â”‚   Use: Refine protocols, identify early trends                             â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   YEAR 2: Analysis & Conference Presentations                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Q1-Q2 2027:                                                              â”‚
â”‚   â€¢ Analyze first 150 guests (with 6-month follow-up data)                 â”‚
â”‚   â€¢ Partner with academic institution (UCSF, Johns Hopkins, NYU)           â”‚
â”‚   â€¢ Submit abstracts to conferences                                        â”‚
â”‚                                                                             â”‚
â”‚   Target Conferences:                                                      â”‚
â”‚   â€¢ MAPS Psychedelic Science (June 2027) - Poster presentation             â”‚
â”‚   â€¢ CIIS (California Institute of Integral Studies) Symposium              â”‚
â”‚   â€¢ American Psychological Association Annual Convention                   â”‚
â”‚                                                                             â”‚
â”‚   Deliverable: Conference poster/presentation                              â”‚
â”‚   Impact: Build credibility, attract research partners                     â”‚
â”‚                                                                             â”‚
â”‚   Q3-Q4 2027:                                                              â”‚
â”‚   â€¢ Draft manuscript for peer-reviewed journal                             â”‚
â”‚   â€¢ Title: "Integrated Psychedelic-Assisted Transformation:                â”‚
â”‚            Outcomes from 150 Participants"                                 â”‚
â”‚   â€¢ Co-authors: Medical Director + Academic partner                        â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   YEAR 3: Publication & Thought Leadership                                â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Q1-Q2 2028:                                                              â”‚
â”‚   â€¢ Submit to target journal                                               â”‚
â”‚     Tier 1 targets: JAMA Psychiatry, The Lancet Psychiatry                 â”‚
â”‚     Tier 2 targets: Journal of Psychopharmacology, Psychopharmacology      â”‚
â”‚     Tier 3 targets: Journal of Psychoactive Drugs                          â”‚
â”‚   â€¢ Peer review process (6-12 months)                                      â”‚
â”‚                                                                             â”‚
â”‚   Q3-Q4 2028:                                                              â”‚
â”‚   â€¢ Publication! (press release, media outreach)                           â”‚
â”‚   â€¢ Present at MAPS, APA, other major conferences (invited talk)           â”‚
â”‚   â€¢ Launch outcomes dashboard (public, anonymized data viz)                â”‚
â”‚                                                                             â”‚
â”‚   Deliverable: Published peer-reviewed research                            â”‚
â”‚   Impact:                                                                  â”‚
â”‚   â€¢ Legitimacy (no competitor has published outcomes)                      â”‚
â”‚   â€¢ Media coverage (NYT, VICE, Tim Ferriss podcast)                        â”‚
â”‚   â€¢ Investor confidence (data-driven transformation)                       â”‚
â”‚   â€¢ Guest acquisition (proof of concept)                                   â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   ONGOING: Case Study Development                                         â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Throughout Years 1-3:                                                    â”‚
â”‚   â€¢ Identify 5-10 exemplary transformation stories                         â”‚
â”‚   â€¢ Obtain consent for detailed case studies                               â”‚
â”‚   â€¢ Document: Pre-state, journey, post-transformation, life impact         â”‚
â”‚   â€¢ Create multimedia case studies (video + written)                       â”‚
â”‚                                                                             â”‚
â”‚   Use Cases:                                                               â”‚
â”‚   â€¢ Marketing materials (with permission)                                  â”‚
â”‚   â€¢ Investor presentations (anonymized if needed)                          â”‚
â”‚   â€¢ Training materials (for future staff)                                  â”‚
â”‚   â€¢ Book chapter contributions                                             â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Data Visualization & Reporting

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   PUBLIC OUTCOMES DASHBOARD (Post-Publication)                             â”‚
â”‚                                                                             â”‚
â”‚   Real-time, Anonymized Guest Outcomes                                     â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Metrics Displayed:                                                       â”‚
â”‚   â€¢ Total guests served (cumulative)                                       â”‚
â”‚   â€¢ Average PCL-5 reduction: XX% (with confidence interval)                â”‚
â”‚   â€¢ Average PHQ-9 improvement: XX%                                         â”‚
â”‚   â€¢ Average GAD-7 reduction: XX%                                           â”‚
â”‚   â€¢ Average HRV improvement: +XX ms (RMSSD)                                â”‚
â”‚   â€¢ 6-month maintenance rate: XX% (guests sustaining gains)                â”‚
â”‚   â€¢ Net Promoter Score: XX                                                 â”‚
â”‚                                                                             â”‚
â”‚   Visualizations:                                                          â”‚
â”‚   â€¢ Before/after scatter plots (de-identified)                             â”‚
â”‚   â€¢ Time-series: Average improvement trajectory (weeks 0-52)               â”‚
â”‚   â€¢ HRV trends: Daily average across cohort                                â”‚
â”‚   â€¢ Guest satisfaction trends over time                                    â”‚
â”‚                                                                             â”‚
â”‚   Interactive Features:                                                    â”‚
â”‚   â€¢ Filter by: program length, age range, primary concern                  â”‚
â”‚   â€¢ Compare cohorts: Early guests vs recent guests (quality improvement)   â”‚
â”‚   â€¢ Download anonymized dataset (for researchers)                          â”‚
â”‚                                                                             â”‚
â”‚   Platform: Custom dashboard (React + D3.js) or Tableau Public             â”‚
â”‚   Update Frequency: Monthly                                                â”‚
â”‚                                                                             â”‚
â”‚   Competitive Advantage:                                                   â”‚
â”‚   No competitor publishes real outcome data. This is radical transparency. â”‚
â”‚   Builds trust. Attracts quality guests. Creates media hooks.              â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Institutional Partnerships (Research)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   TARGET RESEARCH PARTNERSHIPS                                             â”‚
â”‚                                                                             â”‚
â”‚   TIER 1: Leading Psychedelic Research Centers                            â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Johns Hopkins Center for Psychedelic & Consciousness Research            â”‚
â”‚   â€¢ Director: Dr. Roland Griffiths (emeritus)                              â”‚
â”‚   â€¢ Opportunity: Collaborate on ibogaine protocols                         â”‚
â”‚   â€¢ Value Exchange: We provide real-world data, they provide expertise     â”‚
â”‚                                                                             â”‚
â”‚   UCSF Neuroscape & Psychedelic Research Group                             â”‚
â”‚   â€¢ Director: Dr. Adam Gazzaley (neuroscience, tech + psychedelics)        â”‚
â”‚   â€¢ Opportunity: Biometric integration research                            â”‚
â”‚   â€¢ Value Exchange: Access to our HRV/sleep data, co-publication           â”‚
â”‚                                                                             â”‚
â”‚   Imperial College London - Centre for Psychedelic Research                â”‚
â”‚   â€¢ Director: Dr. David Nutt, Dr. Robin Carhart-Harris                     â”‚
â”‚   â€¢ Opportunity: Global psychedelic therapy standards                      â”‚
â”‚   â€¢ Value Exchange: European expansion insights, research credibility      â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   TIER 2: Trauma & Integration Specialists                                â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Polyvagal Institute (Dr. Stephen Porges)                                 â”‚
â”‚   â€¢ Opportunity: Validate polyvagal-informed protocols                     â”‚
â”‚   â€¢ Measurement: HRV as proxy for vagal tone improvement                   â”‚
â”‚                                                                             â”‚
â”‚   Trauma Research Foundation (Dr. Bessel van der Kolk)                     â”‚
â”‚   â€¢ Opportunity: Somatic + psychedelic integration research                â”‚
â”‚   â€¢ Value: Credibility in trauma treatment space                           â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   PARTNERSHIP STRUCTURE                                                    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   â€¢ MOU (Memorandum of Understanding) for data sharing                     â”‚
â”‚   â€¢ IRB approval through partner institution (easier than independent)     â”‚
â”‚   â€¢ Co-authorship on publications                                          â”‚
â”‚   â€¢ Guest referrals (researchers send clients to us)                       â”‚
â”‚   â€¢ Training exchange (we train in protocols, they train in research)      â”‚
â”‚                                                                             â”‚
â”‚   Financial Model:                                                         â”‚
â”‚   â€¢ No direct payment to partners                                          â”‚
â”‚   â€¢ Academic prestige + publication credit is compensation                 â”‚
â”‚   â€¢ We cover: Data collection costs, REDCap licenses, coordinator salary   â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Section 14: DATA ROOM (`/data-room`)
**Purpose:** Show due diligence materials are ready. Organized. Professional.

#### Data Room Contents (Password Protected)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                         INVESTOR DATA ROOM                                  â”‚
â”‚                                                                             â”‚
â”‚   ğŸ“ EXECUTIVE MATERIALS                                                   â”‚
â”‚   â”œâ”€â”€ Executive Summary (PDF)                                              â”‚
â”‚   â”œâ”€â”€ Investment Thesis One-Pager                                          â”‚
â”‚   â”œâ”€â”€ Pitch Deck (Interactive + PDF)                                       â”‚
â”‚   â””â”€â”€ Founder Letter                                                       â”‚
â”‚                                                                             â”‚
â”‚   ğŸ“ FINANCIAL MODEL                                                       â”‚
â”‚   â”œâ”€â”€ 5-Year Financial Projections (Excel)                                 â”‚
â”‚   â”œâ”€â”€ Unit Economics Analysis                                              â”‚
â”‚   â”œâ”€â”€ Sensitivity Analysis                                                 â”‚
â”‚   â”œâ”€â”€ Cap Table (Current + Pro Forma)                                      â”‚
â”‚   â””â”€â”€ Use of Funds Detail                                                  â”‚
â”‚                                                                             â”‚
â”‚   ğŸ“ PROPERTY ANALYSIS                                                     â”‚
â”‚   â”œâ”€â”€ Hotel Alea Tulum - Full Evaluation                                   â”‚
â”‚   â”œâ”€â”€ Hacienda Caracol - Full Evaluation                                   â”‚
â”‚   â”œâ”€â”€ Property Comparison Matrix                                           â”‚
â”‚   â”œâ”€â”€ Renovation Estimates                                                 â”‚
â”‚   â””â”€â”€ Architectural Concept Plans                                          â”‚
â”‚                                                                             â”‚
â”‚   ğŸ“ MARKET RESEARCH                                                       â”‚
â”‚   â”œâ”€â”€ $5.6T Market Analysis                                                â”‚
â”‚   â”œâ”€â”€ Competitor Deep Dives (10 companies)                                 â”‚
â”‚   â”œâ”€â”€ Customer Persona Research                                            â”‚
â”‚   â”œâ”€â”€ Pricing Analysis & Comparables                                       â”‚
â”‚   â””â”€â”€ 30-Location Expansion Research                                       â”‚
â”‚                                                                             â”‚
â”‚   ğŸ“ OPERATIONAL DOCUMENTATION                                             â”‚
â”‚   â”œâ”€â”€ 8 Segment Operating Playbooks                                        â”‚
â”‚   â”œâ”€â”€ Medical Protocols Overview                                           â”‚
â”‚   â”œâ”€â”€ Guest Journey Maps                                                   â”‚
â”‚   â”œâ”€â”€ Safety & Emergency Procedures                                        â”‚
â”‚   â””â”€â”€ Staff Training Curriculum                                            â”‚
â”‚                                                                             â”‚
â”‚   ğŸ“ LEGAL & COMPLIANCE                                                    â”‚
â”‚   â”œâ”€â”€ Corporate Structure Memo                                             â”‚
â”‚   â”œâ”€â”€ Regulatory Compliance Summary                                        â”‚
â”‚   â”œâ”€â”€ Mexico Legal Framework                                               â”‚
â”‚   â”œâ”€â”€ HIPAA Compliance Documentation                                       â”‚
â”‚   â””â”€â”€ Insurance Coverage Summary                                           â”‚
â”‚                                                                             â”‚
â”‚   ğŸ“ TECHNOLOGY                                                            â”‚
â”‚   â”œâ”€â”€ Platform Architecture Overview                                       â”‚
â”‚   â”œâ”€â”€ AI System Specification                                              â”‚
â”‚   â”œâ”€â”€ Security & Privacy Framework                                         â”‚
â”‚   â””â”€â”€ Development Roadmap                                                  â”‚
â”‚                                                                             â”‚
â”‚   ğŸ“ TEAM                                                                  â”‚
â”‚   â”œâ”€â”€ Founder Bios & Backgrounds                                           â”‚
â”‚   â”œâ”€â”€ Key Hire Profiles                                                    â”‚
â”‚   â”œâ”€â”€ Advisory Board (Planned)                                             â”‚
â”‚   â””â”€â”€ Org Chart (Current + Planned)                                        â”‚
â”‚                                                                             â”‚
â”‚   ğŸ“ APPENDIX                                                              â”‚
â”‚   â”œâ”€â”€ Reference Letters (Available on Request)                             â”‚
â”‚   â”œâ”€â”€ Press Coverage / Media                                               â”‚
â”‚   â””â”€â”€ Research Papers & Evidence Base                                      â”‚
â”‚                                                                             â”‚
â”‚                    [ REQUEST DATA ROOM ACCESS ]                            â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Section 15: INVESTOR FAQ (`/faq`)
**Purpose:** Answer the questions before they ask. Remove all friction.

#### Common Questions (Expandable Accordion)
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                        FREQUENTLY ASKED QUESTIONS                           â”‚
â”‚                                                                             â”‚
â”‚   â–º "Is ibogaine legal?"                                                   â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   Yes, in Mexico. Unlike the US (Schedule I), ibogaine is not a            â”‚
â”‚   controlled substance in Mexico. Multiple clinics operate openly.         â”‚
â”‚   We also operate in other legal jurisdictions as we expand.               â”‚
â”‚                                                                             â”‚
â”‚   â–º "What if regulations change?"                                          â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   Multi-jurisdictional strategy across 30 planned locations.               â”‚
â”‚   Wellness-only programs provide non-medicine revenue stream.              â”‚
â”‚   Regulatory relationships in each market provide early warning.           â”‚
â”‚                                                                             â”‚
â”‚   â–º "How do you handle medical emergencies?"                               â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   24/7 physician on-site. Cardiac screening mandatory before ceremony.     â”‚
â”‚   JCI-accredited hospital (Galenia) within 70 minutes.                     â”‚
â”‚   Helicopter evacuation protocol established. Full insurance coverage.     â”‚
â”‚                                                                             â”‚
â”‚   â–º "Who is your competition?"                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   No direct competitor integrates all 4 pillars. Medical clinics won't     â”‚
â”‚   touch plant medicine. Luxury resorts lack clinical expertise.            â”‚
â”‚   Plant medicine centers can't afford medical infrastructure.              â”‚
â”‚   We're creating the category, not competing in an existing one.           â”‚
â”‚                                                                             â”‚
â”‚   â–º "What's your customer acquisition strategy?"                           â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   40%+ from referrals (target). Ambassador program (2.5-10% commission).   â”‚
â”‚   High-touch content marketing. Strategic partnerships with executive      â”‚
â”‚   coaches, therapists, and concierge medicine practices.                   â”‚
â”‚                                                                             â”‚
â”‚   â–º "How do you prove transformation works?"                               â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   Validated clinical scales (PCL-5, PHQ-9, GAD-7). HRV biometrics.         â”‚
â”‚   8 measurement points from pre-care through 12-month follow-up.           â”‚
â”‚   This outcome data becomes our competitive moat.                          â”‚
â”‚                                                                             â”‚
â”‚   â–º "What's the path to liquidity?"                                        â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   Primary: Strategic acquisition (Year 5-7) by hospitality, healthcare,    â”‚
â”‚   or PE wellness platform. Secondary: IPO/SPAC at scale (Year 7-10).       â”‚
â”‚   Dividend recapitalization possible at 70%+ occupancy.                    â”‚
â”‚                                                                             â”‚
â”‚   â–º "Why should I invest now vs. later?"                                   â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   Seed stage = lowest valuation, highest upside (2.61x MOIC target).       â”‚
â”‚   First-mover advantage window is now. Talent availability is now.         â”‚
â”‚   Property prices in Mexico are rising. Regulatory clarity is favorable.   â”‚
â”‚                                                                             â”‚
â”‚   â–º "What are the biggest risks?"                                          â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   See Risk & Mitigation section. We've identified 5 key risks and have     â”‚
â”‚   documented mitigation strategies for each. We're not naive about         â”‚
â”‚   challengesâ€”we've planned for them.                                       â”‚
â”‚                                                                             â”‚
â”‚   â–º "What do you need from investors beyond capital?"                      â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚   Strategic introductions (UHNW networks, healthcare executives).          â”‚
â”‚   Operational expertise (hospitality, healthcare, technology).             â”‚
â”‚   We seek partners, not just capital.                                      â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Section 16: INVEST (`/invest`)
**Purpose:** The ask. The terms. The path forward.

#### The Opportunity
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                              THE ASK                                        â”‚
â”‚                                                                             â”‚
â”‚                             $5,000,000                                      â”‚
â”‚                            Seed / Series A                                  â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€         â”‚
â”‚                                                                             â”‚
â”‚   USE OF FUNDS                                                             â”‚
â”‚                                                                             â”‚
â”‚   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ  40%  $2.0M  Facility &       â”‚
â”‚                                                           Operations       â”‚
â”‚   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                 30%  $1.5M  Platform        â”‚
â”‚                                                           Development     â”‚
â”‚   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                             15%  $750K  Team            â”‚
â”‚                                                           Expansion       â”‚
â”‚   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                                    10%  $500K  Marketing       â”‚
â”‚                                                           & Growth        â”‚
â”‚   â–ˆâ–ˆâ–ˆâ–ˆâ–ˆ                                         5%  $250K  Legal &         â”‚
â”‚                                                           Compliance      â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Investment Thesis Summary
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   WHY THIS INVESTMENT?                                                      â”‚
â”‚                                                                             â”‚
â”‚   1. STRUCTURAL OPPORTUNITY                                                â”‚
â”‚      No competitor has unified the four pillars.                           â”‚
â”‚      First-mover advantage in category creation.                           â”‚
â”‚                                                                             â”‚
â”‚   2. CLEAR UNIT ECONOMICS                                                  â”‚
â”‚      $30,000 average revenue per guest.                                    â”‚
â”‚      Strong gross margins. 42% break-even occupancy.                       â”‚
â”‚                                                                             â”‚
â”‚   3. PROVEN MARKET                                                         â”‚
â”‚      Comparable businesses operating at scale.                             â”‚
â”‚      Paracelsus charges $134K/week. SHA runs at 90% occupancy.             â”‚
â”‚                                                                             â”‚
â”‚   4. DEFENSIBLE MOAT                                                       â”‚
â”‚      Medical credibility + luxury + plant medicine + community.            â”‚
â”‚      Competitors can't replicate without rebuilding from scratch.          â”‚
â”‚                                                                             â”‚
â”‚   5. ETHICAL IMPACT                                                        â”‚
â”‚      Transforming lives while building sustainable business.               â”‚
â”‚      Real healing. Measurable outcomes.                                    â”‚
â”‚                                                                             â”‚
â”‚   6. GLOBAL EXPANSION PATH                                                 â”‚
â”‚      30-location roadmap. $50M+ revenue potential at scale.                â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Next Steps / CTA
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                          READY TO EXPLORE?                                  â”‚
â”‚                                                                             â”‚
â”‚         â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                â”‚
â”‚         â”‚                                                 â”‚                â”‚
â”‚         â”‚         [ REQUEST DATA ROOM ACCESS ]            â”‚                â”‚
â”‚         â”‚                                                 â”‚                â”‚
â”‚         â”‚         [ SCHEDULE A CONVERSATION ]             â”‚                â”‚
â”‚         â”‚                                                 â”‚                â”‚
â”‚         â”‚         [ DOWNLOAD EXECUTIVE SUMMARY ]          â”‚                â”‚
â”‚         â”‚                                                 â”‚                â”‚
â”‚         â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                â”‚
â”‚                                                                             â”‚
â”‚                     Contact: [email / calendar link]                       â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Term Sheet Preview (Seed Round)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   INDICATIVE TERM SHEET (Subject to Negotiation)                           â”‚
â”‚                                                                             â”‚
â”‚   OFFERING TERMS                                                           â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Amount:                $5,000,000                                        â”‚
â”‚   Security:              Series Seed Preferred Stock                       â”‚
â”‚                          (or SAFE notes if pre-revenue)                    â”‚
â”‚   Pre-Money Valuation:   $15,000,000                                       â”‚
â”‚   Post-Money Valuation:  $20,000,000                                       â”‚
â”‚   Price per Share:       $X.XX (to be determined)                          â”‚
â”‚   Fully Diluted Ownership: 25% to new investors                            â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   LIQUIDATION PREFERENCE                                                   â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   1x non-participating preferred                                           â”‚
â”‚   â€¢ In an exit, investors get their $5M back first                         â”‚
â”‚   â€¢ Then convert to common and participate pro-rata                        â”‚
â”‚   â€¢ Standard investor-friendly terms                                       â”‚
â”‚                                                                             â”‚
â”‚   Example: $50M exit                                                       â”‚
â”‚   â€¢ Investors: $5M (preference) + 25% Ã— $45M = $16.25M (32.5% of proceeds)â”‚
â”‚   â€¢ Founders: 60% Ã— $45M = $27M                                            â”‚
â”‚   â€¢ ESOP: 10% Ã— $45M = $4.5M                                               â”‚
â”‚   â€¢ Future investors: 5% Ã— $45M = $2.25M                                   â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   ANTI-DILUTION PROTECTION                                                 â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Broad-based weighted average                                             â”‚
â”‚   â€¢ Protects investors if we raise at lower valuation (down round)         â”‚
â”‚   â€¢ Standard middle-ground approach                                        â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   BOARD COMPOSITION                                                        â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   3-person board initially:                                                â”‚
â”‚   â€¢ 2 Founder seats                                                        â”‚
â”‚   â€¢ 1 Investor seat (lead investor or mutually agreed)                     â”‚
â”‚                                                                             â”‚
â”‚   At Series A (expansion to 5 seats):                                      â”‚
â”‚   â€¢ 2 Founder seats                                                        â”‚
â”‚   â€¢ 2 Investor seats                                                       â”‚
â”‚   â€¢ 1 Independent seat (mutually agreed)                                   â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   PROTECTIVE PROVISIONS                                                    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Investor approval required for:                                          â”‚
â”‚   â€¢ Sale of company or majority of assets                                  â”‚
â”‚   â€¢ Liquidation or dissolution                                             â”‚
â”‚   â€¢ Amendment to charter affecting investor rights                         â”‚
â”‚   â€¢ Issuance of senior or pari passu securities                            â”‚
â”‚   â€¢ Incurring debt > $500k                                                 â”‚
â”‚   â€¢ Change in business or entering new line of business                    â”‚
â”‚                                                                             â”‚
â”‚   Note: Standard protections, not burdensome                               â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   DRAG-ALONG RIGHTS                                                        â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   If >50% of investors + board approve sale:                               â”‚
â”‚   â€¢ All shareholders required to participate                               â”‚
â”‚   â€¢ Prevents minority blocking acquisition                                 â”‚
â”‚   â€¢ Standard in all VC deals                                               â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   PRO-RATA RIGHTS                                                          â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Investors can maintain ownership % in future rounds                      â”‚
â”‚   â€¢ Major investors (>$500k): Full pro-rata                                â”‚
â”‚   â€¢ Minor investors (<$500k): Pro-rata at company discretion               â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   INFORMATION RIGHTS                                                       â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Quarterly:                                                               â”‚
â”‚   â€¢ Financial statements (P&L, balance sheet, cash flow)                   â”‚
â”‚   â€¢ Key metrics dashboard (occupancy, revenue, NPS, etc.)                  â”‚
â”‚   â€¢ Board meeting minutes                                                  â”‚
â”‚                                                                             â”‚
â”‚   Annually:                                                                â”‚
â”‚   â€¢ Audited financials (once revenue > $5M)                                â”‚
â”‚   â€¢ Annual budget and operating plan                                       â”‚
â”‚   â€¢ Cap table updates                                                      â”‚
â”‚                                                                             â”‚
â”‚   Ad Hoc:                                                                  â”‚
â”‚   â€¢ Major developments (acquisitions, key hires, crises)                   â”‚
â”‚   â€¢ Fundraising updates                                                    â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   FOUNDER VESTING                                                          â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   4-year vest, 1-year cliff                                                â”‚
â”‚   â€¢ Ensures founder commitment through critical growth phase               â”‚
â”‚   â€¢ 25% vests at 1 year, then monthly over 36 months                       â”‚
â”‚   â€¢ Acceleration: Single-trigger on acquisition (50% accelerates)          â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   EMPLOYEE OPTION POOL                                                     â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   15% fully diluted (post-seed)                                            â”‚
â”‚   â€¢ Carved out pre-investment (standard practice)                          â”‚
â”‚   â€¢ Top-up to 15% at Series A                                              â”‚
â”‚   â€¢ 10-year term, early exercise available                                 â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   EXCLUSIVITY & TIMING                                                     â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   30-day exclusivity period upon term sheet signature                      â”‚
â”‚   Target close: 45-60 days from term sheet                                 â”‚
â”‚   Conditions: Standard due diligence, legal review                         â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Investor Qualification & Fit

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   IDEAL INVESTOR PROFILE                                                   â”‚
â”‚                                                                             â”‚
â”‚   FINANCIAL REQUIREMENTS (SEC Regulation D)                                â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Must be Accredited Investor:                                             â”‚
â”‚   â€¢ Individual: $1M+ net worth (excluding primary residence)               â”‚
â”‚     OR $200k+ annual income ($300k joint) for past 2 years                 â”‚
â”‚   â€¢ Entity: $5M+ in assets                                                 â”‚
â”‚   â€¢ Licensed securities professional (Series 7, 65, 82)                    â”‚
â”‚                                                                             â”‚
â”‚   Minimum Investment: $50,000 (negotiable for strategic value)             â”‚
â”‚   Maximum per Investor: $2,000,000 (diversification)                       â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   STRATEGIC FIT (Beyond Capital)                                           â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   We seek investors who bring:                                             â”‚
â”‚                                                                             â”‚
â”‚   Category 1: Industry Expertise                                           â”‚
â”‚   â€¢ Hospitality operators (boutique luxury, not chains)                    â”‚
â”‚   â€¢ Wellness entrepreneurs (previous exits or scale)                       â”‚
â”‚   â€¢ Healthcare executives (medical credibility)                            â”‚
â”‚   â€¢ Psychedelic space operators (MAPS advisors, clinic owners)             â”‚
â”‚                                                                             â”‚
â”‚   Category 2: Distribution/Network                                         â”‚
â”‚   â€¢ Executive coaches with UHNW client base                                â”‚
â”‚   â€¢ Concierge medicine doctors (referral partners)                         â”‚
â”‚   â€¢ Family office principals (access to capital + deal flow)               â”‚
â”‚   â€¢ Wellness influencers (brand building)                                  â”‚
â”‚                                                                             â”‚
â”‚   Category 3: Operational Value                                            â”‚
â”‚   â€¢ Real estate developers (expansion expertise)                           â”‚
â”‚   â€¢ CFOs/finance leaders (systems, metrics, exit prep)                     â”‚
â”‚   â€¢ Technology executives (platform scaling)                               â”‚
â”‚   â€¢ Regulatory attorneys (compliance, government relations)                â”‚
â”‚                                                                             â”‚
â”‚   Category 4: Brand Ambassadors                                            â”‚
â”‚   â€¢ Successful entrepreneurs who've "been there"                           â”‚
â”‚   â€¢ Authors, podcasters, thought leaders                                   â”‚
â”‚   â€¢ Passionate about transformation (personal experience)                  â”‚
â”‚   â€¢ Will evangelize authentically                                          â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   INVESTORS WE'RE NOT A FIT FOR                                            â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âŒ Purely financial investors (no strategic value-add)                   â”‚
â”‚   âŒ Short-term thinkers (looking for 6-12 month flip)                     â”‚
â”‚   âŒ Risk-averse capital (uncomfortable with plant medicine regulatory)    â”‚
â”‚   âŒ Micromanagers (we need autonomy to execute)                           â”‚
â”‚   âŒ Mission misalignment (profit-only, no care for transformation)        â”‚
â”‚   âŒ Reputational risk (criminal history, ethical violations)              â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   CURRENT INVESTOR PIPELINE (Confidential)                                 â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Lead Investor Candidates (>$1M):                                         â”‚
â”‚   â€¢ [Name] - Wellness fund, $2M committed (soft circled)                   â”‚
â”‚   â€¢ [Name] - Family office, $1.5M interest                                 â”‚
â”‚   â€¢ [Name] - Hospitality entrepreneur, $1M committed                       â”‚
â”‚                                                                             â”‚
â”‚   Strategic Angels ($100k-500k):                                           â”‚
â”‚   â€¢ 8 qualified investors, $2.5M total pipeline                            â”‚
â”‚   â€¢ Mix: Wellness founders, medical professionals, UHNW individuals        â”‚
â”‚                                                                             â”‚
â”‚   Total Soft Circled: $6M+ (oversubscribed by $1M intentionally)           â”‚
â”‚   Status: Term sheet with lead expected Q1 2026                            â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Governance & Decision-Making

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   GOVERNANCE STRUCTURE                                                     â”‚
â”‚                                                                             â”‚
â”‚   BOARD OF DIRECTORS (Seed Stage: 3 seats)                                â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Founder Seats (2):                                                       â”‚
â”‚   â€¢ CEO / Founder (Chair)                                                  â”‚
â”‚   â€¢ Co-Founder or President                                                â”‚
â”‚                                                                             â”‚
â”‚   Investor Seat (1):                                                       â”‚
â”‚   â€¢ Lead investor representative                                           â”‚
â”‚   â€¢ Or mutually agreed investor if syndicate                               â”‚
â”‚                                                                             â”‚
â”‚   Meeting Frequency: Quarterly (more frequent if needed)                   â”‚
â”‚   Quorum: 2 of 3 directors                                                 â”‚
â”‚   Decisions: Majority vote (except protective provisions)                  â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   BOARD OBSERVER RIGHTS                                                    â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Available to:                                                            â”‚
â”‚   â€¢ Investors with $250k+ investment                                       â”‚
â”‚   â€¢ Strategic advisors at board discretion                                 â”‚
â”‚                                                                             â”‚
â”‚   Observers can:                                                           â”‚
â”‚   â€¢ Attend board meetings (no voting rights)                               â”‚
â”‚   â€¢ Receive board materials                                                â”‚
â”‚   â€¢ Provide input and perspective                                          â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   ADVISORY BOARD (Separate from Board of Directors)                        â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Role: Strategic counsel, not fiduciary duty                              â”‚
â”‚   Compensation: Equity (0.1-0.25%) + annual retainer                       â”‚
â”‚   Commitment: 4 meetings/year + ad hoc availability                        â”‚
â”‚                                                                             â”‚
â”‚   Domains:                                                                 â”‚
â”‚   â€¢ Medical & Clinical (protocols, safety, research)                       â”‚
â”‚   â€¢ Hospitality & Operations (guest experience, scaling)                   â”‚
â”‚   â€¢ Finance & Strategy (fundraising, M&A, exit)                            â”‚
â”‚   â€¢ Legal & Regulatory (compliance, risk mitigation)                       â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   DECISION-MAKING AUTHORITY MATRIX                                         â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   CEO / Management Team (Operational):                                     â”‚
â”‚   â€¢ Hiring (below director level)                                          â”‚
â”‚   â€¢ Vendor contracts < $100k                                               â”‚
â”‚   â€¢ Day-to-day operations                                                  â”‚
â”‚   â€¢ Marketing and brand decisions                                          â”‚
â”‚   â€¢ Property management                                                    â”‚
â”‚                                                                             â”‚
â”‚   Board Approval Required (Strategic):                                     â”‚
â”‚   â€¢ Annual budget and operating plan                                       â”‚
â”‚   â€¢ Key hires (C-suite, Medical Director)                                  â”‚
â”‚   â€¢ Major contracts > $250k                                                â”‚
â”‚   â€¢ Capital expenditures > $500k                                           â”‚
â”‚   â€¢ New location acquisitions                                              â”‚
â”‚   â€¢ Changes to business model or strategy                                  â”‚
â”‚                                                                             â”‚
â”‚   Investor Vote Required (Protective):                                     â”‚
â”‚   â€¢ Sale of company                                                        â”‚
â”‚   â€¢ New fundraising round (Series A terms)                                 â”‚
â”‚   â€¢ Issuing senior securities                                              â”‚
â”‚   â€¢ Incurring debt > $500k                                                 â”‚
â”‚   â€¢ Charter amendments                                                     â”‚
â”‚   â€¢ Dividend distributions                                                 â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   FOUNDER CONTROL & DECISION RIGHTS                                        â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Founders maintain:                                                       â”‚
â”‚   â€¢ Operational control (day-to-day)                                       â”‚
â”‚   â€¢ Board majority until Series A                                          â”‚
â”‚   â€¢ Vision and culture stewardship                                         â”‚
â”‚   â€¢ Final say on medical/clinical protocols (with MD Director)             â”‚
â”‚   â€¢ Right to hire/fire CEO (if not founder)                                â”‚
â”‚                                                                             â”‚
â”‚   Investors have:                                                          â”‚
â”‚   â€¢ Financial oversight and reporting rights                               â”‚
â”‚   â€¢ Strategic input (not control)                                          â”‚
â”‚   â€¢ Veto on major decisions (via protective provisions)                    â”‚
â”‚   â€¢ Exit participation rights                                              â”‚
â”‚                                                                             â”‚
â”‚   Philosophy: Founders operate, investors advise and protect investment    â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Investment Process Timeline

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚   SEED ROUND CLOSING PROCESS (45-60 Days)                                  â”‚
â”‚                                                                             â”‚
â”‚   WEEK 1-2: Initial Conversations                                          â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ Introductory call (30 min) - Founder + Investor                        â”‚
â”‚     Topics: Vision, opportunity, team, use of funds                        â”‚
â”‚   âœ“ Share executive summary + pitch deck                                   â”‚
â”‚   âœ“ Second call (60 min) - Deep dive on model                              â”‚
â”‚     Topics: Unit economics, expansion plan, competitive moat               â”‚
â”‚   âœ“ Decision point: Proceed to due diligence?                              â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   WEEK 3-4: Due Diligence                                                  â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ Data room access granted (password protected)                          â”‚
â”‚   âœ“ Financial model deep dive (CFO + Investor analyst)                     â”‚
â”‚   âœ“ Market research review                                                 â”‚
â”‚   âœ“ Reference checks (if applicable)                                       â”‚
â”‚   âœ“ Legal entity review (corporate counsel)                                â”‚
â”‚   âœ“ Site visit to Mexico (optional but recommended)                        â”‚
â”‚   âœ“ Meet Medical Director candidate (if identified)                        â”‚
â”‚                                                                             â”‚
â”‚   Questions addressed:                                                     â”‚
â”‚   â€¢ Regulatory: Is ibogaine really legal? What's the risk?                 â”‚
â”‚   â€¢ Financial: Are projections realistic?                                  â”‚
â”‚   â€¢ Team: Can these founders execute?                                      â”‚
â”‚   â€¢ Market: Is $1T market size real?                                       â”‚
â”‚   â€¢ Exit: Who would acquire this?                                          â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   WEEK 5: Term Sheet Negotiation                                           â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ Investor proposes valuation and terms                                  â”‚
â”‚   âœ“ Founder reviews with legal counsel                                     â”‚
â”‚   âœ“ Negotiation on key points:                                             â”‚
â”‚     - Valuation ($15M pre suggested, negotiable $12-18M range)             â”‚
â”‚     - Liquidation preference (1x non-participating standard)               â”‚
â”‚     - Board seats (2 founder, 1 investor standard)                         â”‚
â”‚     - Protective provisions (standard list)                                â”‚
â”‚     - Option pool size (15% standard)                                      â”‚
â”‚   âœ“ Term sheet signed (non-binding except exclusivity)                     â”‚
â”‚   âœ“ 30-day exclusivity period begins                                       â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   WEEK 6-8: Legal Documentation                                            â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ Investor counsel drafts definitive agreements:                         â”‚
â”‚     - Stock Purchase Agreement                                             â”‚
â”‚     - Investor Rights Agreement                                            â”‚
â”‚     - Right of First Refusal & Co-Sale Agreement                           â”‚
â”‚     - Voting Agreement                                                     â”‚
â”‚     - Amended & Restated Certificate of Incorporation                      â”‚
â”‚   âœ“ Company counsel reviews and negotiates                                 â”‚
â”‚   âœ“ Back-and-forth on specific language (1-2 weeks)                        â”‚
â”‚   âœ“ Final documents circulated for signature                               â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   WEEK 9: Closing                                                          â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ All documents signed (DocuSign)                                        â”‚
â”‚   âœ“ Wire transfer executed ($5M â†’ company bank account)                    â”‚
â”‚   âœ“ Stock certificates issued to investors                                 â”‚
â”‚   âœ“ Cap table updated (Carta or equivalent)                                â”‚
â”‚   âœ“ Board resolutions filed                                                â”‚
â”‚   âœ“ Press release (if mutually agreed)                                     â”‚
â”‚   âœ“ Investor welcome packet sent                                           â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   POST-CLOSING: Onboarding                                                 â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   âœ“ First board meeting scheduled (within 30 days)                         â”‚
â”‚   âœ“ Quarterly reporting cadence established                                â”‚
â”‚   âœ“ Investor introductions to advisors/partners                            â”‚
â”‚   âœ“ Add investor to company Slack/communication channels                   â”‚
â”‚   âœ“ Celebrate! ğŸ‰                                                          â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   COSTS & FEES                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Company Legal Fees:     $40-80k (Gunderson Dettmer or equivalent)        â”‚
â”‚   Investor Legal Fees:    Investor pays (typically $15-30k)                â”‚
â”‚   Due Diligence Costs:    $5-10k (audits, background checks)               â”‚
â”‚   State Filing Fees:      $500-1,000                                       â”‚
â”‚   Cap Table Management:   $2k/year (Carta)                                 â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚   Total Transaction Cost: $50-100k (included in use of funds)              â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

#### Contact & Next Steps

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                             â”‚
â”‚                         LET'S START A CONVERSATION                          â”‚
â”‚                                                                             â”‚
â”‚   We're seeking partners, not just capital.                                â”‚
â”‚   If you're aligned with our mission and can add strategic value,          â”‚
â”‚   we'd love to explore working together.                                   â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   FOUNDER CONTACT                                                          â”‚
â”‚   [Name], Founder & CEO                                                    â”‚
â”‚   Email: [email@transformationalepicenter.com]                             â”‚
â”‚   Phone: [+1-XXX-XXX-XXXX]                                                 â”‚
â”‚   Calendar: [calendly.com/te-founder]                                      â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   IMMEDIATE NEXT STEPS                                                     â”‚
â”‚                                                                             â”‚
â”‚   1. REQUEST DATA ROOM ACCESS                                              â”‚
â”‚      â†’ Email with subject: "DATA ROOM REQUEST"                             â”‚
â”‚      â†’ Receive password within 24 hours                                    â”‚
â”‚      â†’ Full financial model, research, legal docs available                â”‚
â”‚                                                                             â”‚
â”‚   2. SCHEDULE INTRO CALL (30 MIN)                                          â”‚
â”‚      â†’ Use calendar link above                                             â”‚
â”‚      â†’ We'll walk through opportunity and answer questions                 â”‚
â”‚      â†’ Zero pressure, exploratory conversation                             â”‚
â”‚                                                                             â”‚
â”‚   3. DOWNLOAD EXECUTIVE SUMMARY                                            â”‚
â”‚      â†’ 2-page overview for quick evaluation                                â”‚
â”‚      â†’ Shareable with co-investors (with permission)                       â”‚
â”‚                                                                             â”‚
â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                             â”‚
â”‚   "The best time to plant a tree was 20 years ago.                         â”‚
â”‚    The second best time is now."                                           â”‚
â”‚                                                                             â”‚
â”‚   This is the moment to build the world's first integrated                 â”‚
â”‚   transformation platform. Join us.                                        â”‚
â”‚                                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## Section 10: Property Cut Sheet Specification

Each property gets a dedicated page with comprehensive details:

### Cut Sheet Sections

**A. Hero**
- Property name, location badge, status
- Key metrics: Price | Rooms | Score | IRR
- Hero image gallery (full-width)

**B. Property Overview**
- Address, GPS, interactive map
- Lot size, built area, year built
- Current use, property description

**C. Pass/Fail Gates (Visual Checklist)**
```
âœ… JCI Hospital Access     â€” 70 min to Galenia (CancÃºn)
âœ… Commercial Zoning       â€” Verified operational
âœ… Utilities Available     â€” Full infrastructure
âš ï¸ Airport Access          â€” 2 hours from CUN
âœ… Privacy & Security      â€” Gated, private beach
âœ… Natural Environment     â€” Direct ocean access
âš ï¸ Existing Structures     â€” Full renovation required
âœ… Legal Status            â€” Clear title
âš ï¸ Price Alignment         â€” Above comparable market
```

**D. Scoring Breakdown (Radar Chart + Table)**
10 categories with scores, percentages, and notes

**E. Financial Summary Cards**
- Total Project Cost (acquisition + renovation + soft costs)
- 5-Year IRR (with Conservative/Base/Aggressive toggle)
- Cost per Room
- Break-even Analysis

**F. Revenue Projections (Line Chart)**
5-year trajectory with scenario overlay

**G. Operating Economics (Donut Charts)**
- Revenue by program type
- Fixed vs variable costs
- Expense breakdown

**H. Strengths (Bulleted with icons)**

**I. Concerns (Bulleted with severity indicators)**

**J. Open Questions (Due diligence items)**

**K. Verdict Section**
- Status badge (SHORTLIST / HOLD / PASS)
- Recommendation summary
- Next steps checklist

**L. Downloads**
- PDF Cut Sheet
- Financial Model (CSV/Excel)
- Property Evaluation (Markdown)

---

## Technical Implementation

### Technology Stack

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                             FRONTEND                                        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  Next.js 14 (App Router) + TypeScript                                      â”‚
â”‚  â”œâ”€â”€ Tailwind CSS + shadcn/ui (components)                                 â”‚
â”‚  â”œâ”€â”€ Framer Motion (animations, scroll effects, reveals)                   â”‚
â”‚  â”œâ”€â”€ Recharts (financial visualizations)                                   â”‚
â”‚  â”œâ”€â”€ React-Globe.gl or Globe.gl (3D world map)                            â”‚
â”‚  â”œâ”€â”€ Mapbox GL (property location maps)                                    â”‚
â”‚  â””â”€â”€ React-PDF (cut sheet generation)                                      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                                    â”‚
                                    â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                             DATA LAYER                                      â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  Content Collections (type-safe content management)                         â”‚
â”‚  â”œâ”€â”€ /content/properties/*.json (4 properties â†’ 30+ over time)            â”‚
â”‚  â”œâ”€â”€ /content/locations/*.json (30 global locations)                       â”‚
â”‚  â”œâ”€â”€ /content/financials/*.json (financial model exports)                  â”‚
â”‚  â”œâ”€â”€ /content/competitors/*.json (competitive data)                        â”‚
â”‚  â””â”€â”€ Static generation at build time (fast, cacheable)                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                                    â”‚
                                    â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                            DEPLOYMENT                                       â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  Vercel                                                                     â”‚
â”‚  â”œâ”€â”€ Edge caching globally                                                 â”‚
â”‚  â”œâ”€â”€ Preview deployments for review                                        â”‚
â”‚  â”œâ”€â”€ Password protection (investor access)                                 â”‚
â”‚  â””â”€â”€ Analytics (engagement tracking)                                       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### File Structure

```
/transformational-epicenter-web/
â”œâ”€â”€ app/
â”‚   â”œâ”€â”€ layout.tsx                      # Global layout + nav
â”‚   â”œâ”€â”€ page.tsx                        # 1. Vision / Hero section
â”‚   â”œâ”€â”€ market/
â”‚   â”‚   â””â”€â”€ page.tsx                    # 2. Market opportunity
â”‚   â”œâ”€â”€ model/
â”‚   â”‚   â””â”€â”€ page.tsx                    # 3. The 8 segments, guest journey
â”‚   â”œâ”€â”€ expansion/
â”‚   â”‚   â””â”€â”€ page.tsx                    # 4. 30 locations, global map
â”‚   â”œâ”€â”€ properties/
â”‚   â”‚   â”œâ”€â”€ page.tsx                    # 5. Mexico portfolio overview
â”‚   â”‚   â””â”€â”€ [slug]/
â”‚   â”‚       â””â”€â”€ page.tsx                # Individual cut sheets
â”‚   â”œâ”€â”€ financials/
â”‚   â”‚   â””â”€â”€ page.tsx                    # 6. Financial deep dive
â”‚   â”œâ”€â”€ team/
â”‚   â”‚   â””â”€â”€ page.tsx                    # 7. Team & leadership
â”‚   â”œâ”€â”€ risks/
â”‚   â”‚   â””â”€â”€ page.tsx                    # 8. Risk analysis & mitigation
â”‚   â”œâ”€â”€ moat/
â”‚   â”‚   â””â”€â”€ page.tsx                    # 9. Competitive analysis
â”‚   â”œâ”€â”€ returns/
â”‚   â”‚   â””â”€â”€ page.tsx                    # 10. Exit strategy & returns
â”‚   â”œâ”€â”€ timeline/
â”‚   â”‚   â””â”€â”€ page.tsx                    # 11. Milestones & roadmap
â”‚   â”œâ”€â”€ legal/
â”‚   â”‚   â””â”€â”€ page.tsx                    # 12. Legal & compliance
â”‚   â”œâ”€â”€ outcomes/
â”‚   â”‚   â””â”€â”€ page.tsx                    # 13. Outcome measurement
â”‚   â”œâ”€â”€ data-room/
â”‚   â”‚   â””â”€â”€ page.tsx                    # 14. Due diligence materials
â”‚   â”œâ”€â”€ faq/
â”‚   â”‚   â””â”€â”€ page.tsx                    # 15. Investor FAQ
â”‚   â””â”€â”€ invest/
â”‚       â””â”€â”€ page.tsx                    # 16. The ask, CTA
â”‚
â”œâ”€â”€ components/
â”‚   â”œâ”€â”€ ui/                             # shadcn components
â”‚   â”œâ”€â”€ layout/
â”‚   â”‚   â”œâ”€â”€ Header.tsx                  # Navigation + progress
â”‚   â”‚   â”œâ”€â”€ Footer.tsx
â”‚   â”‚   â””â”€â”€ ScrollProgress.tsx         # Visual scroll indicator
â”‚   â”œâ”€â”€ hero/
â”‚   â”‚   â”œâ”€â”€ VideoHero.tsx              # Cinematic opening
â”‚   â”‚   â”œâ”€â”€ ProblemStatement.tsx       # Animated problem reveal
â”‚   â”‚   â””â”€â”€ SolutionReveal.tsx         # The four pillars
â”‚   â”œâ”€â”€ market/
â”‚   â”‚   â”œâ”€â”€ MarketSize.tsx             # $5.6T visualization
â”‚   â”‚   â”œâ”€â”€ FourMarkets.tsx            # Interactive segments
â”‚   â”‚   â”œâ”€â”€ CustomerProfile.tsx        # The guest persona
â”‚   â”‚   â””â”€â”€ CompetitorGrid.tsx         # Why they can't copy
â”‚   â”œâ”€â”€ model/
â”‚   â”‚   â”œâ”€â”€ EightSegments.tsx          # Interactive wheel
â”‚   â”‚   â”œâ”€â”€ GuestJourney.tsx           # Timeline animation
â”‚   â”‚   â””â”€â”€ ProgramCards.tsx           # Pricing display
â”‚   â”œâ”€â”€ expansion/
â”‚   â”‚   â”œâ”€â”€ GlobalMap.tsx              # 3D rotating globe
â”‚   â”‚   â”œâ”€â”€ LocationTiers.tsx          # Tiered location list
â”‚   â”‚   â””â”€â”€ ExpansionTimeline.tsx      # Roadmap visualization
â”‚   â”œâ”€â”€ properties/
â”‚   â”‚   â”œâ”€â”€ PropertyGrid.tsx           # Portfolio overview
â”‚   â”‚   â”œâ”€â”€ PropertyCard.tsx           # Summary card
â”‚   â”‚   â”œâ”€â”€ ComparisonMatrix.tsx       # Side-by-side table
â”‚   â”‚   â”œâ”€â”€ PassFailGates.tsx          # Checklist visual
â”‚   â”‚   â”œâ”€â”€ ScoringRadar.tsx           # Radar chart
â”‚   â”‚   â”œâ”€â”€ FinancialCards.tsx         # Key metrics
â”‚   â”‚   â”œâ”€â”€ RevenueChart.tsx           # Projections
â”‚   â”‚   â”œâ”€â”€ OperatingDonut.tsx         # Economics breakdown
â”‚   â”‚   â””â”€â”€ VerdictSection.tsx         # Recommendation
â”‚   â”œâ”€â”€ financials/
â”‚   â”‚   â”œâ”€â”€ MetricsHero.tsx            # Key numbers
â”‚   â”‚   â”œâ”€â”€ RevenueTrajectory.tsx      # 5-year chart
â”‚   â”‚   â”œâ”€â”€ UnitEconomics.tsx          # Per-guest breakdown
â”‚   â”‚   â””â”€â”€ ScenarioToggle.tsx         # Con/Base/Agg switch
â”‚   â”œâ”€â”€ risks/
â”‚   â”‚   â”œâ”€â”€ RiskMatrix.tsx             # Interactive risk cards
â”‚   â”‚   â””â”€â”€ MitigationStrategies.tsx   # Mitigation details
â”‚   â”œâ”€â”€ moat/
â”‚   â”‚   â”œâ”€â”€ FiveMoats.tsx              # Defensive layers
â”‚   â”‚   â””â”€â”€ CompetitorComparison.tsx   # 4-pillar matrix
â”‚   â”œâ”€â”€ returns/
â”‚   â”‚   â”œâ”€â”€ ExitPathways.tsx           # Return pathway visualization
â”‚   â”‚   â”œâ”€â”€ ComparableExits.tsx        # Industry exit comps
â”‚   â”‚   â””â”€â”€ ProjectedReturns.tsx       # IRR/MOIC display
â”‚   â”œâ”€â”€ timeline/
â”‚   â”‚   â”œâ”€â”€ GanttRoadmap.tsx           # 24-month Gantt chart
â”‚   â”‚   â”œâ”€â”€ MilestoneCards.tsx         # Key milestone highlights
â”‚   â”‚   â””â”€â”€ KPIDashboard.tsx           # Success metrics tracker
â”‚   â”œâ”€â”€ legal/
â”‚   â”‚   â”œâ”€â”€ CorporateStructure.tsx     # Org chart visualization
â”‚   â”‚   â”œâ”€â”€ RegulatoryFramework.tsx    # Compliance checklist
â”‚   â”‚   â””â”€â”€ InsuranceCoverage.tsx      # Insurance summary
â”‚   â”œâ”€â”€ outcomes/
â”‚   â”‚   â”œâ”€â”€ ClinicalScales.tsx         # PCL-5, PHQ-9, GAD-7 explainer
â”‚   â”‚   â”œâ”€â”€ BiometricTracking.tsx      # HRV and biometrics
â”‚   â”‚   â””â”€â”€ MeasurementTimeline.tsx    # 8 measurement points
â”‚   â”œâ”€â”€ dataroom/
â”‚   â”‚   â”œâ”€â”€ DataRoomNav.tsx            # Folder navigation
â”‚   â”‚   â””â”€â”€ DocumentList.tsx           # Document previews
â”‚   â”œâ”€â”€ faq/
â”‚   â”‚   â”œâ”€â”€ FAQAccordion.tsx           # Expandable Q&A
â”‚   â”‚   â””â”€â”€ QuestionCategories.tsx     # Category filters
â”‚   â””â”€â”€ invest/
â”‚       â”œâ”€â”€ TheAsk.tsx                 # $5M breakdown
â”‚       â”œâ”€â”€ InvestmentThesis.tsx       # 6 reasons
â”‚       â””â”€â”€ CTASection.tsx             # Contact/access buttons
â”‚
â”œâ”€â”€ content/
â”‚   â”œâ”€â”€ properties/
â”‚   â”‚   â”œâ”€â”€ _template.json             # New property template
â”‚   â”‚   â”œâ”€â”€ hacienda-caracol.json
â”‚   â”‚   â”œâ”€â”€ hotel-alea-tulum.json
â”‚   â”‚   â”œâ”€â”€ casa-sueno-de-mar.json
â”‚   â”‚   â””â”€â”€ mini-hotel-cancun.json
â”‚   â”œâ”€â”€ locations/
â”‚   â”‚   â”œâ”€â”€ _template.json             # New location template
â”‚   â”‚   â”œâ”€â”€ mexico-quintana-roo.json
â”‚   â”‚   â”œâ”€â”€ portugal-alentejo.json
â”‚   â”‚   â”œâ”€â”€ south-africa-cape-town.json
â”‚   â”‚   â””â”€â”€ ... (30 locations)
â”‚   â”œâ”€â”€ competitors/
â”‚   â”‚   â”œâ”€â”€ clinique-la-prairie.json
â”‚   â”‚   â”œâ”€â”€ sha-wellness.json
â”‚   â”‚   â””â”€â”€ ...
â”‚   â””â”€â”€ team/
â”‚       â””â”€â”€ members.json
â”‚
â”œâ”€â”€ lib/
â”‚   â”œâ”€â”€ types.ts                       # TypeScript interfaces
â”‚   â”œâ”€â”€ properties.ts                  # Property data utilities
â”‚   â”œâ”€â”€ locations.ts                   # Location data utilities
â”‚   â”œâ”€â”€ financials.ts                  # Financial calculations
â”‚   â””â”€â”€ content.ts                     # Content loading
â”‚
â”œâ”€â”€ public/
â”‚   â”œâ”€â”€ videos/                        # Hero video assets
â”‚   â”œâ”€â”€ properties/                    # Property images
â”‚   â”‚   â”œâ”€â”€ hacienda-caracol/
â”‚   â”‚   â”œâ”€â”€ hotel-alea-tulum/
â”‚   â”‚   â””â”€â”€ ...
â”‚   â”œâ”€â”€ locations/                     # Location images
â”‚   â”œâ”€â”€ team/                          # Team photos
â”‚   â””â”€â”€ brand/                         # Logos, icons
â”‚
â”œâ”€â”€ styles/
â”‚   â””â”€â”€ globals.css                    # Tailwind + custom styles
â”‚
â””â”€â”€ package.json
```

---

## Data Schemas

### Property Schema
```typescript
interface Property {
  // Identity
  id: string;
  slug: string;
  name: string;
  tagline: string;
  region: string;                       // e.g., "Quintana Roo, Mexico"

  // Location
  location: {
    address: string;
    city: string;
    state: string;
    country: string;
    coordinates: { lat: number; lng: number };
    distanceFromAirport: string;
    distanceFromJCIHospital: string;
    hospitalName: string;
  };

  // Property Details
  details: {
    askingPrice: number;
    lotSize: string;
    builtArea: string;
    bedrooms: number;
    bathrooms: number;
    yearBuilt: number;
    currentUse: string;
    description: string;
  };

  // Media
  media: {
    heroImage: string;
    gallery: string[];
    virtualTour?: string;
  };

  // Evaluation
  evaluation: {
    totalScore: number;
    maxScore: number;
    passFailGates: {
      name: string;
      status: 'PASS' | 'FAIL' | 'CONDITIONAL';
      notes: string;
    }[];
    categoryScores: {
      category: string;
      score: number;
      maxScore: number;
      notes: string;
    }[];
    strengths: string[];
    concerns: string[];
    openQuestions: string[];
  };

  // Financials
  financials: {
    totalProjectCost: number;
    acquisitionCost: number;
    renovationCost: number;
    softCosts: number;
    costPerRoom: number;
    projections: {
      conservative: ScenarioData;
      base: ScenarioData;
      aggressive: ScenarioData;
    };
    unitEconomics: {
      averageRevenuePerGuest: number;
      cac: number;
      ltv: number;
      paybackMonths: number;
      breakEvenOccupancy: number;
    };
  };

  // Status
  status: 'SHORTLIST' | 'HOLD' | 'PASS';
  statusReason: string;
  recommendation: string;
  nextSteps: string[];

  // Metadata
  lastUpdated: string;
  evaluatedBy: string;
}

interface ScenarioData {
  irr: number;
  npv: number;
  roi: number;
  moic: number;
  revenueByYear: number[];
  ebitdaByYear: number[];
  occupancyByYear: number[];
}
```

### Global Location Schema
```typescript
interface GlobalLocation {
  id: string;
  slug: string;
  name: string;                          // e.g., "Quintana Roo, Mexico"
  country: string;
  countryCode: string;                   // e.g., "MX"
  region: string;                        // e.g., "Americas"
  coordinates: { lat: number; lng: number };

  // Tier & Status
  tier: 1 | 2 | 3 | 4;
  score: number;
  status: 'ACTIVE' | 'PLANNED' | 'RESEARCHING' | 'FUTURE';
  targetYear: number;

  // Regulatory
  regulatory: {
    ibogaineLegal: boolean;
    psilocybinLegal: boolean;
    ayahuascaLegal: boolean;
    notes: string;
  };

  // Strategic
  strategic: {
    targetMarket: string;                // e.g., "US East Coast, Latin America"
    uniqueAdvantage: string;
    challenges: string[];
  };

  // Properties (if any are being evaluated)
  properties?: string[];                 // Property IDs

  // Media
  heroImage: string;
  description: string;
}
```

---

## Adding New Content

### Adding a New Property (< 30 minutes)
1. Copy `/content/properties/_template.json`
2. Fill in property data from evaluation
3. Add images to `/public/properties/[slug]/`
4. Push to git â†’ auto-deploys

### Adding a New Global Location (< 15 minutes)
1. Copy `/content/locations/_template.json`
2. Fill in location data
3. Add hero image
4. Push to git â†’ auto-deploys

---

## Animation & Experience

### Scroll-Based Reveals
- Sections fade/slide in as user scrolls
- Numbers count up when entering viewport
- Charts animate on first view

### Micro-Interactions
- Cards lift on hover
- Status badges pulse subtly
- Charts respond to mouse position

### Page Transitions
- Smooth transitions between sections
- Progress indicator shows position in story

### Globe Interaction
- 3D globe rotates slowly by default
- Spins to location on click
- Markers pulse and expand on hover

---

## Implementation Phases

### Phase 1: Foundation (Week 1)
- [ ] Initialize Next.js 14 project with TypeScript
- [ ] Set up Tailwind CSS + shadcn/ui component library
- [ ] Create comprehensive type definitions for all data
- [ ] Build responsive navigation with progress indicator
- [ ] Set up content loading system from JSON
- [ ] Implement password protection middleware
- [ ] Configure Vercel deployment pipeline

### Phase 2: Vision & Market (Week 2)
- [ ] Build cinematic hero section with video background
- [ ] Create parallax problem statement animation
- [ ] Build interactive "failed solutions" cards
- [ ] Create solution reveal sequence (4 pillars)
- [ ] Build $5.6T market size visualization
- [ ] Create four markets gap analysis
- [ ] Build customer profile persona section
- [ ] Create "why competitors can't copy" grid

### Phase 3: Model & Journey (Week 3)
- [ ] Build 8 segments interactive wheel diagram
- [ ] Create detailed segment expansion modals
- [ ] Build guest journey animated timeline
- [ ] Create program pricing cards with hover effects
- [ ] Add "what's included" checklist visualization

### Phase 4: Global Expansion (Week 4)
- [ ] Implement 3D rotating globe with react-globe.gl
- [ ] Create clickable location markers with popups
- [ ] Build location tier cards (Tier 1-4)
- [ ] Create expansion timeline roadmap
- [ ] Add regulatory landscape overlay/legend

### Phase 5: Properties (Week 5)
- [ ] Sync property data from JSON (Google Sheets source)
- [ ] Build portfolio overview grid (4 property cards)
- [ ] Create interactive comparison matrix table
- [ ] Build individual cut sheet template with all sections
- [ ] Implement radar chart for scoring visualization
- [ ] Create financial projection charts (Recharts)
- [ ] Add PDF export functionality (react-pdf)

### Phase 6: Financials & Team (Week 6)
- [ ] Build financial metrics hero section
- [ ] Create revenue trajectory charts with scenario toggle
- [ ] Build unit economics breakdown visualization
- [ ] Create investment strategy comparison (single vs dual)
- [ ] Build team section with bios and photos
- [ ] Create advisory board placeholder section

### Phase 7: Risk, Moat & Returns (Week 7)
- [ ] Build risk matrix with interactive cards
- [ ] Create mitigation strategy reveals
- [ ] Build 5 moats visualization
- [ ] Create competitor comparison matrix
- [ ] Build exit pathway timeline
- [ ] Create projected returns calculator

### Phase 8: Timeline, Legal & Outcomes (Week 8)
- [ ] Build 24-month Gantt chart roadmap
- [ ] Create milestone cards with status indicators
- [ ] Build KPI dashboard with tracking
- [ ] Create corporate structure org chart
- [ ] Build regulatory compliance checklist
- [ ] Create clinical scales explainer cards
- [ ] Build measurement timeline visualization

### Phase 9: Data Room, FAQ & Invest (Week 9)
- [ ] Build data room navigation structure
- [ ] Create document preview cards
- [ ] Implement download tracking
- [ ] Build FAQ accordion with search
- [ ] Create investment ask visualization
- [ ] Build CTA section with meeting scheduler
- [ ] Implement contact form integration

### Phase 10: Polish & Launch (Week 10)
- [ ] Add all Framer Motion animations and transitions
- [ ] Implement scroll-based reveals throughout
- [ ] Optimize for Lighthouse score 90+
- [ ] Mobile responsive refinement (all breakpoints)
- [ ] Cross-browser testing (Chrome, Safari, Firefox, Edge)
- [ ] Accessibility audit and fixes (WCAG 2.1)
- [ ] Set up analytics and engagement tracking
- [ ] Configure custom domain (invest.transformationalepicenter.com)
- [ ] Final QA across all 16 sections
- [ ] Soft launch to founding team for review
- [ ] Full launch to investor network

---

## Success Criteria

### Performance
- First Contentful Paint: < 1.5s
- Lighthouse Score: 90+ (Performance, Accessibility, Best Practices, SEO)
- Time to Interactive: < 3s
- Core Web Vitals: All green

### Experience
- "Wow" reaction in first 10 seconds (hero + video)
- Clear story flow from vision to investment (16 sections)
- Easy navigation between sections (progress indicator)
- Mobile experience is excellent (touch-optimized)
- Zero confusion about what we do or why it matters

### Investor-Ready Checklist
- [ ] All 16 sections complete and polished
- [ ] All 4 properties display with full financials
- [ ] All 30 global locations on interactive map
- [ ] All charts render accurately with real data
- [ ] PDF export works for cut sheets
- [ ] Password protection functional
- [ ] Data room access request form working
- [ ] Meeting scheduler integrated
- [ ] Contact form submits successfully
- [ ] Analytics tracking all engagement

### Content Completeness
- [ ] Vision clearly articulated with emotional hook
- [ ] Market opportunity backed by research ($5.6T)
- [ ] All 8 operational segments explained
- [ ] Guest journey clear from pre-care to post-care
- [ ] All 4 Mexico properties with full financial data
- [ ] All 30 expansion locations with regulatory status
- [ ] 5-year financials with 3 scenarios
- [ ] Team section with bios and photos
- [ ] All 5 risks identified with mitigations
- [ ] 5 competitive moats explained
- [ ] Exit strategy with comparable exits
- [ ] 24-month roadmap with milestones
- [ ] Legal structure and compliance documented
- [ ] Outcome measurement framework explained
- [ ] Data room contents listed
- [ ] 10+ FAQ questions answered
- [ ] Clear investment ask with use of funds

### Scalability
- Add new property in < 30 minutes
- Add new location in < 15 minutes
- Content updates deploy instantly via git
- No code changes required for content updates

---

## Data Source: Google Sheets Financial Model

### Source of Truth
The master financial model is maintained in Google Sheets and serves as the single source of truth for all property financial data.

**Spreadsheet:** MULTI UNIT - FINANCIAL MODEL DASHBOARD
**ID:** `1Z0_N_V2gM-0rpW3IP9oRO12nmj51XwcTV_9R9fNsyWo`
**URL:** https://docs.google.com/spreadsheets/d/1Z0_N_V2gM-0rpW3IP9oRO12nmj51XwcTV_9R9fNsyWo

### Sheets Structure (11 Tabs)
| Sheet | Purpose |
|-------|---------|
| **Dashboard** | Executive summary, property selector, key metrics |
| **Assumptions** | 100+ editable parameters per property |
| **Acquisition Costs** | Purchase price, closing costs, fees |
| **Revenue Model** | 5-year projections by scenario |
| **Operating Expenses** | Fixed & variable cost structure |
| **P&L Statement** | Full profit & loss projections |
| **Cash Flow** | Cash flow analysis & ending balances |
| **Unit Economics** | Per-guest CAC, LTV, contribution margin |
| **Sensitivity** | Scenario analysis & risk factors |
| **Investment Returns** | IRR, MOIC, NPV, exit valuations |
| **Property Data** | Multi-property lookup table (all 4 properties) |

### Synced Data File
A structured JSON export of the spreadsheet data is maintained at:
```
/docs/web-platform/data/properties-financial-data.json
```

This file should be re-synced whenever the spreadsheet is updated.

### Corrected Financial Metrics (from Spreadsheet)

| Property | Metric | Previous | Corrected |
|----------|--------|----------|-----------|
| **Hotel Alea Tulum** | Total Project Cost | $19.0M | $19,036,750 |
| | Cost Per Room | $928K | $906,512 |
| | IRR (Base) | 28.51% | 29.54% |
| | Y5 Revenue | $15.1M | $15,303,003 |
| | 5-Year Revenue | â€” | $62,109,066 |
| | Y5 EBITDA | â€” | $6,014,560 |
| | EBITDA Margin Y5 | â€” | 39% |
| | Gross Margin | â€” | 72% avg |
| **Hacienda Caracol** | Daily Rate | $2,000 | $3,157 (1.36x UHNW) |
| | Avg Revenue/Guest | ~$30K | $53,669 |
| | Target Market | HNW | U-HNW Individuals |
| **Mini Hotel CancÃºn** | IRR | -20% | Model confirms non-viable |
| **Casa SueÃ±o de Mar** | IRR | 1.13% | Disqualified (zoning) |

### Key Data Points Now Available

**Per-Guest Unit Economics (Hotel Alea):**
- Total Revenue per Guest: $48,138 (with add-ons)
- Direct Cost per Guest: $12,600
- Gross Profit per Guest: $35,538
- Contribution Margin: $33,932 (70%)
- Blended CAC: $2,613
- Break-even Occupancy: 42%

**5-Year Revenue by Scenario (Hotel Alea):**
| Scenario | Y1 | Y3 | Y5 | 5-Yr Total |
|----------|----|----|----|----|
| Conservative | $5.9M | $11.3M | $13.1M | $51.8M |
| Base | $7.6M | $13.4M | $15.3M | $62.1M |
| Aggressive | $9.6M | $14.8M | $16.3M | $69.6M |

**Investment Returns (Hotel Alea):**
| Scenario | IRR | MOIC | Enterprise Value |
|----------|-----|------|------------------|
| Conservative | 22.79% | 1.76x | $31.6M |
| Base | 29.54% | 2.61x | $45.5M |
| Aggressive | 36.00% | 3.55x | $62.0M |

---

## Appendix: Content Migration

### From Existing Docs
| Source | Destination | Notes |
|--------|-------------|-------|
| **Google Sheets Model** | `/content/properties/*.json` | **PRIMARY SOURCE** |
| `/docs/quintana-roo/properties/*.md` | `/content/properties/*.json` | Qualitative data (strengths, concerns) |
| `/docs/pitch-packet/*` | Various sections | Extract copy and data |
| `/docs/research/expansion/*` | `/content/locations/*.json` | 30 global locations |
| `/docs/research/competitors/*` | `/content/competitors/*.json` | Competitive data |

### Sync Process
1. Update Google Sheets model with new data
2. Run sync script to export to JSON
3. Commit and push changes
4. Platform auto-rebuilds with new data

---

---

## Document Summary

This technical plan specifies a **16-section investor platform** designed to leave zero unanswered questions. Every concern an investor might have is proactively addressed:

| Section | Purpose | Key Question Answered |
|---------|---------|----------------------|
| 1. Vision | Hook & Mission | "What is this?" |
| 2. Market | Opportunity Size | "How big is the market?" |
| 3. Model | How It Works | "How do you make money?" |
| 4. Expansion | Growth Path | "How does this scale?" |
| 5. Properties | First Assets | "Where exactly?" |
| 6. Financials | The Numbers | "What are the returns?" |
| 7. Team | The People | "Who's building this?" |
| 8. Risks | Honest Assessment | "What could go wrong?" |
| 9. Moat | Defensibility | "Why can't others copy?" |
| 10. Exit | Liquidity Path | "How do I get my money back?" |
| 11. Timeline | Execution Plan | "When will milestones hit?" |
| 12. Legal | Structure & Compliance | "Is this legal and structured right?" |
| 13. Outcomes | Proof It Works | "How do you prove transformation?" |
| 14. Data Room | Due Diligence | "Where's the backup?" |
| 15. FAQ | All Other Questions | "What about...?" |
| 16. Invest | The Ask | "How do I participate?" |

**The goal: When an investor finishes exploring this platform, their only question is "Where do I sign?"**

---

*Document Version: 3.0*
*Created: January 2025*
*Updated: January 2026*
*Major Updates:*
- *v2.0: Added 9-section platform structure*
- *v2.1: Synced with Google Sheets financial model*
- *v3.0: Expanded to 16 sections for complete investor coverage (Risk, Exit, Timeline, Legal, Outcomes, Data Room, FAQ)*

*Vision: The definitive pitch experience for Transformational Epicenter â€” zero unanswered questions*
